- Primary & Secondary Antibodies - Technical Resources
- Phosphospecific Antibodies
- Anti-GFP Antibodies
- ABfinity™ Recombinant Monoclonal Antibody Technology
- Antibodies For Transcription Factors
- Secondary Detection and Signal Amplification
- Antibodies for Neuroscience
- Antibodies for Cytokines, Chemokines & Growth Factors
- Cell Junction Antibody References
- Polyclonal ZO-1 Antibodies
- Antibodies-and-Secondary-Detection
-
Cell Junction Antibody References
 |
High quality Invitrogen cell junction antibodies from Invitrogen produce highly specific identification of target proteins. You'll detect only the junction protein you want, not all of those in the surrounding vicinity. In fact, Invitrogen antibodies are widely used and cited in the literature, demonstrating their reliability in a variety of different applications. See below for a select list of publications referencing our cell junction antibodies. View references for these product types: |
| Cat # | Product | Authors | Journal | Volume | Page(s) | Year | Application(s) |
|---|---|---|---|---|---|---|---|
| Adherens Junction Antibody Product References | |||||||
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hoover KB, et al. | Am J Pathol | 153(6) | 1767-1773 | 1998 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Auersperg N, et al. | PNAS | 96 | 6249-6254 | 1999 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Day ML, et al. | J Biol Chem | 274(14) | 9656-9664 | 1999 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Corn PG, et al. | Clin Cancer Res | 6 | 4243-4248 | 2000 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gottardi CJ, et al. | J Cell Biol | 153(5) | 1049-1059 | 2000 | WB, IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hazan RB, et al. | J Cell Biol | 148(4) | 779-790 | 2000 | WB, IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Heimann R, et al. | Cancer Res | 60 | 298-304 | 2000 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hsu M, et al. | J Cell Sci | 113 | 1535-1542 | 2000 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Acs G, et al. | Arch Pathol Lab Med | 125 | 198-201 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Adam L, et al. | J Biol Chem | 276(30) | 28443-28450 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gallicano GI, et al. | Development | 128 | 929-941 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gregoire L, et al. | Clin Cancer Res | 7 | 4280-4287 | 2001 | WB, IHC (paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Jacobs TW, et al. | Am J Surg Pathol | 25(2) | 229-36 | 2001 | IHC(FFPE)1:500 |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kaplan DK, et al. | J Biol Chem | 276(47) | 44037-44043 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Luo Y, et al. | Development | 128 | 459-469 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Machado JC, et al. | Oncogene | 20 | 1525-1528 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Meigs TE, et al | PNAS | 98(2) | 519-534 | 2001 | IF, WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Naora H, et al. | PNAS | 98(26) | 15209-15214 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Rashid MG, et al. | Cancer Res | 61 | 489-492 | 2001 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zavadil J, et al. | PNAS | 98(12) | 6686-6691 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zhong Y, et al. | Clin Cancer Res | 7 | 1683-1687 | 2001 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Alpaugh ML, et al. | Oncogene | 21 | 3631-3643 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hajra KM, et al. | Cancer Res | 62 | 1613-1618 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kim J-T, et al. | J Biol Chem | 277(35) | 31938-31948 | 2002 | IF, adhesion blocking studies |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Laura RP, et al. | J Biol Chem | 277(15) | 12906-12914 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Li Q, et al. | J Biol Chem | 277(48) | 46447-46455 | 2002 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Muller N, et al. | Oncogene | 21 | 6049-6058 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Niessen CM, Gumbiner BM. | J Cell Biol | 156(2) | 389-399 | 2002 | ? |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Sahai E, Marshall CJ. | Nature Cell Biol | 4 | 408-415 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tran NL, et al. | J Biol Chem | 277(36) | 32905-32914 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Weaver VM, et al. | Cancer Cell | 2 | 205-216 | 2002 | blocking |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Boussioutas A, et al. | Cancer Res | 63 | 2569-2577 | 2003 | IHC (paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Chan AOO, et al. | J Clin Oncol | 21(12) | 2288-2293 | 2003 | IHC (paraffin, 1:200) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kowalski PJ, et al. | Breast Cancer Res | 5 | R217-R222 | 2003 | IHC (FFPE, Ventana Biotek Techmate 500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kuefer R, et al. | Clin Cancer Res | 9(17) | 6447-6452 | 2003 | WB (Hu prostate) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Rios-Doria J, et al. | J Biol Chem | 278(2) | 1372-1379 | 2003 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Suriano G, et al. | Hum Mol Genet | 12 | 575-582 | 2003 | IHC (froz) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tian F, et al. | Cancer Res | 63 | 8284-8292 | 2003 | IF, WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Troyanovsky RB, et al. | Mol Cell Biol | 23(22) | 7965-7972 | 2003 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gottardi CJ, Gumbiner BM. | Am J Physiol Cell Physiol | 286 | C747-756 | 2004 | WB (1:10,000) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Haven CJ, et al. | Cancer Res | 64(20) | 7405-7411 | 2004 | IHC (paraffin, 1:500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Lecuit M, et al. | PNAS | 101(16) | 6152-6157 | 2004 | IHC (FFPE and froz, 1:500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tobey NA, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G1042-1049 | 2004 | IHC (Rb, PFA-fixed, paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Peignon G, et al. | J Biol Chem | 281(6) | 3560-3568 | 2006 | IF (1:200) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Horiguchi Y, et al. | J Histochem Cytochem | 42(10) | 1333-1340 | 1994 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Watabe M, et al. | J Cell Biol | 127(1) | 247-256 | 1994 | IP |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Blauvelt A, et al. | J Invest Dermatology | 104 | 193-6 | 1995 | Flow Cytometry |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Glukhova M, et al. | Am J Pathol | 146 | 706-716 | 1995 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Sanna M, et al. | Anat Pathol | 105(4) | 394-402 | 1995 | IHC (frozen) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Siitonen SM, et al. | Anatomic Pathology | 105(4) | 394-402 | 1996 | IHC (1:800) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Braga VMM, et al. | J Cell Biol | 137(6) | 1421-1431 | 1997 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hoover KB, et al. | Am J Pathol | 153(6) | 1767-1773 | 1998 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kondo K, et al. | Cancer Res | 58 | 2014-2019 | 1998 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Soto H, et al. | Human Pathology | 30(11) | 1344-1349 | 1999 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Acs G, et al. | Arch Pathol Lab Med | 125 | 198-201 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zavadil, et al. | PNAS | 98(12) | 7573-7578 | 2001 | IF and WB |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Takeichi M. | Development | 102 | 639-655 | 1988 | WB |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (pos), IHC |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Binding comp, |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Babich M, et al. | Life Sciences | 54(11) | PL-201-PL20 8 | 1994 | Immunostain |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Fannon A, et al. | J Cell Biol | 129 (1) | 189-202 | 1995 | |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | Cell-cell adhesion blocking (pos) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hosono S, et al. | J Biol Chem | 275(15) | 10943-10953 | 2000 | WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Mulac-Jericevic B, et al. | Science | 289 | 1751-1754 | 2000 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Carothers AM, et al. | J Biol Chem | 276(42) | 39094-39102 | 2001 | WB, IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Bouchard M, et al. | Genes Dev | 16(22) | 2958-2970 | 2002 | IHC (Ms) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | DasGupta R, et al. | J Cell Biol | 158(2) | 331-344 | 2002 | IF (Ms), WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gritli-Linde A, et al. | Development | 129 | 5323-5337 | 2002 | IHC (Ms, PFA, paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Lopez T, Hanahan D. | Cancer Cell | 1 | 339-353 | 2002 | IHC - frozen, Ms |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Ngan ESW, et al. | PNAS | 99(17) | 11187-11192 | 2002 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Pelengaris S, et al. | Cell | 109 | 321-334 | 2002 | IHC - paraffin, Ms |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Wali RK, et al. | Cancer Epidemiol Biomarker s Prev | 11 | 1653-1662 | 2002 | WB, IHC (rat) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Welm BE, et al. | J Cell Biol | 157(4) | 703-714 | 2002 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Yoon M, Spear PG. | J Virol | 76(14) | 7203-7208 | 2002 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Davis J, et al. | J Cell Sci | 116 | 2157-2167 | 2003 | WB, IHC (Ms eye, froz, 0.1ug/mL) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gouyon F, et al. | J Physiol | 552 | 823-832 | 2003 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Kopp T, et al. | J Immunol | 171 | 5438-5444 | 2003 | FC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Lallemand D, et al. | Genes Dev | 17(9) | 1090-1100 | 2003 | IF (Ms, 1:250) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Sakai T, et al. | Genes Dev | 17(7) | 926-940 | 2003 | ICC (Ms) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Devaux JJ, et al. | J Neurosci | 24(5) | 1236-1244 | 2004 | IHC (Ms, Rt, froz, 1:50) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Fouquet S, et al. | J Biol Chem | 279(41) | 43061-43069 | 2004 | IF (Ms intestine, 1:250), WB (1:2,500) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hogan C, et al. | Mol Cell Biol | 24(15) | 6690-6700 | 2004 | IF (Hu) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Linehan MM, et al. | J Virol | 78 | 2530-2536 | 2004 | IF (Ms, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Oshima RG, et al. | Cancer Res | 64 | 169-179 | 2004 | IF (Ms tissue, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Wandzioch E, et al. | PNAS | 101(47) | 16549-16554 | 2004 | IHC (Ms embryo, paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tricaud N, et al. | J Neurosci | 25(13) | 3259-3269 | 2005 | IHC (Ms sciatic nerve, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Peignon G, et al. | J Biol Chem | 281(6) | 3560-3568 | 2006 | IF (1:250) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Takeichi M. | Development | 102 | 639-655 | 1988 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (neg ctrl) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hirano S, et al. | Cell | 70 | 293-301 | 1992 | WB, IP |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Flow |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Babich M and Foti RP. | Life Sciences | 54(11) | PL-201-PL20 8 | 1994 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Horiguchi Y, et al. | J Histochem Cytochem | 42(10) | 1333-1340 | 1994 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Nagafuchi A, et al. | J Cell Biol | 127(1) | 235-245 | 1994 | IB,IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tsarfaty I, et al. | Science | 263 | 98-101 | 1994 | IHC (paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Watabe M, et al. | J Cell Biol | 127(1) | 247-251 | 1994 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Fannon AM, et al. | J Cell Biol | 129(1) | 189-202 | 1995 | IP, WB, IHC (frozen) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Palacios J, et al. | Am J Pathol | 146 | 605-612 | 1995 | IHC(oct) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | IP, IF, WB, Flow |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Shibamoto S, et al. | J Cell Biol | 128(5) | 949-957 | 1995 | HECD-2-IP, WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Mbalaviele G, et al. | Cancer Res | 56 | 4063-4070 | 1996 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Braga VMM, et al. | J Cell Biol | 137(6) | 1421-1431 | 1997 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Dunn RJ, et al. | J Histochem Cytochem | 45(1) | 129-141 | 1997 | IHC (frozen/OCT) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gallicano GI, et al. | J Cell Biol | 143(7) | 2009-2022 | 1998 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Perl AK, et al. | Nature Med | 5(3) | 286-291 | 1999 | F |
| 13-2000 | Rt anti-P-cadherin | Liu G, et al. | J Clin Invest | 112(2) | 209-221 | 2003 | Injected into rats |
| 13-2000 | Rt anti-P-cadherin | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 13-2000 | Rt anti-P-cadherin | Rico M, et al. | Am J Physiol Renal Physiol | 289 | F431-441 | 2005 | IF (1:50) |
| 13-2000 | Rt anti-P-cadherin | Takeichi, M. | Development | 102 | 639-655 | 1988 | Adhesion Inhibition |
| 13-2000 | Rt anti-P-cadherin | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (pos), IHC |
| 13-2000 | Rt anti-P-cadherin | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-2000 | Rt anti-P-cadherin | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Inhibition studies, |
| 13-2000 | Rt anti-P-cadherin | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | Cell-cell adhesion blocking (neg. cntl.) |
| 13-2000 | Rt anti-P-cadherin | Jamora C, et al. | Nature | 422 | 317-322 | 2003 | IHC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Mahlapuu M, et al. | Development | 128 | 155-166 | 2001 | IHC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Ryan PL, et al | PNAS | 98(8) | 4323-4327 | 2001 | ICC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Robinson EE, et al. | J Cell Sci | 116 | 377-386 | 2003 | FC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Ciesiolka M, et al. | J Cell Sci | 117 | 4325-4339 | 2004 | WB (Xen) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Hatta K, et al. | Nature | 320(6061) | 447-449 | 1986 | WB, IHC (frozen) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Takeichi M. | Development | 102 | 639-655 | 1988 | Adhesion Inhibition |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Hirano S, et al. | Cell | 70 | 293-301 | 1992 | WB, IP, IF |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Bixby JL, et al. | J Neurosci | 13(8) | 3421-3432 | 1993 | WB |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Balsamo J, et al. | J Cell Biol | 129(5) | 1391-1401 | 1995 | Affinity Chromatography, WB |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Zong CS, et al. | J Biol Chem | 272(3) | 1500-1506 | 1997 | WB ( no data shown ) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Huttenlocher A, et al. | J Cell Biol | 141(2) | 515-526 | 1998 | cell inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Day ML, et al. | J Biol Chem | 274(14) | 9656-9664 | 1999 | blocking studies |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mueller S, et al. | Cancer Res | 60 | 156-163 | 2000 | blocking studies |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Reinacher-Schick A, Gumbiner BM. | J Cell Biol | 152(3) | 491-502 | 2001 | WB |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Klingelhofer J, et al. | Oncogene | 22 | 1181-1188 | 2003 | |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mariner DJ, et al. | J Cell Sci | 117 | 1339-1350 | 2004 | Blocking (1ug/mL) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Merot Y, et al. | J Biol Chem | 279(25) | 26184-26191 | 2004 | WB (1:1000) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Dalrymple S, et al. | Cancer Res | 65 | 9269-9279 | 2005 | Blocking (2ug/mL) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Pang J-H, et al. | J Biol Chem | 280(4) | 3043-3050 | 2005 | IP |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Katayama M, et al. | J Oncol Int | 5 | 1049-1057 | 1994 | ELISA, WB, Adhesion Inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Watabe M, et al. | J Cell Biol | 127(1) | 247-256 | 1994 | IP |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mitra, et al. | Lab Invest | 76 | 99-107 | 1997 | Blocking |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | St. Croix B, et al. | J Cell Biol | 142(2) | 557-571 | 1998 | Inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Orford K, et al. | J Cell Biol | 146(4) | 855-867 | 1999 | |
| 13-5800 | Ms anti-P-cadherin | Muller N, et al. | Oncogene | 21 | 6049-6058 | 2002 | |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | J Cell Biol | 109 | 1787-1794 | 1989 | ICC, WB, cell-cell adhesion blocking (pos) |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | Cancer Res | 49 | 2128-2133 | 1989 | WB, IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | Cancer Res | 51 | 2185-2192 | 1991 | WB, IHC |
| 13-5800 | Ms anti-P-cadherin | Doki Y, et al. | Cancer Res | 53 | 3421-3426 | 1993 | WB |
| 13-5800 | Ms anti-P-cadherin | Morton RA, et al. | Cancer Res | 53 | 3585-3590 | 1993 | IF, WB, IP |
| 13-5800 | Ms anti-P-cadherin | Rasbridge SA. | J Pathol | 169 | 245-250 | 1993 | IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Yasui W, et al. | Internation J of Cancer | 54 | 49-52 | 1993 | WB, IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Hodivala KJ. | J Cell Biol | 124(4) | 589-600 | 1994 | IF, Stratification Inhibition |
| 13-5800 | Ms anti-P-cadherin | Glukhova M, et al. | Am J Pathol | 146 | 706-716 | 1995 | IF |
| 13-5800 | Ms anti-P-cadherin | Palacios J, et al. | Am J Pathol | 146 | 605-612 | 1995 | IHC(oct) |
| 13-5800 | Ms anti-P-cadherin | Braga VMM, et al. | J Cell Biol | 137 (6) | 1421-1431 | 1997 | |
| 13-8400 | Ms anti-beta-Catenin | Sakanaka C, Williams LT. | J Biol Chem | 274(20) | 14090-14093 | 1999 | IP |
| 13-8400 | Ms anti-beta-Catenin | Woo PL, et al. | J Biol Chem | 274(46) | 32818-32828 | 1999 | ICC |
| 13-8400 | Ms anti-beta-Catenin | Tachibana K, et al. | J Cell Biol | 150(5) | 1161-1175 | 2000 | IF |
| 13-8400 | Ms anti-beta-Catenin | Adam L, et al. | J Biol Chem | 276(30) | 28443-28450 | 2001 | IP, IF |
| 13-8400 | Ms anti-beta-Catenin | Dottori M, et al | Development | 128 | 4127-4138 | 2001 | IHC |
| 13-8400 | Ms anti-beta-Catenin | Kaplan DK, et al. | J Biol Chem | 276(47) | 44037-44043 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Meigs TE, et al. | PNAS | 98(2) | 519-534 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Rashid MG, et al. | Cancer Res | 61 | 489-492 | 2001 | IP, WB |
| 13-8400 | Ms anti-beta-Catenin | Vallorosi CJ, et al. | J Biol Chem | 275(2) | 3328-3334 | 2001 | IP and WB |
| 13-8400 | Ms anti-beta-Catenin | Carmichael J, et al. | J Biol Chem | 277(37) | 33791-33798 | 2002 | WB, ICC |
| 13-8400 | Ms anti-beta-Catenin | Kramer KL, et al. | Cell | 111 | 981-990 | 2002 | WB |
| 13-8400 | Ms anti-beta-Catenin | Ren J, et al. | J Biol Chem | 277(20) | 17616-17622 | 2002 | WB |
| 13-8400 | Ms anti-beta-Catenin | Swinney DC, et al. | J Biol Chem | 277(26) | 23573-23581 | 2002 | ELISA |
| 13-8400 | Ms anti-beta-Catenin | Warchol ME. | J Neurosci | 22(7) | 2607-2616 | 2002 | ICC (Ck) |
| 13-8400 | Ms anti-beta-Catenin | Bamji SX, et al. | Neuron | 40 | 719-731 | 2003 | IF (rats) |
| 13-8400 | Ms anti-beta-Catenin | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 13-8400 | Ms anti-beta-Catenin | Matsumura K, et al. | Blood | 101 | 1367-1374 | 2003 | |
| 13-8400 | Ms anti-beta-Catenin | Rios-Doria J, et al. | J Biol Chem | 278(2) | 1372-1379 | 2003 | IP |
| 13-8400 | Ms anti-beta-Catenin | Hill DA, et al. | J Cell Sci | 117 | 5847-5854 | 2004 | WB |
| 13-8400 | Ms anti-beta-Catenin | Kaplan DD, et al. | J Biol Chem | 279(12) | 10829-10832 | 2004 | IF |
| 13-8400 | Ms anti-beta-Catenin | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | IF (Ms kidney, froz, 1:100) |
| 13-8400 | Ms anti-beta-Catenin | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 13-8400 | Ms anti-beta-Catenin | Yamamoto M. | J Biol Chem | 272(19) | 12492-12494 | 1997 | IP, WB |
| 13-8400 | Ms anti-beta-Catenin | Sakanaka C, et al. | PNAS | 95 | 3020-3023 | 1998 | IP |
| 13-8400 | Ms anti-beta-Catenin | Wu S, et al. | PNAS | 95 | 14979-14984 | 1998 | WB |
| 13-8400 | Ms anti-beta-Catenin | Meigs TE, et al. | PNAS | 98(2) | 519-534 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-8500 | Ms anti-gamma-Catenin | Ilan N, et al. | J Biol Chem | 275(28) | 21435-21443 | 2000 | IHC |
| 13-8500 | Ms anti-gamma-Catenin | Grooteclaes M, et al. | PNAS | 100(8) | 4568-4573 | 2003 | WB |
| 13-8500 | Ms anti-gamma-Catenin | Klingelhofer J, et al. | Oncogene | 22 | 1181-1188 | 2003 | |
| 13-8500 | Ms anti-gamma-Catenin | Li Y, et al. | Molec Cancer Res | 1 | 765-775 | 2003 | WB, IF |
| 13-8500 | Ms anti-gamma-Catenin | Kaplan DD, et al. | J Biol Chem | 279(12) | 10829-10832 | 2004 | WB |
| 13-8500 | Ms anti-gamma-Catenin | Descargues P, et al. | Nature Genetics | 37 | 56-65 | 2005 | WB, IHC (ms) |
| 13-8500 | Ms anti-gamma-Catenin | Silberberg M, et al. | Am J Physiol Renal Physiol | 288 | F1153-1163 | 2005 | Confocal IF (Hu kidney, 1:100) |
| 13-9700 | Ms anti-alpha-Catenin | Allport JR, et al. | J Cell Biol | 148(1) | 203-216 | 1999 | IF |
| 13-9700 | Ms anti-alpha-Catenin | Giannini AL, et al. | J Biol Chem | 275(29) | 21883-21888 | 2000 | WB |
| 13-9700 | Ms anti-alpha-Catenin | Carothers AM, et al. | J Biol Chem | 276(42) | 39094-39102 | 2001 | WB |
| 13-9700 | Ms anti-alpha-Catenin | Scheffers MS, et al. | Hum Mol Genet | 11 | 59-67 | 2002 | |
| 13-9700 | Ms anti-alpha-Catenin | Jacquemier J, et al. | Cancer Res | 65(3) | 767-779 | 2005 | IHC (FFPE) |
| 13-9700 | Ms anti-alpha-Catenin | Allport JR, et al. | J Exp Med | 186 | 517-527 | 1997 | IF |
| 13-9700 | Ms anti-alpha-Catenin | Yamamoto M. | J Biol Chem | 272(19) | 12492-12494 | 1997 | IP, WB |
| 32-6100 | Ms anti-Desmoglein-2 | Silberberg M, et al. | Am J Physiol Renal Physiol | 288 | F1153-1163 | 2005 | IF (Hu kidney cells, 1:25) |
| 33-3900 | Ms anti-N-cadherin | Hazan RB, et al. | J Cell Biol | 148(4) | 779-790 | 2000 | WB, IHC, migration inhibition |
| 33-3900 | Ms anti-N-cadherin | van Raamsdock CD, et al. | Development | 127 | 5439-5448 | 2000 | IHC |
| 33-3900 | Ms anti-N-cadherin | Gottardi CJ, et al. | J Cell Biol | 153(5) | 1049-1059 | 2001 | WB |
| 33-3900 | Ms anti-N-cadherin | Janssens B, et al. | J Cell Sci | 114 | 3177-3188 | 2001 | IF |
| 33-3900 | Ms anti-N-cadherin | Kotelevets L, et al. | J Cell Biol | 155(7) | 1129-1135 | 2001 | WB |
| 33-3900 | Ms anti-N-cadherin | Luo Y, et al. | Development | 128 | 459-469 | 2001 | IHC |
| 33-3900 | Ms anti-N-cadherin | Xu X, et al. | J Cell Biol | 154(1) | 217-229 | 2001 | IHC |
| 33-3900 | Ms anti-N-cadherin (3B9) | Andrieux A, et al. | Genes Dev | 16(18) | 2350-2364 | 2002 | WB (Ms) |
| 33-3900 | Ms anti-N-cadherin | Laura RP, et al. | J Biol Chem | 277(15) | 12906-12914 | 2002 | WB |
| 33-3900 | Ms anti-N-cadherin | Niessen CM, Gumbiner BM. | J Cell Biol | 156(2) | 389-399 | 2002 | IF |
| 33-3900 | Ms anti-N-cadherin | Suyama K, et al. | Cancer Cell | 2 | 301-314 | 2002 | WB, IP |
| 33-3900 | Ms anti-N-cadherin (3B9) | Davani S, et al. | Circulation | 108 | 253-258 | 2003 | IHC (Rt heart, paraffin, |
| 33-3900 | Ms anti-N-cadherin | Kang J-S, et al. | PNAS | 100(7) | 3989-3994 | 2003 | WB |
| 33-3900 | Ms anti-N-cadherin | Krueger SR, et al. | Neuron | 40 | 945-957 | 2003 | IF (rats) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Robinson EE, et al. | J Cell Sci | 116 | 377-386 | 2003 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Rubinek T, et al. | J Clin Endocrinol Metab | 88(8) | 3724-3730 | 2003 | IF (paraffin, 1:100) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Bharti S, et al. | Mol Cell Biol | 15(1) | 397-406 | 2004 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Hill DA, et al. | J Cell Sci | 117 | 5847-5854 | 2004 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Luo Y, Radice GL. | J Cell Biol | 169(1) | 29-34 | 2005 | IF (HUVEC, HVMEC), Confirmation of siRNA knockdown (IF) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Pon YL, et al. | J Biol Chem | 280(15) | 15438-15448 | 2005 | IP, WB (1:1,000) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Siu MKY, et al. | J Biol Chem | 280(26) | 25029-25047 | 2005 | IP |
| 33-3900 | Ms anti-N-cadherin (3B9) | Wattel S, et al. | Oncogene | 24 | 6902-6916 | 2005 | WB, IHC (Hu thyroid adenoma, froz) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | WB, ICC |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Kim M-K, et al. | App Immunohistochem Mole c Morphol | 10(4) | 332-338 | 2002 | IHC (paraffin) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Palacios J, et al. | Clin Cancer Res | 9(10) | 3606-3614 | 2003 | IHC (Hu breast cancer, paraffin, 1:200) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Guerini V, et al. | Cancer Res | 65(12) | 5445-5453 | 2005 | WB (1:200) |
| 33-9600 | Ms anti-p120 Catenin (C-term) | Wu J, et al. | Hybridoma | 17(2) | 175-183 | 1999 | WB, IP, IF |
| 33-9600 | Ms anti-p120 Catenin (C-term) | Humtsoe JO, et al. | EMBO J | 22 | 1539-1554 | 2003 | WB |
| 33-9600 | Ms anti-p120 Catenin | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 33-9700 | Ms anti-p120 Catenin (N-term) | Wu J, et al. | Hybridoma | 17(2) | 175-183 | 1999 | WB, IP, IF |
| 33-9700 | Ms anti-p120 Catenin (N-term) | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | WB |
| 35-4700 | Ms anti-Ksp-cadherin | Thedieck C, et al. | Br J Cancer | 92 | 2010-2017 | 2005 | ICC (Hu RCC cells, 1:50), IHC (Hu kidney, froz, 1:50) |
| 35-4700 | Ms anti-Ksp-cadherin | Yamamoto M, et al. | Am J Physiol Renal Physiol | 290 | F52-60 | 2006 | IHC (Ms froz, 1:100), confocal IF |
| 71-1200 | Rb anti-alpha-Catenin | Quinlan MP, Hyatt JL. | Cell Growth Differ | 10 | 839-854 | 1999 | IP, IF |
| 71-1200 | Rb anti-alpha-Catenin | Mauro L, et al. | J Biol Chem | 276(43) | 39892-39897 | 2001 | WB, IP |
| 71-1200 | Rb anti-alpha-Catenin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-1200 | Rb anti-alpha-Catenin | Mucha DR, et al. | Am J Physiol Heart Circ Phy siol | 284 | H994-1002 | 2003 | ICC (Bv, 1:100) |
| 71-1200 | Rb anti-alpha-Catenin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | WB (Rt) |
| 71-1200 | Rb anti-alpha-Catenin | Osta WA, et al. | Cancer Res | 64(16) | 5818-5824 | 2004 | WB |
| 71-1200 | Rb anti-alpha-Catenin | Kolly C, et al. | J Invest Dermatol | 124 | 1014-1025 | 2005 | WB (Dog) |
| 71-1200 | Rb anti-alpha-Catenin | Margulis A, et al. | Cancer Res | 65(5) | 1783-1791 | 2005 | WB |
| 71-1200 | Rb anti-alpha-Catenin | St Croix B, et al. | J Cell Biology | 142(2) | 557-571 | 1998 | WB |
| 71-2700 | Rb anti-beta-Catenin | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 71-2700 | Rb anti-beta-Catenin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-2700 | Rb anti-beta-Catenin | Walters RW, et al. | Cell | 110 | 789-799 | 2003 | WB, IP, ICC |
| 71-2700 | Rb anti-beta-Catenin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | IF (Rt, froz), WB (Rt) |
| 71-2700 | Rb anti-beta-Catenin | Osta WA, et al. | Cancer Res | 64(16) | 5818-5824 | 2004 | WB |
| 71-2700 | Rb anti-beta-Catenin | Reymond N, et al. | J Exp Med | 199 | 1331-1341 | 2004 | IF (Hu) |
| 71-2700 | Rb anti-beta-Catenin | Margulis A, et al. | Cancer Res | 65(5) | 1783-1791 | 2005 | IF |
| 71-2700 | Rb anti-beta-Catenin | Yongqing L, et al. | J Biol Chem | 276(38) | 35239-35242 | 2001 | WB |
| 71-7100 | Rb anti-pan-cadherin | Colonnese MT, et al. | J Neurophysiol | 89 | 57-68 | 2003 | WB (Rt) |
| 71-7100 | Rb anti-pan-cadherin | Croft DR, et al. | Cancer Res | 64(24) | 8994-9001 | 2004 | IF |
| 71-7100 | Rb anti-pan-cadherin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | WB (Rt) |
| 71-7100 | Rb anti-pan-cadherin | Ren Y-G, et al. | Mol Cell Biol | 15(11) | 5064-5074 | 2004 | WB (Hu) |
| 71-7100 | Rb anti-pan-cadherin | Schedin PJ, et al. | Oncogene | 23 | 1766-1779 | 2004 | IHC (1:400) |
| 71-7600 | Rb anti-cadherin-11 | Straub BK, et al. | J Cell Sci | 116 | 4985-4995 | 2003 | |
| 71-7600 | Rb anti-cadherin-11 | Morimoto AM, et al. | Oncogene | 23 | 1618-1626 | 2004 | |
| Gap Junction Antibody Product References | |||||||
| 13-8100 | Ms anti-CX26 (12H10) | Ito A, et al. | J Clin Invest | 105(9) | 1189-97 | 2000 | WB 1:300, IHC (PFA-fixed, Hu) |
| 13-8100 | Ms anti-CX26 (12H10) | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | |
| 13-8100 | Ms anti-CX26 (12H10) | Rouan F, et al. | J Cell Sci | 114 | 2105-2113 | 2001 | IHC (frozen), WB |
| 13-8100 | Ms anti-CX26 (12H10) | Solomon IC, et al. | Resp Pathol | 129 | 101-121 | 2001 | IHC |
| 13-8100 | Ms anti-CX26 (12H10) | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF WB |
| 13-8100 | Ms anti-CX26 (12H10) | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | WB (1:1000) |
| 13-8100 | Ms anti-CX26 (12H10) | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | |
| 13-8100 | Ms anti-CX26 (12H10) | Gemel J, et al. | J Cell Sci | 117 | 2469-2480 | 2004 | IF (1:500) |
| 13-8100 | Ms anti-CX26 (12H10) | Saito T, et al. | Oncogene | 23 | 1109-1116 | 2004 | IF (1:500) |
| 13-8100 | Ms anti-CX26 (12H10) | Thomas T, et al. | J Biol Chem | 279(18) | 19157-19168 | 2004 | ICC (1:200) |
| 13-8100 | Ms anti-Cx26 (CX-12H10) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IF |
| 13-8100 | Ms anti-CX26 (12H10) | You S, et al. | Cancer Res | 58 | 1498-1502 | 1998 | IHC (Frozen) |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Alvarez-Maubecin V, et al. | J Neurosci | 20(11) | 4091-4098 | 2000 | ICC (rat) |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Peracchia C, et al. | J Biol Chem | 275(34) | 26220-26224 | 2000 | IF |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Solomon IC, et al. | Resp Pathol | 129 | 101-121 | 2001 | IHC |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:500), WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Saito T, et al. | Oncogene | 23 | 1109-1116 | 2004 | IF (1:500) |
| 13-8200 | Ms anti-Cx32 (CX-2C2) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Li J, et al. | J Comp Neurol | 379(4) | 571-591 | 1997 | WB (1:200), IHC (froz), EM |
| 13-8300 | Ms anti-CX43 | Beardslee MA, et al. | Circ Res | 87 | 656-662 | 2000 | WB IF |
| 13-8300 | Ms anti-CX43 | Ciray HN, et al. | Am J Obstet Gynecol | 182 | 926-930 | 2000 | IF |
| 13-8300 | Ms anti-Cx43 | Quist AP, et al. | J Cell Biol | 148(5) | 1063-1074 | 2000 | IF |
| 13-8300 | Ms anti-CX43 | Bruzzone S, et al. | J Biol Chem | 276(51) | 48300-48308 | 2001 | WB |
| 13-8300 | Ms anti-CX43 | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 13-8300 | Ms anti-Cx43 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 13-8300 | Ms anti-CX43 | Dubina MV, et al. | Oncogene | 21 | 4992-4996 | 2002 | |
| 13-8300 | Ms anti-CX43 | Piechocki MP, et al. | Clin Cancer Res | 8 | 870-877 | 2002 | IP, WB |
| 13-8300 | Ms anti-CX43 | Caton D, et al. | J Cell Sci | 116 | 2285-2294 | 2003 | WB (Rt) |
| 13-8300 | Ms anti-CX43 | Chen J-T, et al. | Clin Cancer Res | 9(11) | 4200-4204 | 2003 | WB (Hu, 1:1000) |
| 13-8300 | Ms anti-CX43 | Christ GJ, et al. | Am J Physiol Regulatory Int egrative Comp Physiol | 284 | R1241-1248 | 2003 | WB (1:500) |
| 13-8300 | Ms anti-Cx43 | Eugenin EA, et al. | J Immunol | 170 | 1320-1328 | 2003 | WB, IF |
| 13-8300 | Ms anti-CX43 | Gutstein DE, et al. | J Cell Sci | 116 | 875-885 | 2003 | WB, IF (Ms heart, froz) |
| 13-8300 | Ms anti-CX43 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB |
| 13-8300 | Ms anti-Cx43 (CX-1B1) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IF, WB |
| 13-8300 | Ms anti-CX43 | Li W, et al. | J Biol Chem | 280(9) | 7941-7948 | 2005 | WB, IF |
| 13-8300 | Ms anti-CX43 | Muramatsu T. | J Histochem Cytochem | 44(1) | 49-56 | 1996 | |
| 13-8300 | Ms anti-CX43 | Hayashi T, et al. | Cancer Letters | 112 | 103-111 | 1997 | WB |
| 13-8300 | Ms anti-CX43 | Koval M, et al. | J Cell Biol | 137(4) | 847-857 | 1997 | IF |
| 13-8300 | Ms anti-CX43 | Masgrau-Peya E, et al. | J Histochem Cytochem | 45(9) | 1207-1215 | 1997 | IF 1:500dilution |
| 13-8300 | Ms anti-CX43 | Nagy JI, et al. | Exp Cell Res | 236 | 127-136 | 1997 | WB, IHC, EM |
| 13-8300 | Ms anti-CX43 | Xie H, et al. | J Cell Biol | 137(1) | 203-210 | 1997 | WB |
| 13-8300 | Ms anti-CX43 | Li WEI, et al. | Eur J Neurosci | 10 | 2444-2463 | 1998 | WB, IHC |
| 13-8300 | Ms anti-CX43 | Martin PE, et al. | J Biol Chem | 273(3) | 1719-1726 | 1998 | WB |
| 13-8300 | Ms anti-CX43 | Toyofuku T, et al. | J Biol Chem | 273(3) | 1519-1528 | 1998 | WB |
| 13-8300 | Ms anti-CX43 | Bittman KS, et al. | Cerebral Cortex | 9 | 188-195 | 1999 | IF |
| 13-8300 | Ms anti-CX43 | Nagy JI, et al. | Neuroscience | 88(2) | 447-468 | 1999 | IF |
| 13-8300 | Ms anti-CX43 | Xie H, et al. | Neuroscience | 88(2) | 447-468 | 1999 | |
| 13-8300 | Ms anti-CX43 | Li WEI, Nagy JI. | Neurosci | 97 (1) | 113-123 | 2000 | WB, iHC |
| 13-8300 | Ms anti-CX43 | Li WEI, Nagy JI. | Eur J Neurosci | 12 | 2644-2650 | 2000 | |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | Neuroscience | 88 | 447-468 | 1999 | |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | J Comp Neurol | 441(4) | 302-323 | 2001 | IF (1:500) |
| 33-2500 | Ms anti-Cx30 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, IHC (froz), Immunogold labeling |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:500), WB |
| 33-2500 | Ms anti-Cx30 | Sun J, et al. | Am J Physiol Cell Physiol | 288 | C613-623 | 2005 | WB (1:1,000), IP, IHC (Ms cochlea, 1:200) |
| 33-2500 | Ms anti-Cx30 | Jagger DJ, Forge A. | J Neurosci | 26(4) | 1260-1268 | 2006 | IF (Rt cochlea, 1:200) |
| 33-4300 | Ms anti-Cx50 | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 33-4300 | Ms anti-Cx50 | Lin D, et al. | Mol Vision | 10 | 688-695 | 2004 | WB, IP (Rt) |
| 33-5800 | Ms anti-CX26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | WB, IF |
| 33-5800 | Ms anti-CX26 | Rouan F, et al. | J Cell Sci | 114 | 2105-2113 | 2001 | IHC (frozen), WB |
| 33-5800 | Ms anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 33-5800 | Ms anti-Cx26 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 33-5800 | Ms anti-CX26 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 33-5800 | Ms anti-Cx26 | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | IF (paraffin) |
| 33-5800 | Ms anti-Cx26 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:200), WB |
| 34-4200 | Rb anti-Cx29 | Li X, et al. | Eur J Neurosci | 16 | 795-806 | 2002 | ICC (froz Ms sciatic nerve), immunogold labeling, WB |
| 34-4200 | Rb anti-Cx29 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 34-4200 | Rb anti-Cx29 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 34-4200 | Rb anti-Cx29 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 34-4200 | Rb anti-Cx29 | Tricaud N, et al. | J Neurosci | 25(13) | 3259-3269 | 2005 | IHC (Ms sciatic nerve, froz) |
| 34-5700 | Rb anti-Connexin 32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 34-5700 | Rb anti-Connexin 32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 34-5700 | Rb anti-Connexin 32 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 34-5700 | Rb anti-Connexin 32 | Zhu L, et al. | Mol Cell Biol | 24(7) | 2673-2681 | 2004 | IHC (Ms, 1:200) |
| 35-5000 | Ms anti-Cx43 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:150), WB |
| 35-5000 | Ms anti-Cx43 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 35-5000 | Ms anti-Cx43 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 35-5000 | Ms anti-Cx43 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 35-8900 | Ms anti-Cx32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 35-8900 | Ms anti-Cx32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 35-8900 | Ms anti-Cx32 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 36-4600 | Rb anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB (Ms) |
| 36-4600 | Rb anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz), Immunogold labeling |
| 36-4600 | Rb anti-Cx36 | Lin B, et al. | J Neurosci | 25(28) | 6696-6701 | 2005 | ICC (Ms retina) |
| 36-4700 | Rb anti-CX47 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 36-4700 | Rb anti-CX47 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 36-4700 | Rb anti-Cx47 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB |
| 37-4500 | Ms anti-Cx47 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB |
| 37-4600 | Ms anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | IHC (froz, Ms), WB (Ms) |
| 37-4600 | Ms anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz) |
| 51-2800 | Rb anti-Cx26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | IF, WB |
| 51-2800 | Rb anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 51-2800 | Rb anti-CX26 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC, IF |
| 51-2800 | Rb anti-Cx26 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:200), WB |
| 51-2800 | Rb anti-CX26 | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:200) |
| 51-2800 | Rb anti-Cx26 | Teubner B, et al. | Hum Mol Genet | 12 | 13-21 | 2003 | IHC (Ms, froz, 1:100) |
| 51-2800 | Rb anti-Cx26 | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IP, IF (Hu Bx-PC-3) |
| 51-6200 | Rb anti-Cx36 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | Immunogold labeling |
| 51-6200 | Rb anti-Cx36 | Yi H, Massey SC. | PNAS | 102(37) | 13313-13318 | 2005 | ICC (Ms retina, 1:250) |
| 51-6200 | Rb anti-Cx36 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2003 | WB (Ms), IP |
| 51-6300 | Rb anti-Cx36 | Pereda A, et al. | J Neurosci | 23(20) | 7489-7503 | 2003 | Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz), Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Maxeiner S, et al. | J Neurosci | 25(3) | 566-576 | 2005 | IHC (Ms retina, PFA-fixed, 1:500) |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 71-0500 | Rb anti-Cx26 | Ciray HN, et al. | Am J Obstet Gynecol | 182 | 926-930 | 2000 | IF |
| 71-0500 | Rb anti-CX26 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 280 | 191-202 | 2001 | WB |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | WB, IF |
| 71-0500 | Rb anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 71-0500 | Rb anti-CX26 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF |
| 71-0500 | Rb anti-Cx26 | Qin H, et al. | J Biol Chem | 277(32) | 29132-29138 | 2002 | ICC |
| 71-0500 | Rb anti-Cx26 | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | ICC (Ms) |
| 71-0500 | Rb anti-Cx26 | Dufresne J, et al. | Am J Physiol Cell Physiol | 284 | C33-43 | 2003 | ICC (rat) |
| 71-0500 | Rb anti-CX26 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0500 | Rb anti-Cx26 | Locke D, et al. | Biochemistry | 44(39) | 13027-13042 | 2005 | ICC, WB |
| 71-0500 | Rb anti-Cx26 | Kelsell DP, et al. | Nature | 387 | 80-83 | 1997 | IHC (frozen, Hu) 1:100 |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | Neuroscience | 78(2) | 533-548 | 1997 | WB (1:1000), IHC (frozen) 1:500s |
| 71-0500 | Rb anti-Cx26 | Bittman KS, et al | Cerebral Cortex | 9 | 188-195 | 1999 | IF |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | Neuroscience | 88(2) | 447-468 | 1999 | WB |
| 71-0500 | Rb anti-Cx26 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0500 | Rb anti-Cx26 | Yazulla S, Studholme KM. | J Neurocytology | 30 | 551-592 | 2001 | ICC (Zebrafish 1:100) |
| 71-0600 | Rb anti-CX32 | Das Sarma J, et al. | J Cell Sci | 114 | 4013-4024 | 2001 | IF |
| 71-0600 | Rb anti-CX32 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 71-0600 | Rb anti-CX32 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 71-0600 | Rb anti-CX32 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF |
| 71-0600 | Rb anti-CX32 | Das Sarma J, et al. | J Biol Chem | 277(23) | 20911-20918 | 2002 | IF |
| 71-0600 | Rb anti-CX32 | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | ICC |
| 71-0600 | Rb anti-Cx32 | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | ICC (Ms) |
| 71-0600 | Rb anti-Cx32 | Dufresne J, et al. | Am J Physiol Cell Physiol | 284 | C33-43 | 2003 | ICC (rat) |
| 71-0600 | Rb anti-CX32 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0600 | Rb anti-CX32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 71-0600 | Rb anti-CX32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-0600 | Rb anti-CX32 | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:200) |
| 71-0600 | Rb anti-Cx32 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (froz, Ms) |
| 71-0600 | Rb anti-Cx32 | Huang Y, et al. | J Neurosci | 25(31) | 7111-7120 | 2005 | WB |
| 71-0600 | Rb anti-Cx32 | Scherer SS, et al. | J Neurosci | 25(6) | 1550-1559 | 2005 | WB, IHC (Ms nerves, froz, 1:200) |
| 71-0600 | Rb anti-CX32 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0600 | Rb anti-CX32 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 71-0700 | Rb anti-CX43 | Beardslee MA, et al. | Circ Res | 83 | 629-635 | 1998 | IF |
| 71-0700 | Rb anti-CX43 | Li WEI, et al. | Eur J Neurosci | 10 | 2444-2463 | 1998 | WB, IHC |
| 71-0700 | Rb anti-CX43 | Stregiopoulos K, et al. | Circ Res | 84 | 1144-1155 | 1999 | IP |
| 71-0700 | Rb anti-CX43 | Beardslee MA, et al. | Circ Res | 87 | 656-662 | 2000 | WB IF |
| 71-0700 | Rb anti-CX43 | Li WEI, et al. | Neuroscience | 97(1) | 113-123 | 2000 | WB, IHC |
| 71-0700 | Rb anti-CX43 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0700 | Rb anti-Cx43 | Quist AP, et al. | J Cell Biol | 148(5) | 1063-1074 | 2000 | IF |
| 71-0700 | Rb anti-CX43 | Thomas SP, et al. | Circ Res | 87 | 467-473 | 2000 | IF |
| 71-0700 | Rb anti-Cx43 | Umhauer S, et al. | Am J Obstet Gynecol | 182 | 999-1000 | 2000 | IHC (froz, 1:800) |
| 71-0700 | Rb anti-CX43 | Bruzzone S, et al. | J Biol Chem | 276(51) | 48300-48308 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | De Pina-Benabou MH, et al. | J Neurosci | 21(17) | 6635-6643 | 2001 | ICC - Ms spinal cord |
| 71-0700 | Rb anti-CX43 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 280 | 191-202 | 2001 | WB IF |
| 71-0700 | Rb anti-CX43 | Oguro K, et al. | J Neurosci | 21(19) | 7534-7542 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | Papadaki M, et al. | Am J Phsiol Heart Circ Phys iol | 280 | 168-178 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | Anderson SC, et al. | Invest Ophthalmol Vis Sci | 43 | 978-986 | 2002 | IHC (Rb cornea, PFA, 1:100) |
| 71-0700 | Rb anti-CX43 | El-Sabban ME, et al. | Blood | 99 | 3383-3389 | 2002 | WB |
| 71-0700 | Rb anti-CX43 | Grueterich M, et al. | Invest Ophthalmol Vis Sci | 43 | 63-71 | 2002 | IHC (froz, 1:200) |
| 71-0700 | Rb anti-CX43 | Li H, et al. | Am J Physiol Heart Circ Phy siol | 282 | H2124-2133 | 2002 | WB (1:1000), ICC (1:200) |
| 71-0700 | Rb anti-Cx43 | Pierce BT, et al. | Am J Obstet Gynecol | 186 | 504-511 | 2002 | IHC (Hu, Rt; froz; 1:200) |
| 71-0700 | Rb anti-CX43 | Plotkin LI, et al. | J Biol Chem | 277(10) | 8648-8657 | 2002 | WB, IP |
| 71-0700 | Rb anti-CX43 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 71-0700 | Rb anti-CX43 | Schwanke U, et al. | Am J Physiol Heart Circ Phy siol | 283 | H1740-1742 | 2002 | WB (Ms) |
| 71-0700 | Rb anti-CX43 | Abdelmohsen K, et al. | J Biol Chem | 278(40) | 38360-38367 | 2003 | WB |
| 71-0700 | Rb anti-CX43 | Carystinos GD, et al. | Mol Pharm | 63 | 821-831 | 2003 | WB |
| 71-0700 | Rb anti-CX43 | Caton D, et al. | J Cell Sci | 116 | 2285-2294 | 2003 | IF (Rt, 1:500) |
| 71-0700 | Rb anti-CX43 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0700 | Rb anti-CX43 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1213-1221 | 2003 | ICC (Rt), WB, IP |
| 71-0700 | Rb anti-CX43 | Lee T-M, Chou T-F. | Am J Physiol Heart Circ Phy siol | 285 | H1650-1659 | 2003 | WB (Dog) |
| 71-0700 | Rb anti-CX43 | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 71-0700 | Rb anti-Cx43 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | WB |
| 71-0700 | Rb anti-Cx43 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-0700 | Rb anti-CX43 | Nihei OK, et al. | Am J Physiol Cell Physiol | 285 | C1304-1313 | 2003 | IF (Ms) |
| 71-0700 | Rb anti-CX43 | Provost N, et al. | Am J Physiol Cell Physiol | 284 | C51-59 | 2003 | ICC (1:100), WB |
| 71-0700 | Rb anti-CX43 | Scheffler B, et al. | Development | 130 | 5533-5541 | 2003 | ICC (Ms brain, pFA-fixed, 1:300) |
| 71-0700 | Ms anti-CX43 | Simard M, et al. | J Neurosci | 23(27) | 9254-9262 | 2003 | IHC (Rt, 1:500) |
| 71-0700 | Rb anti-CX43 | Thomas MA, et al. | J Cell Sci | 116 | 2213-2222 | 2003 | IP, WB |
| 71-0700 | Rb anti-CX43 | Ye Z-C, et al. | J Neurosci | 23(9) | 3588-3596 | 2003 | ICC (Rt neurons, 1ug/mL) |
| 71-0700 | Rb anti-CX43 | Bao X, et al. | J Biol Chem | 279(19) | 20058-20066 | 2004 | WB |
| 71-0700 | Rb anti-CX43 | Bao X, et al. | Am J Physiol Cell Physiol | 286 | C647-654 | 2004 | WB |
| 71-0700 | Rb anti-CX43 | Forster C, et al. | PNAS | 101(39) | 14234-14239 | 2004 | IF (Ms, paraffin, 1:100) |
| 71-0700 | Rb anti-CX43 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (froz, Ms) |
| 71-0700 | Rb anti-CX43 | Poelzing S, et al. | Am J Physiol Heart Circ Phy siol | 286 | H2001-2009 | 2004 | IF (Dog heart, FFPE, citrate, 1:400) |
| 71-0700 | Rb anti-CX43 | Poelzing S, Rosenbaum DS. | Am J Physiol Heart Circ Phy siol | 286 | H1762-1780 | 2004 | IF (Dog heart, FFPE, citrate, 1:400) |
| 71-0700 | Rb anti-Cx43 | Cho WJ, Daniel EE. | Am J Physiol Gastroint Live r Physiol | 288 | G571-585 | 2005 | Confocal IF (Ms muscle, 1:100) |
| 71-0700 | Rb anti-Cx43 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine), WB |
| 71-0700 | Rb anti-Cx43 | Momose-Sato Y, et al. | J Neurophysiol | 94 | 1606-1622 | 2005 | IHC (Rt, froz, 1:100) |
| 71-0700 | Rb anti-Cx43 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-0700 | Rb anti-Cx43 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 71-0700 | Rb anti-Cx43 | Betsuyaku T, et al. | Am J Physiol Heart Circ Phy siol | 290 | H163-171 | 2006 | WB (Ms, 1:5,000), IHC (Ms heart, FFPE, 1:500) |
| 71-2200 | Rb anti-CX30 | Nagy JI, et al. | Neuroscience | 88 | 447-468 | 1999 | WB, IHC, IF |
| 71-2200 | Rb anti-CX30 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | IF (1:100) |
| 71-2200 | Rb anti-CX30 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 71-2200 | Rb anti-Cx30 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 71-2200 | Rb anti-CX30 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 71-2200 | Rb anti-CX30 | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | IF (paraffin) |
| 71-2200 | Rb anti-Cx30 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 71-2200 | Rb anti-Cx30 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-2200 | Rb anti-CX30 | Teubner B, et al. | Hum Mol Genet | 12 | 13-21 | 2003 | WB |
| 71-2200 | Rb anti-CX30 | Theis M, et al. | J Neurosci | 23(3) | 766-776 | 2003 | IF (Ms, 1:500), WB (Ms, 1:250) |
| 71-2200 | Rb anti-CX30 | Maass K, et al. | Mol Cell Biol | 15(10) | 4597-4608 | 2004 | IF (Ms, froz) |
| 71-2200 | Rb anti-CX30 | Thomas T, et al. | J Biol Chem | 279(18) | 19157-19168 | 2004 | ICC |
| 71-2200 | Rb anti-Cx30 | McCulloch F, et al. | Am J Physiol Renal Physiol | 289 | F1304-1312 | 2005 | WB (Rt, 1:250), IF (Rt kidney, 1:50) |
| 71-2200 | Rb anti-Cx30 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB (1:1,000), IF |
| Tight Junction Antibody Product References | |||||||
| 32-5600 | Ms anti-Claudin-2 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:4000) |
| 32-5600 | Ms anti-Claudin-2 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9400 | Ms anti-Claudin-4 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 32-9400 | Ms anti-Claudin-4 | Colegio OR, et al. | Am J Physiol Cell Physiol | 283 | C142-147 | 2002 | WB (1:4000) |
| 32-9400 | Ms anti-Claudin-4 | Bonne S, et al. | J Cell Biol | 161(2) | 403-416 | 2003 | IF (1:1000) |
| 32-9400 | Ms anti-Claudin-4 | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:4000), IF |
| 32-9400 | Ms anti-Claudin-4 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9400 | Ms anti-Claudin-4 | Mitic LL, et al. | Protein Sci | 12 | 218-227 | 2003 | WB (1:4000) |
| 32-9400 | Ms anti-Claudin-4 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:250) |
| 32-9400 | Ms anti-Claudin-4 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 32-9400 | Ms anti-Claudin-4 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 32-9400 | Ms anti-Claudin-4 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | WB (Hu) |
| 32-9400 | Ms anti-Claudin-4 | Jones C, et al. | Cancer Res | 64(9) | 3037-3045 | 2004 | IHC (paraffin, 1:100) |
| 32-9400 | Ms anti-Claudin-4 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 32-9400 | Ms anti-Claudin-4 | Lo D, et al. | Int Immunol | 16(1) | 91-99 | 2004 | IHC (froz, Hu, Ms) |
| 32-9400 | Ms anti-Claudin-4 | Matsuda M, et al. | J Cell Sci | 117 | 1247-1257 | 2004 | IF (transfected) |
| 32-9400 | Ms anti-Claudin-4 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Yamauchi K, et al. | PNAS | 101 | 4690-4694 | 2004 | WB |
| 32-9400 | Ms anti-Claudin-4 | Agarwal R, et al. | Cancer Res | 65(16) | 7378-7385 | 2005 | WB (verification of gene knockdown) |
| 32-9400 | Ms anti-Claudin-4 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 32-9400 | Ms anti-Claudin-4 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 32-9400 | Ms anti-Claudin-4 | De Craene B, et al. | Cancer Res | 65(14) | 6237-6244 | 2005 | IF/ICC |
| 32-9400 | Ms anti-Claudin-4 | D'Souza T, et al. | J Biol Chem | 280(28) | 26233-26240 | 2005 | WB (1:250), IP |
| 32-9400 | Ms anti-Claudin-4 | Le Moellic C, et al. | Am J Physiol Cell Physiol | 289 | C1513-1521 | 2005 | IF (1:50), IP (1:40), WB (1:1,000) |
| 32-9400 | Ms anti-Claudin-4 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:200), IF (MDCK, 1:500) |
| 32-9400 | Ms anti-Claudin-4 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:400), IF (1:400), WB |
| 32-9400 | Ms anti-Claudin-4 | Santin AD, et al. | Cancer Res | 65(10) | 4334-4342 | 2005 | IHC (FFPE, Hu ovarian tumors, citrate) |
| 32-9400 | Ms anti-Claudin-4 | Shlyonsky V, et al. | J Biol Chem | 280(25) | 24181-24187 | 2005 | ICC |
| 32-9400 | Ms anti-Claudin-4 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:2,000), WB (DIEC) |
| 32-9400 | Ms anti-Claudin-4 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 32-9800 | Ms anti-Claudin-15 | Colegio OR, et al. | Am J Physiol Cell Physiol | 283 | C142-147 | 2002 | WB (1:2000), IF (1:100) |
| 32-9800 | Ms anti-Claudin-15 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9800 | Ms anti-Claudin-15 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 33-1500 | Ms anti-Occludin | Clarke H, et al. | J Cell Sci | 113 | 3187-3196 | 2000 | IF |
| 33-1500 | Ms anti-Occludin | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IF (1:250), WB |
| 33-1500 | Ms anti-Occludin | Mohammad-Panah, et al. | J Biol Chem | 276(11) | 8306-8313 | 2001 | IF |
| 33-1500 | Ms anti-Occludin | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | IHC, WB |
| 33-1500 | Ms anti-Occludin | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | IF |
| 33-1500 | Ms anti-Occludin | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB |
| 33-1500 | Ms anti-Occludin | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 33-1500 | Ms anti-Occludin | Gudjonsson T, et al. | Genes Dev | 16(6) | 693-706 | 2002 | ICC |
| 33-1500 | Ms anti-Occludin | Lemmers C, et al. | J Biol Chem | 277(28) | 25408-25415 | 2002 | ICC |
| 33-1500 | Ms anti-Occludin | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | WB, IF |
| 33-1500 | Ms anti-Occludin | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | IF |
| 33-1500 | Ms anti-Occludin | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:1500) |
| 33-1500 | Ms anti-Occludin | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 33-1500 | Ms anti-Occludin | Taouil K, et al. | J Biol Chem | 278(19) | 17320-17327 | 2003 | IF |
| 33-1500 | Ms anti-Occludin | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 33-1500 | Ms anti-Occludin | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | IP |
| 33-1500 | Ms anti-Occludin | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 33-1500 | Ms anti-Occludin | Badizadegan K, et al. | Am J Physiol Cell Physiol | 287 | C1453-1462 | 2004 | |
| 33-1500 | Ms anti-Occludin | Banan A, et al. | Am J Physiol Cell Physiol | 287 | C218-234 | 2004 | IF |
| 33-1500 | Ms anti-Occludin | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 33-1500 | Ms anti-Occludin | Lemmers C, et al. | Mol Cell Biol | 15(3) | 1324-1333 | 2004 | IF (1:200) |
| 33-1500 | Ms anti-Occludin | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 33-1500 | Ms anti-Occludin | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | WB (Hu, 1:250) |
| 33-1500 | Ms anti-Occludin | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 33-1500 | Ms anti-Occludin | Smith MS, et al. | J Virol | 78 | 4444-4453 | 2004 | WB (Hu) |
| 33-1500 | Ms anti-Occludin | Basuroy S, et al. | Am J Physiol Gastrointest Li ver Physiol | 289 | G367-375 | 2005 | Confocal IF (Hu) |
| 33-1500 | Ms anti-Occludin | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 33-1500 | Ms anti-Occludin | Mottino AD, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G327-336 | 2005 | IF (1:100) |
| 33-1500 | Ms anti-Occludin | Polette M, et al. | Cancer Res | 65(17) | 7691-7698 | 2005 | IF, WB (MCF-7, BT549 cells) |
| 33-1500 | Ms anti-Occludin | Shifflett DE, et al. | Lab Invest | 85 | 1308-1324 | 2005 | IHC (Ms, froz, 0.5ug/mL), WB |
| 33-1500 | Ms anti-Occludin | Wang G, et al. | PNAS | 102(1) | 186-191 | 2005 | ICC, FC |
| 33-1500 | Ms anti-Occludin | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000), WB (DIEC) |
| 33-1500 | Ms anti-Occludin | Chen X, Macara IG. | J Cell Biol | 172 | 671-678 | 2006 | IF |
| 33-1500 | Ms anti-Occludin | Potempa S, et al. | Mol Biol Cell | 9 | 2185-2200 | 1998 | IF |
| 33-1500 | Ms anti-Occludin | Berglund JJ, et al. | Am J Physiol Gastroint Live r Physiol | 281 | G1487-G149 3 | 2001 | IF |
| 33-1511 | FITC-Ms anti-Occludin | Choe MM, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L427-433 | 2003 | IF |
| 33-1511 | FITC-Ms anti-Occludin | Parkinson SJ, et al. | EMBO J | 23 | 77-88 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Boettner B, et al. | PNAS | 97(16) | 9064-9069 | 2000 | IF |
| 33-9100 | Ms anti-ZO-1 | Cohen CJ, et al. | PNAS | 98(26) | 15191-15196 | 2001 | IF |
| 33-9100 | Ms anti-ZO-1 | Naishiro Y, et al. | Cancer Res | 61 | 2751-2758 | 2001 | WB |
| 33-9100 | Ms anti-ZO-1 | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | WB, IHC |
| 33-9100 | Ms anti-ZO-1 | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | IF |
| 33-9100 | Ms anti-ZO-1 | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Cooper CD, Lampe PD. | J Biol Chem | 277(47) | 44962-44968 | 2002 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Patrie KM, et al. | J Biol Chem | 277(33) | 30183-30190 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Ranaldi G, et al. | Am J Physiol Renal Physiol | 283 | F1365-1375 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Cell Biol | 157(1) | 161-172 | 2002 | ICC (1:2000), IHC (froz, rat) |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Biol Chem | 277(30) | 27501-27509 | 2002 | ICC |
| 33-9100 | Ms anti-ZO-1 | Anders M, et al. | Cancer Res | 63 | 2088-2095 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:1500) |
| 33-9100 | Ms anti-ZO-1 | Gentzsch M, et al. | J Biol Chem | 278(8) | 6440-6449 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Gutstein DE, et al. | J Cell Sci | 116 | 875-885 | 2003 | WB, IF (Ms heart, froz) |
| 33-9100 | Ms anti-ZO-1 | Hirabayashi S, et al. | Mol Cell Biol | 23 | 4267-4282 | 2003 | IF (Rt) |
| 33-9100 | Ms anti-ZO-1 | Hurd TW, et al. | Nature Cell Biol | 5 | 137-142 | 2003 | |
| 33-9100 | Ms anti-ZO-1 | Kominsky SL, et al. | Oncogene | 22 | 2021-2033 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Lu Z, et al, | Cancer Cell | 4(6) | 499-515 | 2003 | |
| 33-9100 | Ms anti-ZO-1 | Narayan S, et al. | Invest Ophthalmol Vis Sci | 44 | 4885-4894 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Neunlist M, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1028-1036 | 2003 | IF (Hu, 1:500), WB (1:1,000) |
| 33-9100 | Ms anti-ZO-1 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Cell Sci | 116 | 2895-2906 | 2003 | ICC |
| 33-9100 | Ms anti-ZO-1 | Silvis MR, et al. | J Biol Chem | 278(13) | 11554-11560 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 33-9100 | Ms anti-ZO-1 | Young P, et al. | EMBO J | 22 | 5723-5733 | 2003 | IHC (Ms, PFA_fixed, paraffin) |
| 33-9100 | Ms anti-ZO-1 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Badizadegan K, et al. | Am J Physiol Cell Physiol | 287 | C1453-1462 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Clayburgh DR, et al. | J Biol Chem | 279(53) | 55506-55513 | 2004 | IF (Hu, 2.5 ug/mL) |
| 33-9100 | Ms anti-ZO-1 | Coyne CB, et al. | J Biol Chem | 279(46) | 48079-48084 | 2004 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Estienne V, et al. | Am J Physiol Cell Physiol | 287 | C1763-1768 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 33-9100 | Ms anti-ZO-1 | Kizhatil K, Bennett V. | J Biol Chem | 279(16) | 16706-16714 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | IF (Ms kidney, froz, 1:100) |
| 33-9100 | Ms anti-ZO-1 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | IP (Ms) |
| 33-9100 | Ms anti-ZO-1 | Liu X-F, et al. | Mol Cell Biol | 24(15) | 6665-6675 | 2004 | IF (Dog, 1:500) |
| 33-9100 | Ms anti-ZO-1 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Mohler PJ, et al. | PNAS | 101(50) | 17533-17538 | 2004 | IF (Rt) |
| 33-9100 | Ms anti-ZO-1 | Parker LH, et al. | Nature | 428 | 754-758 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Smith MS, et al. | J Virol | 78 | 4444-4453 | 2004 | WB (Hu) |
| 33-9100 | Ms anti-ZO-1 | Bagnoli F, et al. | PNAS | 102(45) | 16339-16344 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Bratt A, et al. | J Biol Chem | 280(41) | 34859-34869 | 2005 | IF (Bv, Ms) |
| 33-9100 | Ms anti-ZO-1 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 33-9100 | Ms anti-ZO-1 | Caruso-Neves C, et al. | PNAS | 102(48) | 17513-17518 | 2005 | IF (pig LLC-PK1 cells) |
| 33-9100 | Ms anti-ZO-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 33-9100 | Ms anti-ZO-1 | Furuya M, et al. | Cancer Res | 65(7) | 2617-2625 | 2005 | IF (Hu HTOA cells) |
| 33-9100 | Ms anti-ZO-1 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine) |
| 33-9100 | Ms anti-ZO-1 | Guerra L, et al. | J Biol Chem | 280(49) | 40925-40933 | 2005 | Confocal IF |
| 33-9100 | Ms anti-ZO-1 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:500), IF (MDCK, 1:100) |
| 33-9100 | Ms anti-ZO-1 | Lopez C, et al. | J Biol Chem | 280(9) | 8221-8228 | 2005 | IF (4ug/mL, MDCK) |
| 33-9100 | Ms anti-ZO-1 | Mandell KJ, et al. | J Biol Chem | 280 | 11665-11674 | 2005 | WB |
| 33-9100 | Ms anti-ZO-1 | Masuda M, et al. | J Biol Chem | 280(51) | 42164-42171 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Navarro C, et al. | Oncogene | 24 | 4330-4339 | 2005 | IF, confocal imaging (MDCK) |
| 33-9100 | Ms anti-ZO-1 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IP, IF, WB |
| 33-9100 | Ms anti-ZO-1 | Polette M, et al. | Cancer Res | 65(17) | 7691-7698 | 2005 | IF, confocal (MCF-7, BT549 cells), WB, IHC (FFPE invasive breast ductal carcinoma) |
| 33-9100 | Ms anti-ZO-1 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IF (1:250) |
| 33-9100 | Ms anti-ZO-1 | Shin K, et al. | J Cell Biol | 168(5) | 705-711 | 2005 | IF (MDCKII) |
| 33-9100 | Ms anti-ZO-1 | Wang Y, et al. | Am J Physiol Renal Physiol | 289 | F850-862 | 2005 | IF (pig LLC-PK1 cells) |
| 33-9100 | Ms anti-ZO-1 | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | ICC |
| 33-9100 | Ms anti-ZO-1 | Wittchen ES, et al. | J Biol Chem | 280(12) | 11675-11682 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Yoshii T, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G564-570 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Harita Y, et al. | Am J Physiol Renal Physiol | 290 | F335-344 | 2006 | IF (Rt kidney, froz) |
| 33-9111 | Ms anti-ZO-1-FITC | Cummins CL, et al. | Pharm Res | 18(8) | 1102-1109 | 2001 | IF |
| 33-9111 | Ms anti-ZO-1-FITC | Wong C-H, et al. | J Cell Sci | 117 | 783-798 | 2004 | IF (Rt testes, froz. 1:100) |
| 33-9111 | Ms anti-ZO-1-FITC | Bandyopadhyay BC, et al. | J Biol Chem | 280(13) | 12908-12916 | 2005 | IF (MDCK, 1:100) |
| 34-1600 | Rb anti-Claudin-5 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 34-1600 | Rb anti-Claudin-5 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 34-1600 | Rb anti-Claudin-5 | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | IHC (Ms, froz) |
| 34-1600 | Rb anti-Claudin-5 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 34-1600 | Rb anti-Claudin-5 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 34-1600 | Rb anti-Claudin-5 | Rahner C, et al. | J Cell Sci | 117 | 3307-3318 | 2004 | IF (Ck retina) |
| 34-1600 | Rb anti-Claudin-5 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 34-1600 | Rb anti-Claudin-5 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | If (dog intestine, 1:2,000) |
| 34-1600 | Rb anti-Claudin-5 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 20 ug/mL) |
| 34-1700 | Rb anti-Claudin-3 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 34-1700 | Rb anti-Claudin-3 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 34-1700 | Rb anti-Claudin-3 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Ikenouchi J, et al. | J Cell Sci | 116 | 1959-1967 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:200) |
| 34-1700 | Rb anti-Claudin-3 | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 34-1700 | Rb anti-Claudin-3 | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 34-1700 | Rb anti-Claudin-3 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 34-1700 | Rb anti-Claudin-3 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 34-1700 | Rb anti-Claudin-3 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 34-1700 | Rb anti-Claudin-3 | Matsuda M, et al. | J Cell Sci | 117 | 1247-1257 | 2004 | IF (transfected) |
| 34-1700 | Rb anti-Claudin-3 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Yamauchi K, et al. | PNAS | 101 | 4690-4694 | 2004 | WB |
| 34-1700 | Rb anti-Claudin-3 | Agarwal R, et al. | Cancer Res | 65(16) | 7378-7385 | 2005 | WB (verification of gene knockdown) |
| 34-1700 | Rb anti-Claudin-3 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 34-1700 | Rb anti-Claudin-3 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 34-1700 | Rb anti-Claudin-3 | D'Souza T, et al. | J Biol Chem | 280(28) | 26233-26240 | 2005 | WB (1:200), IHC (Hu ovary, ovarian cancer), IF (1:100) |
| 34-1700 | Rb anti-Claudin-3 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | WB, IF (MDCK, 1:500) |
| 34-1700 | Rb anti-Claudin-3 | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin), WB |
| 34-1700 | Rb anti-Claudin-3 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:50), IF (1:200), WB |
| 34-1700 | Rb anti-Claudin-3 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000), WB (DIEC) |
| 34-1700 | Rb anti-Claudin-3 | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 5 ug/mL) |
| 34-5400 | Rb anti-Claudin-16 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 34-9100 | Rb anti-Claudin-7 | Kominsky SL, et al. | Oncogene | 22(13) | 2021-2033 | 2003 | IHC, IF |
| 34-9100 | Rb anti-Claudin-7 | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | WB (1:1,000), IF (Ms kidney, froz, 1:5,000) |
| 34-9100 | Rb anti-Claudin-7 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 34-9100 | Rb anti-Claudin-7 | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | IF (MDCK, 1:500) |
| 34-9100 | Rb anti-Claudin-7 | Yu ASL, et al. | Am J Physiol Cell Physiol | 299 | C1231-1241 | 2005 | WB |
| 35-2500 | Ms anti-Claudin-5 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF |
| 35-2500 | Ms anti-Claudin-5 | Rahner C, et al. | J Cell Sci | 117 | 3307-3318 | 2004 | IF (Ck retina) |
| 35-2500 | Ms anti-Claudin-5 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 35-2500 | Ms anti-Claudin-5 | Musch MW, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G222-231 | 2006 | Confocal IF (Caco-2), WB |
| 36-1700 | Rb anti-JAM-A | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu), WB |
| 36-1700 | Rb anti-JAM-A | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 36-1700 | Rb anti-JAM-A | Mandell KJ, et al. | J Biol Chem | 280 | 11665-11674 | 2005 | WB, IF |
| 36-1700 | Rb anti-JAM-A | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 36-1700 | Rb anti-JAM-A | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 36-4000 | Rb anti-ZO-3 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | |
| 36-4500 | Rb anti-Claudin-11/OSP | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 36-4500 | Rb anti-Claudin-11/OSP | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin) |
| 36-4800 | Rb anti-Claudin-4 | Van Itallie C, et al | J Clin Invest | 107(10) | 1319-27 | 2001 | IF (1:100) human |
| 36-4800 | Rb anti-Claudin-4 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt) |
| 37-4900 | Ms anti-Claudin-1 | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 38-8000 | Rb anti-Claudin-18 (Ms) | Gon Y, et al. | PNAS | 102(26) | 9270-9275 | 2005 | IHC (Ms lung, PFA-fixed, froz) |
| 40-2200 | Rb anti-ZO-1 (Mid) | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF |
| 40-2300 | Rb anti-ZO-1 (N-term) | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF |
| 40-2800 | Rb anti-ZONAB | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF, WB |
| 51-6100 | Rb anti-Claudin-2 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 51-6100 | Rb anti-Claudin-2 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 51-6100 | Rb anti-Claudin-2 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 51-6100 | Rb anti-Claudin-2 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF (Ms sciatic nerve) |
| 51-6100 | Rb anti-Claudin-2 | Sakaguchi T, et al. | J Biol Chem | 277(24) | 21361-21370 | 2002 | IF, IHC (Ms, frozen) |
| 51-6100 | Rb anti-Claudin-2 | Turksen K, Troy T-C. | Development | 129 | 1775-1784 | 2002 | IHC (Ms skin, paraffin, 1:100) |
| 51-6100 | Rb anti-Claudin-2 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | |
| 51-6100 | Rb anti-Claudin-2 | Kansagra K, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1162-1170 | 2003 | WB (Pig, 1:500) |
| 51-6100 | Rb anti-Claudin-2 | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 51-6100 | Rb anti-Claudin-2 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 51-6100 | Rb anti-Claudin-2 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 51-6100 | Rb anti-Claudin-2 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 51-6100 | Rb anti-Claudin-2 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | |
| 51-6100 | Rb anti-Claudin-2 | Balkovetz DF, et al. | Am J Physiol Renal Physiol | 286 | F702-710 | 2004 | WB (MDCK II, 1:250) |
| 51-6100 | Rb anti-Claudin-2 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 51-6100 | Rb anti-Claudin-2 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Hu) |
| 51-6100 | Rb anti-Claudin-2 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 51-6100 | Rb anti-Claudin-2 | Luton F, et al. | Mol Cell Biol | 15(3) | 1134-1145 | 2004 | WB |
| 51-6100 | Rb anti-Claudin-2 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 51-6100 | Rb anti-Claudin-2 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 51-6100 | Rb anti-Claudin-2 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 51-6100 | Rb anti-Claudin-2 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (0.5 ug/mL) |
| 51-6100 | Rb anti-Claudin-2 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 51-6100 | Rb anti-Claudin-2 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | IF (MDCK, 1:500), WB (1:250) |
| 51-6100 | Rb anti-Claudin-2 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:40), IF (1:150), WB |
| 51-6100 | Rb anti-Claudin-2 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 51-6100 | Rb anti-Claudin-2 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 1ug/mL) |
| 51-9000 | Rb anti-Claudin-1 | McCarthy KM, et al. | J Cell Sci | 113 | 3387-3398 | 2000 | WB IF |
| 51-9000 | Rb anti-Claudin-1 | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 51-9000 | Rb anti-Claudin-1 | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 51-9000 | Rb anti-Claudin-1 | Kawabe H et al. | J Biol Chem | 276(51) | 48350-48355 | 2001 | IF |
| 51-9000 | Rb anti-Claudin-1 | Kucharzik T, et al. | Am J Pathol | 159(6) | 2001-2009 | 2001 | IF, WB, IHC (FFPE) ventana ES |
| 51-9000 | Rb anti-Claudin-1 | Miyamori H, et al. | J Biol Chem | 276(30) | 28204-28211 | 2001 | IP, IF |
| 51-9000 | Rb anti-Claudin-1 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC (Paraform fix), Blot Hybridization |
| 51-9000 | Rb anti-Claudin-1 | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | IHC |
| 51-9000 | Rb anti-Claudin-1 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 51-9000 | Rb anti-Claudin-1 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 51-9000 | Rb anti-Claudin-1 | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | |
| 51-9000 | Rb anti-Claudin-1 | Jin M, et al. | Invest Ophthalmol Vis Sci | 43 | 2782-2790 | 2002 | IF |
| 51-9000 | Rb anti-Claudin-1 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF (Ms sciatic nerve) |
| 51-9000 | Rb anti-Claudin-1 | Traweger A et al. | J Biol Chem | 277(12) | 10201-10208 | 2002 | IF WB |
| 51-9000 | Rb anti-Claudin-1 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:3000) |
| 51-9000 | Rb anti-Claudin-1 | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 51-9000 | Rb anti-Claudin-1 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Kansagra K, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1162-1170 | 2003 | WB (Pig, 1:250) |
| 51-9000 | Rb anti-Claudin-1 | Lee S-W, et al. | Nature Medicine | 9(7) | 900-906 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | IHC (froz, Ms) |
| 51-9000 | Rb anti-Claudin-1 | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 51-9000 | Rb anti-Claudin-1 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 51-9000 | Rb anti-Claudin-1 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:200) |
| 51-9000 | Rb anti-Claudin-1 | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | IF |
| 51-9000 | Rb anti-Claudin-1 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 51-9000 | Rb anti-Claudin-1 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Dog, Hu) |
| 51-9000 | Rb anti-Claudin-1 | Epple HJ, et al. | Infect Immun | 72 | 4848-4858 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:50) |
| 51-9000 | Rb anti-Claudin-1 | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu) |
| 51-9000 | Rb anti-Claudin-1 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 51-9000 | Rb anti-Claudin-1 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 51-9000 | Rb anti-Claudin-1 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 51-9000 | Rb anti-Claudin-1 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 51-9000 | Rb anti-Claudin-1 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 51-9000 | Rb anti-Claudin-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 51-9000 | Rb anti-Claudin-1 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine), WB |
| 51-9000 | Rb anti-Claudin-1 | Leyvraz C, et al. | J Cell Biol | 170(3) | 487-496 | 2005 | IF (Ms skin) |
| 51-9000 | Rb anti-Claudin-1 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:250) |
| 51-9000 | Rb anti-Claudin-1 | Meder D, et al. | J Cell Biol | 168(2) | 303-313 | 2005 | IF |
| 51-9000 | Rb anti-Claudin-1 | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 51-9000 | Rb anti-Claudin-1 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 51-9000 | Rb anti-Claudin-1 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 51-9000 | Rb anti-Claudin-1 | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 51-9000 | Rb anti-Claudin-1 | Musch MW, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G222-231 | 2006 | Confocal IF (Caco-2), WB |
| 51-9000 | Rb anti-Claudin-1 | Vermeer PD, et al. | J Biol Chem | 281(3) | 1725-1730 | 2006 | IP (1:500), WB (1:500), ICC (1:100) |
| 61-7300 | Rb anti-ZO-1 | Antonetti DA, et al. | J Biol Chem | 274(33) | 23463-23467 | 1999 | IP |
| 61-7300 | Rb anti-ZO-1 | Mann B, et al. | PNAS | 96 | 1603-1608 | 1999 | WB |
| 61-7300 | Rb anti-ZO-1 | Quinlan MP, Hyatt JL. | Cell Growth Differ | 10(12) | 839-854 | 1999 | IF |
| 61-7300 | Rb anti-ZO-1 | Woo PL, et al. | J Biol Chem | 274(46) | 32818-32828 | 1999 | IF, ICC |
| 61-7300 | Rb anti-ZO-1 | Bazzoni G, et al. | J Biol Chem | 275(27) | 20520-20526 | 2000 | WB, IHC |
| 61-7300 | Rb anti-ZO-1 | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB |
| 61-7300 | Rb anti-ZO-1 | Dickman KG, et al. | Am J Physiol Gastrointestin al Liver Physiol | 279 | 757-766 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 61-7300 | Rb anti-ZO-1 | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IF (1:250), WB |
| 61-7300 | Rb anti-ZO-1 | Li D, Mrsny RJ. | J Cell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Liang TW, et al. | Am J Physiol Cell Physiol | 279 | 1733-1743 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 61-7300 | Rb anti-ZO-1 | Ng KH, et al. | J Cell Sci | 113 | 4241-4251 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 61-7300 | Rb anti-ZO-1 | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Singh U, et al. | J Biol Chem | 275(24) | 18407-18417 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 61-7300 | Rb anti-ZO-1 | Yañez-Mo M, et al | J Cell Sci | 114 | 577-587 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Chen MC, et al. | Am J Physiol Gastrointestin al Liver Physiol | 280 | 264-272 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Cohen CJ, et al. | PNAS | 98(26) | 15191-15196 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Davidson G, et al. | J Cell Sci | 114 | 3359-3366 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Hirata, K et al | J Biol Chem | 276(19) | 16223-16231 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 61-7300 | Rb anti-ZO-1 | Janssens B, et al. | J Cell Sci | 114 | 3177-3188 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Laing, J.G. et al | J Biol Chem | 276(25) | 23051-23055 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Lund RD, et al. | PNAS | 98(17) | 9942-9947 | 2001 | ICC |
| 61-7300 | Rb anti-ZO-1 | Martinez-Estradam O, et al. | J Biol Chem | 276(12) | 9291-9296 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Mauro L, et al. | J Biol Chem | 276(43) | 39892-39897 | 2001 | WB, IP |
| 61-7300 | Rb anti-ZO-1 | Naishiro Y, et al. | Cancer Res | 61 | 2751-2758 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 61-7300 | Rb anti-ZO-1 | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Simons M, et al. | Am J Pathol | 159(3) | 1069-1077 | 2001 | WB |
| 61-7300 | Rb anti-ZO-1 | Straight SW, et al. | Mol Biol Cell | 12 | 1329-1340 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | van der Goes A, et al. | FASEB J | 15(10) | 1852-1854 | 2001 | IHC |
| 61-7300 | Rb anti-ZO-1 | Wang W, et al. | Am J Physiol Heart Circ Phy siol | 280 | 434-440 | 2001 | WB IF |
| 61-7300 | Rb anti-ZO-1 | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Cooper CD, Lampe PD. | J Biol Chem | 277(47) | 44962-44968 | 2002 | WB |
| 61-7300 | Rb anti-ZO-1 | Gelebart P, et al. | J Biol Chem | 277(29) | 26310-26320 | 2002 | ICC |
| 61-7300 | Rb anti-ZO-1 | Glynne PA, et al. | J Biol Chem | 277(36) | 33132-33138 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Gritli-Linde A, et al. | Development | 129 | 5323-5337 | 2002 | IHC (Ms, PFA, paraffin) |
| 61-7300 | Rb anti-ZO-1 | Hamazaki Y, et al. | J Biol Chem | 277(1) | 455-461 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Janda E, et al. | J Cell Biol | 156(2) | 299-313 | 2002 | ICC (froz) |
| 61-7300 | Rb anti-ZO-1 | Lavelle J, et al. | Am J Physiol Renal Physiol | 283 | F242-253 | 2002 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Li Q, et al. | J Biol Chem | 277(48) | 46447-46455 | 2002 | IHC, WB |
| 61-7300 | Rb anti-ZO-1 | Nasdala I, et al. | J Biol Chem | 277(18) | 16294-16303 | 2002 | IF, Confocal microscopy, Immunogold labeling |
| 61-7300 | Rb anti-ZO-1 | Nielsen PA, et al. | J Biol Chem | 277(41) | 38272-38283 | 2002 | IF, WB |
| 61-7300 | Rb anti-ZO-1 | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF, ICC |
| 61-7300 | Rb anti-ZO-1 | Oliver JA, et al. | Am J Physiol Renal Physiol | 283 | F799-809 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Oneyama C, et al. | Oncogene | 21 | 2037-2050 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Pedram A, et al. | J Biol Chem | 277(46) | 44385-44398 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Ramalingam TS, et al. | EMBO J | 21 | 590-601 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Roh MH, et al. | J Cell Biol | 157(1) | 161-172 | 2002 | ICC (1:500), IHC (froz rat) |
| 61-7300 | Rb anti-ZO-1 | Sahai E, Marshall CJ. | Nature Cell Biol | 4 | 408-415 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Vecsey-Semjen B, et al. | Oncogene | 21 | 4646-4662 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | IP |
| 61-7300 | Rb anti-ZO-1 | You Y, et al. | Am J Physiol Lung Cell Mol Physiol | 283 | L1315-1321 | 2002 | IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Anders M, et al. | Cancer Res | 63 | 2088-2095 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | WB, IF, IP |
| 61-7300 | Rb anti-ZO-1 | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:2000) |
| 61-7300 | Rb anti-ZO-1 | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Chin AC, et al. | PNAS | 100(19) | 11104-11109 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 61-7300 | Rb anti-ZO-1 | DeBellefeuille S, et al. | Endocrinology | 144(11) | 5040-5049 | 2003 | ICC (Rt), WB (Rt) |
| 61-7300 | Rb anti-ZO-1 | Ebnet K, et al. | J Cell Sci | 116 | 3879-3891 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Gookin JL, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G967-979 | 2003 | IF (Pig, froz, 1:250) |
| 61-7300 | Rb anti-ZO-1 | Gu X, et al. | Invest Ophthalmol Vis Sci | 44(7) | 3219-3225 | 2003 | ICC (Hu, 1:100) |
| 61-7300 | Rb anti-ZO-1 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt), IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Hirabayashi S, et al. | Mol Cell Biol | 23 | 4267-4282 | 2003 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Hopkins AM, et al. | J Cell Sci | 116 | 725-742 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Kinnemann SC. | EMBO J | 22(16) | 4143-4154 | 2003 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Ko J, et al. | J Neurosci | 23(5) | 1667-1677 | 2003 | WB (2ug/mL) |
| 61-7300 | Rb anti-ZO-1 | Liu G, et al. | J Clin Invest | 112(2) | 209-221 | 2003 | WB |
| 61-7300 | Rb anti-ZO-1 | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | IHC (froz, Ms) |
| 61-7300 | Rb anti-ZO-1 | Mehalow AK, et al. | Hum Mol Genet | 12(17) | 2179-2189 | 2003 | IHC (4% PFA, paraffin); 1:200 |
| 61-7300 | Rb anti-ZO-1 | Nielsen PA, et al. | Mol Biol Cell | 14 | 2470-2481 | 2003 | IHC (Ms eye, PFA-fixed) |
| 61-7300 | Rb anti-ZO-1 | Ostedgaard LS, et al. | PNAS | 100(4) | 1937-1942 | 2003 | ICC |
| 61-7300 | Rb anti-ZO-1 | Peng S, et al. | Invest Ophthalmol Vis Sci | 44(2) | 808-817 | 2003 | IF (Ck embryo, 1:200) |
| 61-7300 | Rb anti-ZO-1 | Shingai T, et al. | J Biol Chem | 278(37) | 35421-35427 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Tugizov SM, et al. | Nature Medicine | 9(3) | 307-314 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 61-7300 | Rb anti-ZO-1 | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | IF (MDCK) |
| 61-7300 | Rb anti-ZO-1 | Walters RW, et al. | Cell | 110 | 789-799 | 2003 | ICC |
| 61-7300 | Rb anti-ZO-1 | Wang S-X, et al. | J Biol Chem | 278(4) | 2713-2722 | 2003 | ICC, IF |
| 61-7300 | Rb anti-ZO-1 | Yang R, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G621-629 | 2003 | IP |
| 61-7300 | Rb anti-ZO-1 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Alvarado JA, et al. | Am J Physiol Cell Physiol | 286 | C621-663 | 2004 | IHC (Hu cornea, froz, 1:200) |
| 61-7300 | Rb anti-ZO-1 | Bailey TA, et al. | Invest Ophthalmol Vis Sci | 45 | 675-684 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | IF (Dog), WB (Hu) |
| 61-7300 | Rb anti-ZO-1 | Brown KA, et al. | Breast Cancer Res | 6 | R215-231 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Chavakis T, et al. | J Biol Chem | 279(53) | 55602-55608 | 2004 | IF (Hu, 5ug/mL) |
| 61-7300 | Rb anti-ZO-1 | Economou CG, et al. | J Cell Sci | 117 | 3281-3294 | 2004 | Confocal microscopy (HGEC) |
| 61-7300 | Rb anti-ZO-1 | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:500) |
| 61-7300 | Rb anti-ZO-1 | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IP, IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Han X, et al. | Am J Physiol Lung Cell Mol Physiol | 286 | L259-267 | 2004 | IP, IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Ikari A, et al. | J Biol Chem | 279(52) | 54826-54832 | 2004 | IF (MDCK) |
| 61-7300 | Rb anti-ZO-1 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu) |
| 61-7300 | Rb anti-ZO-1 | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 61-7300 | Rb anti-ZO-1 | Kausalya PJ, et al. | Mol Cell Biol | 15(12) | 5503-5515 | 2004 | IP, IF (Dog) |
| 61-7300 | Rb anti-ZO-1 | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB (Ms, Hu) |
| 61-7300 | Rb anti-ZO-1 | Maass K, et al. | Mol Cell Biol | 15(10) | 4597-4608 | 2004 | IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 61-7300 | Rb anti-ZO-1 | Oliver JA, et al. | J Clin Invest | 114(6) | 795-804 | 2004 | IF (Rt kidney) |
| 61-7300 | Rb anti-ZO-1 | Otte J-M, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 613-626 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Parkinson SJ, et al. | EMBO J | 23 | 77-88 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Reiser J, et al. | J Clin Invest | 113(10) | 1390-1397 | 2004 | IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Roselli S, et al. | Mol Cell Biol | 24(2) | 550-560 | 2004 | IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB |
| 61-7300 | Rb anti-ZO-1 | Somasiri A, et al. | Cancer Res | 64(15) | 5068-5073 | 2004 | ICC (1:200) |
| 61-7300 | Rb anti-ZO-1 | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IF (Dog, PFA-fixed, 1:300), IP |
| 61-7300 | Rb anti-ZO-1 | Bagnoli F, et al. | PNAS | 102(45) | 16339-16344 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 61-7300 | Rb anti-ZO-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 61-7300 | Rb anti-ZO-1 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 61-7300 | Rb anti-ZO-1 | Koike C, et al. | J Neurosci | 25(44) | 10290-10298 | 2005 | IHC (Ms eye, frozen) |
| 61-7300 | Rb anti-ZO-1 | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF, WB |
| 61-7300 | Rb anti-ZO-1 | Qi A-D, et al. | J Biol Chem | 280(32) | 29169-29175 | 2005 | Confocal microscopy |
| 61-7300 | Rb anti-ZO-1 | Quitsch A, et al. | J Neurosci | 25(2) | 479-487 | 2005 | ICC (MDCKII, 1:750) |
| 61-7300 | Rb anti-ZO-1 | Shifflett DE, et al. | Lab Invest | 85 | 1308-1324 | 2005 | IHC (Ms, froz, 0.5ug/mL), WB |
| 61-7300 | Rb anti-ZO-1 | Singh D, et al. | J Biol Chem | 280(34) | 30416-30421 | 2005 | IP, WB, IF |
| 61-7300 | Rb anti-ZO-1 | Swiatecka-Urban A, et al. | J Biol Chem | 280(44) | 36762-36772 | 2005 | ICC |
| 61-7300 | Rb anti-ZO-1 | Vieira OV, et al. | J Cell Biol | 170(4) | 521-526 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Wang Y, et al. | Am J Physiol Renal Physiol | 289 | F850-862 | 2005 | IF (pig LLC-PK1 cells) |
| 61-7300 | Rb anti-ZO-1 | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | ICC |
| 61-7300 | Rb anti-ZO-1 | Wolff SC, et al. | Am J Physiol Cell Physiol | 288 | C624-632 | 2005 | Confocal IF |
| 61-7300 | Rb anti-ZO-1 | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
| 61-7300 | Rb anti-ZO-1 | Yoshii T, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G564-570 | 2005 | WB |
| 61-7300 | Rb anti-ZO-1 | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 71-1400 | Rb anti-ZO-2 | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 71-1400 | Rb anti-ZO-2 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-1400 | Rb anti-ZO-2 | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 71-1400 | Rb anti-ZO-2 | Meyer TN, et al. | J Biol Chem | 276(25) | 22048-22055 | 2001 | WB |
| 71-1400 | Rb anti-ZO-2 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 71-1400 | Rb anti-ZO-2 | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 71-1400 | Rb anti-ZO-2 | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 71-1400 | Rb anti-ZO-2 | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | |
| 71-1400 | Rb anti-ZO-2 | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | IP |
| 71-1400 | Rb anti-ZO-2 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt), IF (Rt) |
| 71-1400 | Rb anti-ZO-2 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 71-1400 | Rb anti-ZO-2 | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | WB, IP, IF |
| 71-1400 | Rb anti-ZO-2 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | |
| 71-1400 | Rb anti-ZO-2 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Hu) |
| 71-1400 | Rb anti-ZO-2 | Kausalya PJ, et al. | Mol Cell Biol | 15(12) | 5503-5515 | 2004 | IF (Dog) |
| 71-1400 | Rb anti-ZO-2 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 71-1400 | Rb anti-ZO-2 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-1400 | Rb anti-ZO-2 | Singh D, et al. | J Biol Chem | 280(34) | 30416-30421 | 2005 | IP, WB, IF |
| 71-1400 | Rb anti-ZO-2 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 71-1400 | Rb anti-ZO-2 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | Feb 2005; 10.1152/ajpgi.00407.2004 | |||
| 71-1500 | Rb anti-Occludin | Antonetti DA, et al. | J Biol Chem | 274(33) | 23463-23467 | 1999 | WB |
| 71-1500 | Rb anti-Occludin | Lawlor P, et al. | J Neurosci | 19(21) | 9445-9458 | 1999 | ICC |
| 71-1500 | Rb anti-Occludin | Strazielle N, Ghersi-Egea J-F. | J Neurosci | 19(15) | 6275-6289 | 1999 | ICC |
| 71-1500 | Rb anti-Occludin | Tsukamoto T, et al. | J Biol Chem | 274(35) | 24579-24584 | 1999 | WB, ICC |
| 71-1500 | Rb anti-Occludin | Wittchen ES, et al. | J Biol Chem | 274(49) | 35179-35185 | 1999 | IF |
| 71-1500 | Rb anti-Occludin | Bazzoni, G et al | J Biol Chem | 275(27) | 20520-20526 | 2000 | WB, IHC |
| 71-1500 | Rb anti-Occludin | Charron AJ, et al. | J Cell Biol | 149(1) | 111-124 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB, IF |
| 71-1500 | Rb anti-Occludin | Clarke H, et al. | J Cell Sci | 113 | 3187-3196 | 2000 | WB |
| 71-1500 | Rb anti-Occludin | Dickman KG, et al. | Am J Physiol Gastrointestin al Liver Physiol | 279 | 757-766 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 71-1500 | Rb anti-Occludin | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IP (1:1000) |
| 71-1500 | Rb anti-Occludin | Li D, Mrsny RJ. | J Bell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 71-1500 | Rb anti-Occludin | Liang TW, et al. | Am J Physiol Cell Physiol | 279 | 1733-1743 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 71-1500 | Rb anti-Occludin | McCarthy KM, et al. | J Cell Sci | 113 | 3387-3398 | 2000 | WB IF |
| 71-1500 | Rb anti-Occludin | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-1500 | Rb anti-Occludin | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 71-1500 | Rb anti-Occludin | Andreeva AY, et al. | J Biol Chem | 276(42) | 38480-38486 | 2001 | IP, IF |
| 71-1500 | Rb anti-Occludin | Hirase T, et al. | J Biol Chem | 276(13) | 10423-10431 | 2001 | IP |
| 71-1500 | Rb anti-Occludin | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Kucharzik T, et al. | Am J Pathol | 159(6) | 2001-2009 | 2001 | IF, WB |
| 71-1500 | Rb anti-Occludin | Meyer TN, et al | J Biol Chem | 276(25) | 22048-22055 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 71-1500 | Rb anti-Occludin | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Wang W, et al. | Am J Physiol Heart Circ Phy siol | 280 | 434-440 | 2001 | WB IF |
| 71-1500 | Rb anti-Occludin | Wojciak-Stothard B, et al. | J Cell Sci | 114 | 1343-1355 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 71-1500 | Rb anti-Occludin | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | IF, WB |
| 71-1500 | Rb anti-Occludin | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF, WB |
| 71-1500 | Rb anti-Occludin | Feltri ML, et al. | J Cell Biol | 156(1) | 199-209 | 2002 | IHC (Ms, PFA-fixed, froz) |
| 71-1500 | Rb anti-Occludin | Forster C, et al. | PNAS | 99(24) | 15578-15583 | 2002 | IHC (frozen, Ms) |
| 71-1500 | Rb anti-Occludin | Nasdala I, et al. | J Biol Chem | 277(18) | 16294-16303 | 2002 | Confocal microscopy, Immunogold labeling |
| 71-1500 | Rb anti-Occludin | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 71-1500 | Rb anti-Occludin | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | WB, IP, IF |
| 71-1500 | Rb anti-Occludin | Traweger A, et al. | J Biol Chem | 277(12) | 10201-10208 | 2002 | IF WB |
| 71-1500 | Rb anti-Occludin | Wang Y, et al. | Am J Obstet Gynecol | 186 | 214-220 | 2002 | IF |
| 71-1500 | Rb anti-Occludin | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | WB |
| 71-1500 | Rb anti-Occludin | Barber AJ, Antonetti DA. | Invest Ophthalmol Vis Sci | 44 | 5410-5416 | 2003 | IHC (Rt retina, PFA-fixed) |
| 71-1500 | Rb anti-Occludin | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:2000) |
| 71-1500 | Rb anti-Occludin | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 71-1500 | Rb anti-Occludin | Hopkins AM, et al. | J Cell Sci | 116 | 725-742 | 2003 | WB, IF |
| 71-1500 | Rb anti-Occludin | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-1500 | Rb anti-Occludin | Mizuno K, et al. | J Biol Chem | 278(33) | 31240-31250 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Nunbhakdi-Craig V, et al. | J Virol | 77(5) | 2807-2818 | 2003 | IF, WB, Confocal |
| 71-1500 | Rb anti-Occludin | Peng B-H, et al. | J Biol Chem | 278(49) | 49644-49651 | 2003 | WB, IP |
| 71-1500 | Rb anti-Occludin | Rajasekaran SA, et al. | Am J Physiol Cell Physiol | 284 | C1497-1507 | 2003 | IP |
| 71-1500 | Rb anti-Occludin | Reuss B, et al. | J Neurosci | 23(16) | 6404-6412 | 2003 | IF (Ms), WB (Ms) |
| 71-1500 | Rb anti-Occludin | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:100) |
| 71-1500 | Rb anti-Occludin | Tafazoli F, et al. | Infect Immun | 71(2) | 872-881 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Takekuni K, et al. | J Biol Chem | 278(8) | 5497-5500 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Tian Y-C, et al. | Am J Physiol Renal Physiol | 285 | F130-142 | 2003 | ICC (1:100) |
| 71-1500 | Rb anti-Occludin | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Tugizov SM, et al. | Nature Medicine | 9(3) | 307-314 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF (mouse) |
| 71-1500 | Rb anti-Occludin | Yang R, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G621-629 | 2003 | IP |
| 71-1500 | Rb anti-Occludin | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 71-1500 | Rb anti-Occludin | Bailey TA, et al. | Invest Ophthalmol Vis Sci | 45 | 675-684 | 2004 | IF |
| 71-1500 | Rb anti-Occludin | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 71-1500 | Rb anti-Occludin | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | IF (Dog), WB |
| 71-1500 | Rb anti-Occludin | Broughman JR, et al. | Am J Physiol Cell Physiol | 287 | C1312-1323 | 2004 | |
| 71-1500 | Rb anti-Occludin | Epple HJ, et al. | Infect Immun | 72 | 4848-4858 | 2004 | |
| 71-1500 | Rb anti-Occludin | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:500) |
| 71-1500 | Rb anti-Occludin | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IP, IF (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Han X, et al. | Am J Physiol Lung Cell Mol Physiol | 286 | L259-267 | 2004 | IP, IF (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu), WB |
| 71-1500 | Rb anti-Occludin | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 71-1500 | Rb anti-Occludin | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 71-1500 | Rb anti-Occludin | Luton F, et al. | Mol Cell Biol | 15(3) | 1134-1145 | 2004 | WB |
| 71-1500 | Rb anti-Occludin | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 71-1500 | Rb anti-Occludin | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 71-1500 | Rb anti-Occludin | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB |
| 71-1500 | Rb anti-Occludin | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 71-1500 | Rb anti-Occludin | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 71-1500 | Rb anti-Occludin | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 71-1500 | Rb anti-Occludin | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 71-1500 | Rb anti-Occludin | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB, IF |
| 71-1500 | Rb anti-Occludin | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | WB (1:1000), IF (MDCK, 1:250) |
| 71-1500 | Rb anti-Occludin | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin) |
| 71-1500 | Rb anti-Occludin | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 71-1500 | Rb anti-Occludin | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-1500 | Rb anti-Occludin | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
| 71-1500 | Rb anti-Occludin | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 71-1500 | Rb anti-Occludin | Dokladny K, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G204-212 | 2006 | WB, IF (Caco-2) |
| 71-1500 | Rb anti-Occludin | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 71-1500 | Rb anti-Occludin | Vermeer PD, et al. | J Biol Chem | 281(3) | 1725-1730 | 2006 | WB (1:500), ICC (1:100) |
| 71-1500 | Rb anti-Occludin | Sakakibara A, et al. | J Cell Biol | 137(6) | 1393-1401 | 1997 | IP |
| 71-1500 | Rb anti-Occludin | Van Itallie CM, et al | J Cell Sci | 110 | 1113-1121 | 1997 | WB (1:1000) |
| 71-1500 | Rb anti-Occludin | Fanning AS, et al. | J Biol Chem | 275(45) | 29745-29753 | 1998 | IF |
| 71-1500 | Rb anti-Occludin | Jou TS, et al. | J Cell Biology | 142(1) | 101-115 | 1998 | IF, WB |
| 71-1500 | Rb anti-Occludin | Martin-Padura I, et al. | J Cell Biol | 142(1) | 117-127 | 1998 | IF |
| 71-1500 | Rb anti-Occludin | Wu S, et al. | PNAS | 95 | 14979-14848 | 1998 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Li D, Mrsny RJ. | J Cell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF, WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Folpe AL, et al. | Am J Surg Pathol | 26(12) | 1620-26 | 2002 | IHC (FFPE) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Furuse M, et al. | J Cell Biol | 156(6) | 1099-1111 | 2002 | IF (Ms liver, froz), WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Gudjonsson T, et al. | Genes Dev | 16(6) | 693-706 | 2002 | ICC |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Kiuchi-Saishin M, et al. | J Am Soc Nephrol | 13 | 875-886 | 2002 | IF (Ms kidney, froz) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | IP, WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Sakaguchi T, et al. | J Biol Chem | 277(24) | 21361-21370 | 2002 | IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Turksen K, Troy T-C. | Development | 129 | 1775-1784 | 2002 | IHC (Ms, paraffin, 1:100) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:1000) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Fukuhara A, et al. | J Biol Chem | 278(51) | 51885-51893 | 2003 | ICC |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nunbhakdi-Craig V, et al. | J Virol | 77(5) | 2807-2818 | 2003 | IF, WB, Confocal |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Young P, et al. | EMBO J | 22 | 5723-5733 | 2003 | IHC (Ms, PFA_fixed, paraffin) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
| Cat # | Product | Authors | Journal | Volume | Page(s) | Year | Application(s) |
|---|---|---|---|---|---|---|---|
| Adherens Junction Antibody Product References | |||||||
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hoover KB, et al. | Am J Pathol | 153(6) | 1767-1773 | 1998 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Auersperg N, et al. | PNAS | 96 | 6249-6254 | 1999 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Day ML, et al. | J Biol Chem | 274(14) | 9656-9664 | 1999 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Corn PG, et al. | Clin Cancer Res | 6 | 4243-4248 | 2000 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gottardi CJ, et al. | J Cell Biol | 153(5) | 1049-1059 | 2000 | WB, IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hazan RB, et al. | J Cell Biol | 148(4) | 779-790 | 2000 | WB, IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Heimann R, et al. | Cancer Res | 60 | 298-304 | 2000 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hsu M, et al. | J Cell Sci | 113 | 1535-1542 | 2000 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Acs G, et al. | Arch Pathol Lab Med | 125 | 198-201 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Adam L, et al. | J Biol Chem | 276(30) | 28443-28450 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gallicano GI, et al. | Development | 128 | 929-941 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gregoire L, et al. | Clin Cancer Res | 7 | 4280-4287 | 2001 | WB, IHC (paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Jacobs TW, et al. | Am J Surg Pathol | 25(2) | 229-36 | 2001 | IHC(FFPE)1:500 |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kaplan DK, et al. | J Biol Chem | 276(47) | 44037-44043 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Luo Y, et al. | Development | 128 | 459-469 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Machado JC, et al. | Oncogene | 20 | 1525-1528 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Meigs TE, et al | PNAS | 98(2) | 519-534 | 2001 | IF, WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Naora H, et al. | PNAS | 98(26) | 15209-15214 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Rashid MG, et al. | Cancer Res | 61 | 489-492 | 2001 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zavadil J, et al. | PNAS | 98(12) | 6686-6691 | 2001 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zhong Y, et al. | Clin Cancer Res | 7 | 1683-1687 | 2001 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Alpaugh ML, et al. | Oncogene | 21 | 3631-3643 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hajra KM, et al. | Cancer Res | 62 | 1613-1618 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kim J-T, et al. | J Biol Chem | 277(35) | 31938-31948 | 2002 | IF, adhesion blocking studies |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Laura RP, et al. | J Biol Chem | 277(15) | 12906-12914 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Li Q, et al. | J Biol Chem | 277(48) | 46447-46455 | 2002 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Muller N, et al. | Oncogene | 21 | 6049-6058 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Niessen CM, Gumbiner BM. | J Cell Biol | 156(2) | 389-399 | 2002 | ? |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Sahai E, Marshall CJ. | Nature Cell Biol | 4 | 408-415 | 2002 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tran NL, et al. | J Biol Chem | 277(36) | 32905-32914 | 2002 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Weaver VM, et al. | Cancer Cell | 2 | 205-216 | 2002 | blocking |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Boussioutas A, et al. | Cancer Res | 63 | 2569-2577 | 2003 | IHC (paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Chan AOO, et al. | J Clin Oncol | 21(12) | 2288-2293 | 2003 | IHC (paraffin, 1:200) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kowalski PJ, et al. | Breast Cancer Res | 5 | R217-R222 | 2003 | IHC (FFPE, Ventana Biotek Techmate 500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kuefer R, et al. | Clin Cancer Res | 9(17) | 6447-6452 | 2003 | WB (Hu prostate) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Rios-Doria J, et al. | J Biol Chem | 278(2) | 1372-1379 | 2003 | WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Suriano G, et al. | Hum Mol Genet | 12 | 575-582 | 2003 | IHC (froz) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tian F, et al. | Cancer Res | 63 | 8284-8292 | 2003 | IF, WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Troyanovsky RB, et al. | Mol Cell Biol | 23(22) | 7965-7972 | 2003 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Gottardi CJ, Gumbiner BM. | Am J Physiol Cell Physiol | 286 | C747-756 | 2004 | WB (1:10,000) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Haven CJ, et al. | Cancer Res | 64(20) | 7405-7411 | 2004 | IHC (paraffin, 1:500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Lecuit M, et al. | PNAS | 101(16) | 6152-6157 | 2004 | IHC (FFPE and froz, 1:500) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Tobey NA, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G1042-1049 | 2004 | IHC (Rb, PFA-fixed, paraffin) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Peignon G, et al. | J Biol Chem | 281(6) | 3560-3568 | 2006 | IF (1:200) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Horiguchi Y, et al. | J Histochem Cytochem | 42(10) | 1333-1340 | 1994 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Watabe M, et al. | J Cell Biol | 127(1) | 247-256 | 1994 | IP |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Blauvelt A, et al. | J Invest Dermatology | 104 | 193-6 | 1995 | Flow Cytometry |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Glukhova M, et al. | Am J Pathol | 146 | 706-716 | 1995 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Sanna M, et al. | Anat Pathol | 105(4) | 394-402 | 1995 | IHC (frozen) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Siitonen SM, et al. | Anatomic Pathology | 105(4) | 394-402 | 1996 | IHC (1:800) |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Braga VMM, et al. | J Cell Biol | 137(6) | 1421-1431 | 1997 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Hoover KB, et al. | Am J Pathol | 153(6) | 1767-1773 | 1998 | IF |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Kondo K, et al. | Cancer Res | 58 | 2014-2019 | 1998 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Soto H, et al. | Human Pathology | 30(11) | 1344-1349 | 1999 | |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Acs G, et al. | Arch Pathol Lab Med | 125 | 198-201 | 2001 | IHC |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-1700 | Ms anti-E-cadherin (HECD-1) | Zavadil, et al. | PNAS | 98(12) | 7573-7578 | 2001 | IF and WB |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Takeichi M. | Development | 102 | 639-655 | 1988 | WB |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (pos), IHC |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Binding comp, |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Babich M, et al. | Life Sciences | 54(11) | PL-201-PL20 8 | 1994 | Immunostain |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Fannon A, et al. | J Cell Biol | 129 (1) | 189-202 | 1995 | |
| 13-1800 | Rt anti-E-cadherin (ECCD-1) | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | Cell-cell adhesion blocking (pos) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hosono S, et al. | J Biol Chem | 275(15) | 10943-10953 | 2000 | WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Mulac-Jericevic B, et al. | Science | 289 | 1751-1754 | 2000 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Carothers AM, et al. | J Biol Chem | 276(42) | 39094-39102 | 2001 | WB, IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Bouchard M, et al. | Genes Dev | 16(22) | 2958-2970 | 2002 | IHC (Ms) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | DasGupta R, et al. | J Cell Biol | 158(2) | 331-344 | 2002 | IF (Ms), WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gritli-Linde A, et al. | Development | 129 | 5323-5337 | 2002 | IHC (Ms, PFA, paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Lopez T, Hanahan D. | Cancer Cell | 1 | 339-353 | 2002 | IHC - frozen, Ms |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Ngan ESW, et al. | PNAS | 99(17) | 11187-11192 | 2002 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Pelengaris S, et al. | Cell | 109 | 321-334 | 2002 | IHC - paraffin, Ms |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Wali RK, et al. | Cancer Epidemiol Biomarker s Prev | 11 | 1653-1662 | 2002 | WB, IHC (rat) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Welm BE, et al. | J Cell Biol | 157(4) | 703-714 | 2002 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Yoon M, Spear PG. | J Virol | 76(14) | 7203-7208 | 2002 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Davis J, et al. | J Cell Sci | 116 | 2157-2167 | 2003 | WB, IHC (Ms eye, froz, 0.1ug/mL) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gouyon F, et al. | J Physiol | 552 | 823-832 | 2003 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Kopp T, et al. | J Immunol | 171 | 5438-5444 | 2003 | FC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Lallemand D, et al. | Genes Dev | 17(9) | 1090-1100 | 2003 | IF (Ms, 1:250) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Sakai T, et al. | Genes Dev | 17(7) | 926-940 | 2003 | ICC (Ms) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Devaux JJ, et al. | J Neurosci | 24(5) | 1236-1244 | 2004 | IHC (Ms, Rt, froz, 1:50) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Fouquet S, et al. | J Biol Chem | 279(41) | 43061-43069 | 2004 | IF (Ms intestine, 1:250), WB (1:2,500) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hogan C, et al. | Mol Cell Biol | 24(15) | 6690-6700 | 2004 | IF (Hu) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Linehan MM, et al. | J Virol | 78 | 2530-2536 | 2004 | IF (Ms, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Oshima RG, et al. | Cancer Res | 64 | 169-179 | 2004 | IF (Ms tissue, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Wandzioch E, et al. | PNAS | 101(47) | 16549-16554 | 2004 | IHC (Ms embryo, paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tricaud N, et al. | J Neurosci | 25(13) | 3259-3269 | 2005 | IHC (Ms sciatic nerve, froz) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Peignon G, et al. | J Biol Chem | 281(6) | 3560-3568 | 2006 | IF (1:250) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Takeichi M. | Development | 102 | 639-655 | 1988 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (neg ctrl) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Hirano S, et al. | Cell | 70 | 293-301 | 1992 | WB, IP |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Flow |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Babich M and Foti RP. | Life Sciences | 54(11) | PL-201-PL20 8 | 1994 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Horiguchi Y, et al. | J Histochem Cytochem | 42(10) | 1333-1340 | 1994 | IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Nagafuchi A, et al. | J Cell Biol | 127(1) | 235-245 | 1994 | IB,IHC |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Tsarfaty I, et al. | Science | 263 | 98-101 | 1994 | IHC (paraffin) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Watabe M, et al. | J Cell Biol | 127(1) | 247-251 | 1994 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Fannon AM, et al. | J Cell Biol | 129(1) | 189-202 | 1995 | IP, WB, IHC (frozen) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Palacios J, et al. | Am J Pathol | 146 | 605-612 | 1995 | IHC(oct) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | IP, IF, WB, Flow |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Shibamoto S, et al. | J Cell Biol | 128(5) | 949-957 | 1995 | HECD-2-IP, WB |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Mbalaviele G, et al. | Cancer Res | 56 | 4063-4070 | 1996 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Braga VMM, et al. | J Cell Biol | 137(6) | 1421-1431 | 1997 | |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Dunn RJ, et al. | J Histochem Cytochem | 45(1) | 129-141 | 1997 | IHC (frozen/OCT) |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Gallicano GI, et al. | J Cell Biol | 143(7) | 2009-2022 | 1998 | IF |
| 13-1900 | Rt anti-E-cadherin (ECCD-2) | Perl AK, et al. | Nature Med | 5(3) | 286-291 | 1999 | F |
| 13-2000 | Rt anti-P-cadherin | Liu G, et al. | J Clin Invest | 112(2) | 209-221 | 2003 | Injected into rats |
| 13-2000 | Rt anti-P-cadherin | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 13-2000 | Rt anti-P-cadherin | Rico M, et al. | Am J Physiol Renal Physiol | 289 | F431-441 | 2005 | IF (1:50) |
| 13-2000 | Rt anti-P-cadherin | Takeichi, M. | Development | 102 | 639-655 | 1988 | Adhesion Inhibition |
| 13-2000 | Rt anti-P-cadherin | Hirai Y, et al. | Development | 105 | 271-277 | 1989 | Cell-cell adhesion blocking (pos), IHC |
| 13-2000 | Rt anti-P-cadherin | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-2000 | Rt anti-P-cadherin | Tang A, et al. | Nature | 361 | 82-85 | 1993 | Inhibition studies, |
| 13-2000 | Rt anti-P-cadherin | Roh J-Y, et al. | J Cell Biol | 128(5) | 939-947 | 1995 | Cell-cell adhesion blocking (neg. cntl.) |
| 13-2000 | Rt anti-P-cadherin | Jamora C, et al. | Nature | 422 | 317-322 | 2003 | IHC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Mahlapuu M, et al. | Development | 128 | 155-166 | 2001 | IHC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Ryan PL, et al | PNAS | 98(8) | 4323-4327 | 2001 | ICC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Robinson EE, et al. | J Cell Sci | 116 | 377-386 | 2003 | FC |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Ciesiolka M, et al. | J Cell Sci | 117 | 4325-4339 | 2004 | WB (Xen) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Hatta K, et al. | Nature | 320(6061) | 447-449 | 1986 | WB, IHC (frozen) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Takeichi M. | Development | 102 | 639-655 | 1988 | Adhesion Inhibition |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Nose A, et al. | Cell | 61 | 147-155 | 1990 | Epitope Mapping |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Hirano S, et al. | Cell | 70 | 293-301 | 1992 | WB, IP, IF |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Bixby JL, et al. | J Neurosci | 13(8) | 3421-3432 | 1993 | WB |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Balsamo J, et al. | J Cell Biol | 129(5) | 1391-1401 | 1995 | Affinity Chromatography, WB |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Zong CS, et al. | J Biol Chem | 272(3) | 1500-1506 | 1997 | WB ( no data shown ) |
| 13-2100 | Rt anti-N-cadherin (NCD-2) | Huttenlocher A, et al. | J Cell Biol | 141(2) | 515-526 | 1998 | cell inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Day ML, et al. | J Biol Chem | 274(14) | 9656-9664 | 1999 | blocking studies |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mueller S, et al. | Cancer Res | 60 | 156-163 | 2000 | blocking studies |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Reinacher-Schick A, Gumbiner BM. | J Cell Biol | 152(3) | 491-502 | 2001 | WB |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Klingelhofer J, et al. | Oncogene | 22 | 1181-1188 | 2003 | |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mariner DJ, et al. | J Cell Sci | 117 | 1339-1350 | 2004 | Blocking (1ug/mL) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Merot Y, et al. | J Biol Chem | 279(25) | 26184-26191 | 2004 | WB (1:1000) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Dalrymple S, et al. | Cancer Res | 65 | 9269-9279 | 2005 | Blocking (2ug/mL) |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Pang J-H, et al. | J Biol Chem | 280(4) | 3043-3050 | 2005 | IP |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Katayama M, et al. | J Oncol Int | 5 | 1049-1057 | 1994 | ELISA, WB, Adhesion Inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Watabe M, et al. | J Cell Biol | 127(1) | 247-256 | 1994 | IP |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Mitra, et al. | Lab Invest | 76 | 99-107 | 1997 | Blocking |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | St. Croix B, et al. | J Cell Biol | 142(2) | 557-571 | 1998 | Inhibition |
| 13-5700 | Ms anti-E-cadherin (SHE78-7) | Orford K, et al. | J Cell Biol | 146(4) | 855-867 | 1999 | |
| 13-5800 | Ms anti-P-cadherin | Muller N, et al. | Oncogene | 21 | 6049-6058 | 2002 | |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | J Cell Biol | 109 | 1787-1794 | 1989 | ICC, WB, cell-cell adhesion blocking (pos) |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | Cancer Res | 49 | 2128-2133 | 1989 | WB, IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Shimoyama Y, et al. | Cancer Res | 51 | 2185-2192 | 1991 | WB, IHC |
| 13-5800 | Ms anti-P-cadherin | Doki Y, et al. | Cancer Res | 53 | 3421-3426 | 1993 | WB |
| 13-5800 | Ms anti-P-cadherin | Morton RA, et al. | Cancer Res | 53 | 3585-3590 | 1993 | IF, WB, IP |
| 13-5800 | Ms anti-P-cadherin | Rasbridge SA. | J Pathol | 169 | 245-250 | 1993 | IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Yasui W, et al. | Internation J of Cancer | 54 | 49-52 | 1993 | WB, IHC (frozen) |
| 13-5800 | Ms anti-P-cadherin | Hodivala KJ. | J Cell Biol | 124(4) | 589-600 | 1994 | IF, Stratification Inhibition |
| 13-5800 | Ms anti-P-cadherin | Glukhova M, et al. | Am J Pathol | 146 | 706-716 | 1995 | IF |
| 13-5800 | Ms anti-P-cadherin | Palacios J, et al. | Am J Pathol | 146 | 605-612 | 1995 | IHC(oct) |
| 13-5800 | Ms anti-P-cadherin | Braga VMM, et al. | J Cell Biol | 137 (6) | 1421-1431 | 1997 | |
| 13-8400 | Ms anti-beta-Catenin | Sakanaka C, Williams LT. | J Biol Chem | 274(20) | 14090-14093 | 1999 | IP |
| 13-8400 | Ms anti-beta-Catenin | Woo PL, et al. | J Biol Chem | 274(46) | 32818-32828 | 1999 | ICC |
| 13-8400 | Ms anti-beta-Catenin | Tachibana K, et al. | J Cell Biol | 150(5) | 1161-1175 | 2000 | IF |
| 13-8400 | Ms anti-beta-Catenin | Adam L, et al. | J Biol Chem | 276(30) | 28443-28450 | 2001 | IP, IF |
| 13-8400 | Ms anti-beta-Catenin | Dottori M, et al | Development | 128 | 4127-4138 | 2001 | IHC |
| 13-8400 | Ms anti-beta-Catenin | Kaplan DK, et al. | J Biol Chem | 276(47) | 44037-44043 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Meigs TE, et al. | PNAS | 98(2) | 519-534 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Rashid MG, et al. | Cancer Res | 61 | 489-492 | 2001 | IP, WB |
| 13-8400 | Ms anti-beta-Catenin | Vallorosi CJ, et al. | J Biol Chem | 275(2) | 3328-3334 | 2001 | IP and WB |
| 13-8400 | Ms anti-beta-Catenin | Carmichael J, et al. | J Biol Chem | 277(37) | 33791-33798 | 2002 | WB, ICC |
| 13-8400 | Ms anti-beta-Catenin | Kramer KL, et al. | Cell | 111 | 981-990 | 2002 | WB |
| 13-8400 | Ms anti-beta-Catenin | Ren J, et al. | J Biol Chem | 277(20) | 17616-17622 | 2002 | WB |
| 13-8400 | Ms anti-beta-Catenin | Swinney DC, et al. | J Biol Chem | 277(26) | 23573-23581 | 2002 | ELISA |
| 13-8400 | Ms anti-beta-Catenin | Warchol ME. | J Neurosci | 22(7) | 2607-2616 | 2002 | ICC (Ck) |
| 13-8400 | Ms anti-beta-Catenin | Bamji SX, et al. | Neuron | 40 | 719-731 | 2003 | IF (rats) |
| 13-8400 | Ms anti-beta-Catenin | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 13-8400 | Ms anti-beta-Catenin | Matsumura K, et al. | Blood | 101 | 1367-1374 | 2003 | |
| 13-8400 | Ms anti-beta-Catenin | Rios-Doria J, et al. | J Biol Chem | 278(2) | 1372-1379 | 2003 | IP |
| 13-8400 | Ms anti-beta-Catenin | Hill DA, et al. | J Cell Sci | 117 | 5847-5854 | 2004 | WB |
| 13-8400 | Ms anti-beta-Catenin | Kaplan DD, et al. | J Biol Chem | 279(12) | 10829-10832 | 2004 | IF |
| 13-8400 | Ms anti-beta-Catenin | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | IF (Ms kidney, froz, 1:100) |
| 13-8400 | Ms anti-beta-Catenin | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 13-8400 | Ms anti-beta-Catenin | Yamamoto M. | J Biol Chem | 272(19) | 12492-12494 | 1997 | IP, WB |
| 13-8400 | Ms anti-beta-Catenin | Sakanaka C, et al. | PNAS | 95 | 3020-3023 | 1998 | IP |
| 13-8400 | Ms anti-beta-Catenin | Wu S, et al. | PNAS | 95 | 14979-14984 | 1998 | WB |
| 13-8400 | Ms anti-beta-Catenin | Meigs TE, et al. | PNAS | 98(2) | 519-534 | 2001 | WB, IF |
| 13-8400 | Ms anti-beta-Catenin | Vallorosi CJ, et al. | J Biol Chem | 275(5) | 3328-3334 | 2001 | IP and WB |
| 13-8500 | Ms anti-gamma-Catenin | Ilan N, et al. | J Biol Chem | 275(28) | 21435-21443 | 2000 | IHC |
| 13-8500 | Ms anti-gamma-Catenin | Grooteclaes M, et al. | PNAS | 100(8) | 4568-4573 | 2003 | WB |
| 13-8500 | Ms anti-gamma-Catenin | Klingelhofer J, et al. | Oncogene | 22 | 1181-1188 | 2003 | |
| 13-8500 | Ms anti-gamma-Catenin | Li Y, et al. | Molec Cancer Res | 1 | 765-775 | 2003 | WB, IF |
| 13-8500 | Ms anti-gamma-Catenin | Kaplan DD, et al. | J Biol Chem | 279(12) | 10829-10832 | 2004 | WB |
| 13-8500 | Ms anti-gamma-Catenin | Descargues P, et al. | Nature Genetics | 37 | 56-65 | 2005 | WB, IHC (ms) |
| 13-8500 | Ms anti-gamma-Catenin | Silberberg M, et al. | Am J Physiol Renal Physiol | 288 | F1153-1163 | 2005 | Confocal IF (Hu kidney, 1:100) |
| 13-9700 | Ms anti-alpha-Catenin | Allport JR, et al. | J Cell Biol | 148(1) | 203-216 | 1999 | IF |
| 13-9700 | Ms anti-alpha-Catenin | Giannini AL, et al. | J Biol Chem | 275(29) | 21883-21888 | 2000 | WB |
| 13-9700 | Ms anti-alpha-Catenin | Carothers AM, et al. | J Biol Chem | 276(42) | 39094-39102 | 2001 | WB |
| 13-9700 | Ms anti-alpha-Catenin | Scheffers MS, et al. | Hum Mol Genet | 11 | 59-67 | 2002 | |
| 13-9700 | Ms anti-alpha-Catenin | Jacquemier J, et al. | Cancer Res | 65(3) | 767-779 | 2005 | IHC (FFPE) |
| 13-9700 | Ms anti-alpha-Catenin | Allport JR, et al. | J Exp Med | 186 | 517-527 | 1997 | IF |
| 13-9700 | Ms anti-alpha-Catenin | Yamamoto M. | J Biol Chem | 272(19) | 12492-12494 | 1997 | IP, WB |
| 32-6100 | Ms anti-Desmoglein-2 | Silberberg M, et al. | Am J Physiol Renal Physiol | 288 | F1153-1163 | 2005 | IF (Hu kidney cells, 1:25) |
| 33-3900 | Ms anti-N-cadherin | Hazan RB, et al. | J Cell Biol | 148(4) | 779-790 | 2000 | WB, IHC, migration inhibition |
| 33-3900 | Ms anti-N-cadherin | van Raamsdock CD, et al. | Development | 127 | 5439-5448 | 2000 | IHC |
| 33-3900 | Ms anti-N-cadherin | Gottardi CJ, et al. | J Cell Biol | 153(5) | 1049-1059 | 2001 | WB |
| 33-3900 | Ms anti-N-cadherin | Janssens B, et al. | J Cell Sci | 114 | 3177-3188 | 2001 | IF |
| 33-3900 | Ms anti-N-cadherin | Kotelevets L, et al. | J Cell Biol | 155(7) | 1129-1135 | 2001 | WB |
| 33-3900 | Ms anti-N-cadherin | Luo Y, et al. | Development | 128 | 459-469 | 2001 | IHC |
| 33-3900 | Ms anti-N-cadherin | Xu X, et al. | J Cell Biol | 154(1) | 217-229 | 2001 | IHC |
| 33-3900 | Ms anti-N-cadherin (3B9) | Andrieux A, et al. | Genes Dev | 16(18) | 2350-2364 | 2002 | WB (Ms) |
| 33-3900 | Ms anti-N-cadherin | Laura RP, et al. | J Biol Chem | 277(15) | 12906-12914 | 2002 | WB |
| 33-3900 | Ms anti-N-cadherin | Niessen CM, Gumbiner BM. | J Cell Biol | 156(2) | 389-399 | 2002 | IF |
| 33-3900 | Ms anti-N-cadherin | Suyama K, et al. | Cancer Cell | 2 | 301-314 | 2002 | WB, IP |
| 33-3900 | Ms anti-N-cadherin (3B9) | Davani S, et al. | Circulation | 108 | 253-258 | 2003 | IHC (Rt heart, paraffin, |
| 33-3900 | Ms anti-N-cadherin | Kang J-S, et al. | PNAS | 100(7) | 3989-3994 | 2003 | WB |
| 33-3900 | Ms anti-N-cadherin | Krueger SR, et al. | Neuron | 40 | 945-957 | 2003 | IF (rats) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Robinson EE, et al. | J Cell Sci | 116 | 377-386 | 2003 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Rubinek T, et al. | J Clin Endocrinol Metab | 88(8) | 3724-3730 | 2003 | IF (paraffin, 1:100) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Bharti S, et al. | Mol Cell Biol | 15(1) | 397-406 | 2004 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Hill DA, et al. | J Cell Sci | 117 | 5847-5854 | 2004 | WB |
| 33-3900 | Ms anti-N-cadherin (3B9) | Luo Y, Radice GL. | J Cell Biol | 169(1) | 29-34 | 2005 | IF (HUVEC, HVMEC), Confirmation of siRNA knockdown (IF) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Pon YL, et al. | J Biol Chem | 280(15) | 15438-15448 | 2005 | IP, WB (1:1,000) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Siu MKY, et al. | J Biol Chem | 280(26) | 25029-25047 | 2005 | IP |
| 33-3900 | Ms anti-N-cadherin (3B9) | Wattel S, et al. | Oncogene | 24 | 6902-6916 | 2005 | WB, IHC (Hu thyroid adenoma, froz) |
| 33-3900 | Ms anti-N-cadherin (3B9) | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | WB, ICC |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Kim M-K, et al. | App Immunohistochem Mole c Morphol | 10(4) | 332-338 | 2002 | IHC (paraffin) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Palacios J, et al. | Clin Cancer Res | 9(10) | 3606-3614 | 2003 | IHC (Hu breast cancer, paraffin, 1:200) |
| 33-4000 | Ms anti-E-cadherin (4A2C7) | Guerini V, et al. | Cancer Res | 65(12) | 5445-5453 | 2005 | WB (1:200) |
| 33-9600 | Ms anti-p120 Catenin (C-term) | Wu J, et al. | Hybridoma | 17(2) | 175-183 | 1999 | WB, IP, IF |
| 33-9600 | Ms anti-p120 Catenin (C-term) | Humtsoe JO, et al. | EMBO J | 22 | 1539-1554 | 2003 | WB |
| 33-9600 | Ms anti-p120 Catenin | Tinkle CL, et al. | PNAS | 101(2) | 552-557 | 2004 | WB, IF |
| 33-9700 | Ms anti-p120 Catenin (N-term) | Wu J, et al. | Hybridoma | 17(2) | 175-183 | 1999 | WB, IP, IF |
| 33-9700 | Ms anti-p120 Catenin (N-term) | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | WB |
| 35-4700 | Ms anti-Ksp-cadherin | Thedieck C, et al. | Br J Cancer | 92 | 2010-2017 | 2005 | ICC (Hu RCC cells, 1:50), IHC (Hu kidney, froz, 1:50) |
| 35-4700 | Ms anti-Ksp-cadherin | Yamamoto M, et al. | Am J Physiol Renal Physiol | 290 | F52-60 | 2006 | IHC (Ms froz, 1:100), confocal IF |
| 71-1200 | Rb anti-alpha-Catenin | Quinlan MP, Hyatt JL. | Cell Growth Differ | 10 | 839-854 | 1999 | IP, IF |
| 71-1200 | Rb anti-alpha-Catenin | Mauro L, et al. | J Biol Chem | 276(43) | 39892-39897 | 2001 | WB, IP |
| 71-1200 | Rb anti-alpha-Catenin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-1200 | Rb anti-alpha-Catenin | Mucha DR, et al. | Am J Physiol Heart Circ Phy siol | 284 | H994-1002 | 2003 | ICC (Bv, 1:100) |
| 71-1200 | Rb anti-alpha-Catenin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | WB (Rt) |
| 71-1200 | Rb anti-alpha-Catenin | Osta WA, et al. | Cancer Res | 64(16) | 5818-5824 | 2004 | WB |
| 71-1200 | Rb anti-alpha-Catenin | Kolly C, et al. | J Invest Dermatol | 124 | 1014-1025 | 2005 | WB (Dog) |
| 71-1200 | Rb anti-alpha-Catenin | Margulis A, et al. | Cancer Res | 65(5) | 1783-1791 | 2005 | WB |
| 71-1200 | Rb anti-alpha-Catenin | St Croix B, et al. | J Cell Biology | 142(2) | 557-571 | 1998 | WB |
| 71-2700 | Rb anti-beta-Catenin | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 71-2700 | Rb anti-beta-Catenin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-2700 | Rb anti-beta-Catenin | Walters RW, et al. | Cell | 110 | 789-799 | 2003 | WB, IP, ICC |
| 71-2700 | Rb anti-beta-Catenin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | IF (Rt, froz), WB (Rt) |
| 71-2700 | Rb anti-beta-Catenin | Osta WA, et al. | Cancer Res | 64(16) | 5818-5824 | 2004 | WB |
| 71-2700 | Rb anti-beta-Catenin | Reymond N, et al. | J Exp Med | 199 | 1331-1341 | 2004 | IF (Hu) |
| 71-2700 | Rb anti-beta-Catenin | Margulis A, et al. | Cancer Res | 65(5) | 1783-1791 | 2005 | IF |
| 71-2700 | Rb anti-beta-Catenin | Yongqing L, et al. | J Biol Chem | 276(38) | 35239-35242 | 2001 | WB |
| 71-7100 | Rb anti-pan-cadherin | Colonnese MT, et al. | J Neurophysiol | 89 | 57-68 | 2003 | WB (Rt) |
| 71-7100 | Rb anti-pan-cadherin | Croft DR, et al. | Cancer Res | 64(24) | 8994-9001 | 2004 | IF |
| 71-7100 | Rb anti-pan-cadherin | Hinz B, et al. | Mol Cell Biol | 15(9) | 4310-4320 | 2004 | WB (Rt) |
| 71-7100 | Rb anti-pan-cadherin | Ren Y-G, et al. | Mol Cell Biol | 15(11) | 5064-5074 | 2004 | WB (Hu) |
| 71-7100 | Rb anti-pan-cadherin | Schedin PJ, et al. | Oncogene | 23 | 1766-1779 | 2004 | IHC (1:400) |
| 71-7600 | Rb anti-cadherin-11 | Straub BK, et al. | J Cell Sci | 116 | 4985-4995 | 2003 | |
| 71-7600 | Rb anti-cadherin-11 | Morimoto AM, et al. | Oncogene | 23 | 1618-1626 | 2004 | |
| Gap Junction Antibody Product References | |||||||
| 13-8100 | Ms anti-CX26 (12H10) | Ito A, et al. | J Clin Invest | 105(9) | 1189-97 | 2000 | WB 1:300, IHC (PFA-fixed, Hu) |
| 13-8100 | Ms anti-CX26 (12H10) | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | |
| 13-8100 | Ms anti-CX26 (12H10) | Rouan F, et al. | J Cell Sci | 114 | 2105-2113 | 2001 | IHC (frozen), WB |
| 13-8100 | Ms anti-CX26 (12H10) | Solomon IC, et al. | Resp Pathol | 129 | 101-121 | 2001 | IHC |
| 13-8100 | Ms anti-CX26 (12H10) | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF WB |
| 13-8100 | Ms anti-CX26 (12H10) | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | WB (1:1000) |
| 13-8100 | Ms anti-CX26 (12H10) | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | |
| 13-8100 | Ms anti-CX26 (12H10) | Gemel J, et al. | J Cell Sci | 117 | 2469-2480 | 2004 | IF (1:500) |
| 13-8100 | Ms anti-CX26 (12H10) | Saito T, et al. | Oncogene | 23 | 1109-1116 | 2004 | IF (1:500) |
| 13-8100 | Ms anti-CX26 (12H10) | Thomas T, et al. | J Biol Chem | 279(18) | 19157-19168 | 2004 | ICC (1:200) |
| 13-8100 | Ms anti-Cx26 (CX-12H10) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IF |
| 13-8100 | Ms anti-CX26 (12H10) | You S, et al. | Cancer Res | 58 | 1498-1502 | 1998 | IHC (Frozen) |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Alvarez-Maubecin V, et al. | J Neurosci | 20(11) | 4091-4098 | 2000 | ICC (rat) |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Peracchia C, et al. | J Biol Chem | 275(34) | 26220-26224 | 2000 | IF |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Solomon IC, et al. | Resp Pathol | 129 | 101-121 | 2001 | IHC |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:500), WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Saito T, et al. | Oncogene | 23 | 1109-1116 | 2004 | IF (1:500) |
| 13-8200 | Ms anti-Cx32 (CX-2C2) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | |
| 13-8200 | Ms anti-CX32 (CX-2C2) | Li J, et al. | J Comp Neurol | 379(4) | 571-591 | 1997 | WB (1:200), IHC (froz), EM |
| 13-8300 | Ms anti-CX43 | Beardslee MA, et al. | Circ Res | 87 | 656-662 | 2000 | WB IF |
| 13-8300 | Ms anti-CX43 | Ciray HN, et al. | Am J Obstet Gynecol | 182 | 926-930 | 2000 | IF |
| 13-8300 | Ms anti-Cx43 | Quist AP, et al. | J Cell Biol | 148(5) | 1063-1074 | 2000 | IF |
| 13-8300 | Ms anti-CX43 | Bruzzone S, et al. | J Biol Chem | 276(51) | 48300-48308 | 2001 | WB |
| 13-8300 | Ms anti-CX43 | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 13-8300 | Ms anti-Cx43 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 13-8300 | Ms anti-CX43 | Dubina MV, et al. | Oncogene | 21 | 4992-4996 | 2002 | |
| 13-8300 | Ms anti-CX43 | Piechocki MP, et al. | Clin Cancer Res | 8 | 870-877 | 2002 | IP, WB |
| 13-8300 | Ms anti-CX43 | Caton D, et al. | J Cell Sci | 116 | 2285-2294 | 2003 | WB (Rt) |
| 13-8300 | Ms anti-CX43 | Chen J-T, et al. | Clin Cancer Res | 9(11) | 4200-4204 | 2003 | WB (Hu, 1:1000) |
| 13-8300 | Ms anti-CX43 | Christ GJ, et al. | Am J Physiol Regulatory Int egrative Comp Physiol | 284 | R1241-1248 | 2003 | WB (1:500) |
| 13-8300 | Ms anti-Cx43 | Eugenin EA, et al. | J Immunol | 170 | 1320-1328 | 2003 | WB, IF |
| 13-8300 | Ms anti-CX43 | Gutstein DE, et al. | J Cell Sci | 116 | 875-885 | 2003 | WB, IF (Ms heart, froz) |
| 13-8300 | Ms anti-CX43 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB |
| 13-8300 | Ms anti-Cx43 (CX-1B1) | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IF, WB |
| 13-8300 | Ms anti-CX43 | Li W, et al. | J Biol Chem | 280(9) | 7941-7948 | 2005 | WB, IF |
| 13-8300 | Ms anti-CX43 | Muramatsu T. | J Histochem Cytochem | 44(1) | 49-56 | 1996 | |
| 13-8300 | Ms anti-CX43 | Hayashi T, et al. | Cancer Letters | 112 | 103-111 | 1997 | WB |
| 13-8300 | Ms anti-CX43 | Koval M, et al. | J Cell Biol | 137(4) | 847-857 | 1997 | IF |
| 13-8300 | Ms anti-CX43 | Masgrau-Peya E, et al. | J Histochem Cytochem | 45(9) | 1207-1215 | 1997 | IF 1:500dilution |
| 13-8300 | Ms anti-CX43 | Nagy JI, et al. | Exp Cell Res | 236 | 127-136 | 1997 | WB, IHC, EM |
| 13-8300 | Ms anti-CX43 | Xie H, et al. | J Cell Biol | 137(1) | 203-210 | 1997 | WB |
| 13-8300 | Ms anti-CX43 | Li WEI, et al. | Eur J Neurosci | 10 | 2444-2463 | 1998 | WB, IHC |
| 13-8300 | Ms anti-CX43 | Martin PE, et al. | J Biol Chem | 273(3) | 1719-1726 | 1998 | WB |
| 13-8300 | Ms anti-CX43 | Toyofuku T, et al. | J Biol Chem | 273(3) | 1519-1528 | 1998 | WB |
| 13-8300 | Ms anti-CX43 | Bittman KS, et al. | Cerebral Cortex | 9 | 188-195 | 1999 | IF |
| 13-8300 | Ms anti-CX43 | Nagy JI, et al. | Neuroscience | 88(2) | 447-468 | 1999 | IF |
| 13-8300 | Ms anti-CX43 | Xie H, et al. | Neuroscience | 88(2) | 447-468 | 1999 | |
| 13-8300 | Ms anti-CX43 | Li WEI, Nagy JI. | Neurosci | 97 (1) | 113-123 | 2000 | WB, iHC |
| 13-8300 | Ms anti-CX43 | Li WEI, Nagy JI. | Eur J Neurosci | 12 | 2644-2650 | 2000 | |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | Neuroscience | 88 | 447-468 | 1999 | |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | J Comp Neurol | 441(4) | 302-323 | 2001 | IF (1:500) |
| 33-2500 | Ms anti-Cx30 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, IHC (froz), Immunogold labeling |
| 33-2500 | Ms anti-Cx30 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:500), WB |
| 33-2500 | Ms anti-Cx30 | Sun J, et al. | Am J Physiol Cell Physiol | 288 | C613-623 | 2005 | WB (1:1,000), IP, IHC (Ms cochlea, 1:200) |
| 33-2500 | Ms anti-Cx30 | Jagger DJ, Forge A. | J Neurosci | 26(4) | 1260-1268 | 2006 | IF (Rt cochlea, 1:200) |
| 33-4300 | Ms anti-Cx50 | Klepeis VE, et al. | J Cell Sci | 114 | 4185-4195 | 2001 | WB |
| 33-4300 | Ms anti-Cx50 | Lin D, et al. | Mol Vision | 10 | 688-695 | 2004 | WB, IP (Rt) |
| 33-5800 | Ms anti-CX26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | WB, IF |
| 33-5800 | Ms anti-CX26 | Rouan F, et al. | J Cell Sci | 114 | 2105-2113 | 2001 | IHC (frozen), WB |
| 33-5800 | Ms anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 33-5800 | Ms anti-Cx26 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 33-5800 | Ms anti-CX26 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 33-5800 | Ms anti-Cx26 | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | IF (paraffin) |
| 33-5800 | Ms anti-Cx26 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:200), WB |
| 34-4200 | Rb anti-Cx29 | Li X, et al. | Eur J Neurosci | 16 | 795-806 | 2002 | ICC (froz Ms sciatic nerve), immunogold labeling, WB |
| 34-4200 | Rb anti-Cx29 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 34-4200 | Rb anti-Cx29 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 34-4200 | Rb anti-Cx29 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 34-4200 | Rb anti-Cx29 | Tricaud N, et al. | J Neurosci | 25(13) | 3259-3269 | 2005 | IHC (Ms sciatic nerve, froz) |
| 34-5700 | Rb anti-Connexin 32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 34-5700 | Rb anti-Connexin 32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 34-5700 | Rb anti-Connexin 32 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 34-5700 | Rb anti-Connexin 32 | Zhu L, et al. | Mol Cell Biol | 24(7) | 2673-2681 | 2004 | IHC (Ms, 1:200) |
| 35-5000 | Ms anti-Cx43 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:150), WB |
| 35-5000 | Ms anti-Cx43 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 35-5000 | Ms anti-Cx43 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 35-5000 | Ms anti-Cx43 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 35-8900 | Ms anti-Cx32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 35-8900 | Ms anti-Cx32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 35-8900 | Ms anti-Cx32 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 36-4600 | Rb anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB (Ms) |
| 36-4600 | Rb anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz), Immunogold labeling |
| 36-4600 | Rb anti-Cx36 | Lin B, et al. | J Neurosci | 25(28) | 6696-6701 | 2005 | ICC (Ms retina) |
| 36-4700 | Rb anti-CX47 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:400), WB |
| 36-4700 | Rb anti-CX47 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (Ms, froz) |
| 36-4700 | Rb anti-Cx47 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB |
| 37-4500 | Ms anti-Cx47 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB |
| 37-4600 | Ms anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | IHC (froz, Ms), WB (Ms) |
| 37-4600 | Ms anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz) |
| 51-2800 | Rb anti-Cx26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | IF, WB |
| 51-2800 | Rb anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 51-2800 | Rb anti-CX26 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC, IF |
| 51-2800 | Rb anti-Cx26 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:200), WB |
| 51-2800 | Rb anti-CX26 | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:200) |
| 51-2800 | Rb anti-Cx26 | Teubner B, et al. | Hum Mol Genet | 12 | 13-21 | 2003 | IHC (Ms, froz, 1:100) |
| 51-2800 | Rb anti-Cx26 | Lahlou H, et al. | Mol Cell Biol | 25(10) | 4034-4045 | 2005 | IP, IF (Hu Bx-PC-3) |
| 51-6200 | Rb anti-Cx36 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | Immunogold labeling |
| 51-6200 | Rb anti-Cx36 | Yi H, Massey SC. | PNAS | 102(37) | 13313-13318 | 2005 | ICC (Ms retina, 1:250) |
| 51-6200 | Rb anti-Cx36 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2003 | WB (Ms), IP |
| 51-6300 | Rb anti-Cx36 | Pereda A, et al. | J Neurosci | 23(20) | 7489-7503 | 2003 | Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | J Neurocytol | 33 | 131-152 | 2004 | IHC (Ms, froz), Immunogold labeling |
| 51-6300 | Rb anti-Cx36 | Maxeiner S, et al. | J Neurosci | 25(3) | 566-576 | 2005 | IHC (Ms retina, PFA-fixed, 1:500) |
| 51-6300 | Rb anti-Cx36 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 71-0500 | Rb anti-Cx26 | Ciray HN, et al. | Am J Obstet Gynecol | 182 | 926-930 | 2000 | IF |
| 71-0500 | Rb anti-CX26 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 280 | 191-202 | 2001 | WB |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | WB, IF |
| 71-0500 | Rb anti-CX26 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 71-0500 | Rb anti-CX26 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF |
| 71-0500 | Rb anti-Cx26 | Qin H, et al. | J Biol Chem | 277(32) | 29132-29138 | 2002 | ICC |
| 71-0500 | Rb anti-Cx26 | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | ICC (Ms) |
| 71-0500 | Rb anti-Cx26 | Dufresne J, et al. | Am J Physiol Cell Physiol | 284 | C33-43 | 2003 | ICC (rat) |
| 71-0500 | Rb anti-CX26 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0500 | Rb anti-Cx26 | Locke D, et al. | Biochemistry | 44(39) | 13027-13042 | 2005 | ICC, WB |
| 71-0500 | Rb anti-Cx26 | Kelsell DP, et al. | Nature | 387 | 80-83 | 1997 | IHC (frozen, Hu) 1:100 |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | Neuroscience | 78(2) | 533-548 | 1997 | WB (1:1000), IHC (frozen) 1:500s |
| 71-0500 | Rb anti-Cx26 | Bittman KS, et al | Cerebral Cortex | 9 | 188-195 | 1999 | IF |
| 71-0500 | Rb anti-Cx26 | Nagy JI, et al. | Neuroscience | 88(2) | 447-468 | 1999 | WB |
| 71-0500 | Rb anti-Cx26 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0500 | Rb anti-Cx26 | Yazulla S, Studholme KM. | J Neurocytology | 30 | 551-592 | 2001 | ICC (Zebrafish 1:100) |
| 71-0600 | Rb anti-CX32 | Das Sarma J, et al. | J Cell Sci | 114 | 4013-4024 | 2001 | IF |
| 71-0600 | Rb anti-CX32 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 71-0600 | Rb anti-CX32 | Solomon IC, et al. | Respiration Path | 129 | 101-121 | 2001 | IHC |
| 71-0600 | Rb anti-CX32 | Solomon IC, et al. | J Comp Neurol | 440 | 19-Dec | 2001 | IHC IF |
| 71-0600 | Rb anti-CX32 | Das Sarma J, et al. | J Biol Chem | 277(23) | 20911-20918 | 2002 | IF |
| 71-0600 | Rb anti-CX32 | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | ICC |
| 71-0600 | Rb anti-Cx32 | Walcott B, et al. | Am J Physiol Cell Physiol | 282 | C501-507 | 2002 | ICC (Ms) |
| 71-0600 | Rb anti-Cx32 | Dufresne J, et al. | Am J Physiol Cell Physiol | 284 | C33-43 | 2003 | ICC (rat) |
| 71-0600 | Rb anti-CX32 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0600 | Rb anti-CX32 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 71-0600 | Rb anti-CX32 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-0600 | Rb anti-CX32 | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:200) |
| 71-0600 | Rb anti-Cx32 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (froz, Ms) |
| 71-0600 | Rb anti-Cx32 | Huang Y, et al. | J Neurosci | 25(31) | 7111-7120 | 2005 | WB |
| 71-0600 | Rb anti-Cx32 | Scherer SS, et al. | J Neurosci | 25(6) | 1550-1559 | 2005 | WB, IHC (Ms nerves, froz, 1:200) |
| 71-0600 | Rb anti-CX32 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0600 | Rb anti-CX32 | Rash JE, et al. | PNAS | 97(13) | 7573-7578 | 2000 | WB |
| 71-0700 | Rb anti-CX43 | Beardslee MA, et al. | Circ Res | 83 | 629-635 | 1998 | IF |
| 71-0700 | Rb anti-CX43 | Li WEI, et al. | Eur J Neurosci | 10 | 2444-2463 | 1998 | WB, IHC |
| 71-0700 | Rb anti-CX43 | Stregiopoulos K, et al. | Circ Res | 84 | 1144-1155 | 1999 | IP |
| 71-0700 | Rb anti-CX43 | Beardslee MA, et al. | Circ Res | 87 | 656-662 | 2000 | WB IF |
| 71-0700 | Rb anti-CX43 | Li WEI, et al. | Neuroscience | 97(1) | 113-123 | 2000 | WB, IHC |
| 71-0700 | Rb anti-CX43 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-0700 | Rb anti-Cx43 | Quist AP, et al. | J Cell Biol | 148(5) | 1063-1074 | 2000 | IF |
| 71-0700 | Rb anti-CX43 | Thomas SP, et al. | Circ Res | 87 | 467-473 | 2000 | IF |
| 71-0700 | Rb anti-Cx43 | Umhauer S, et al. | Am J Obstet Gynecol | 182 | 999-1000 | 2000 | IHC (froz, 1:800) |
| 71-0700 | Rb anti-CX43 | Bruzzone S, et al. | J Biol Chem | 276(51) | 48300-48308 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | De Pina-Benabou MH, et al. | J Neurosci | 21(17) | 6635-6643 | 2001 | ICC - Ms spinal cord |
| 71-0700 | Rb anti-CX43 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 280 | 191-202 | 2001 | WB IF |
| 71-0700 | Rb anti-CX43 | Oguro K, et al. | J Neurosci | 21(19) | 7534-7542 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | Papadaki M, et al. | Am J Phsiol Heart Circ Phys iol | 280 | 168-178 | 2001 | WB |
| 71-0700 | Rb anti-CX43 | Anderson SC, et al. | Invest Ophthalmol Vis Sci | 43 | 978-986 | 2002 | IHC (Rb cornea, PFA, 1:100) |
| 71-0700 | Rb anti-CX43 | El-Sabban ME, et al. | Blood | 99 | 3383-3389 | 2002 | WB |
| 71-0700 | Rb anti-CX43 | Grueterich M, et al. | Invest Ophthalmol Vis Sci | 43 | 63-71 | 2002 | IHC (froz, 1:200) |
| 71-0700 | Rb anti-CX43 | Li H, et al. | Am J Physiol Heart Circ Phy siol | 282 | H2124-2133 | 2002 | WB (1:1000), ICC (1:200) |
| 71-0700 | Rb anti-Cx43 | Pierce BT, et al. | Am J Obstet Gynecol | 186 | 504-511 | 2002 | IHC (Hu, Rt; froz; 1:200) |
| 71-0700 | Rb anti-CX43 | Plotkin LI, et al. | J Biol Chem | 277(10) | 8648-8657 | 2002 | WB, IP |
| 71-0700 | Rb anti-CX43 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 71-0700 | Rb anti-CX43 | Schwanke U, et al. | Am J Physiol Heart Circ Phy siol | 283 | H1740-1742 | 2002 | WB (Ms) |
| 71-0700 | Rb anti-CX43 | Abdelmohsen K, et al. | J Biol Chem | 278(40) | 38360-38367 | 2003 | WB |
| 71-0700 | Rb anti-CX43 | Carystinos GD, et al. | Mol Pharm | 63 | 821-831 | 2003 | WB |
| 71-0700 | Rb anti-CX43 | Caton D, et al. | J Cell Sci | 116 | 2285-2294 | 2003 | IF (Rt, 1:500) |
| 71-0700 | Rb anti-CX43 | El-Sabban ME, et al. | J Cell Sci | 116 | 3531-3541 | 2003 | WB, ICC (Ms) |
| 71-0700 | Rb anti-CX43 | Guo Y, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1213-1221 | 2003 | ICC (Rt), WB, IP |
| 71-0700 | Rb anti-CX43 | Lee T-M, Chou T-F. | Am J Physiol Heart Circ Phy siol | 285 | H1650-1659 | 2003 | WB (Dog) |
| 71-0700 | Rb anti-CX43 | Luo Y, Radice GL. | J Cell Sci | 116 | 1471-1479 | 2003 | ICC (Ms, PFA-fixed, 1:100) |
| 71-0700 | Rb anti-Cx43 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | WB |
| 71-0700 | Rb anti-Cx43 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-0700 | Rb anti-CX43 | Nihei OK, et al. | Am J Physiol Cell Physiol | 285 | C1304-1313 | 2003 | IF (Ms) |
| 71-0700 | Rb anti-CX43 | Provost N, et al. | Am J Physiol Cell Physiol | 284 | C51-59 | 2003 | ICC (1:100), WB |
| 71-0700 | Rb anti-CX43 | Scheffler B, et al. | Development | 130 | 5533-5541 | 2003 | ICC (Ms brain, pFA-fixed, 1:300) |
| 71-0700 | Ms anti-CX43 | Simard M, et al. | J Neurosci | 23(27) | 9254-9262 | 2003 | IHC (Rt, 1:500) |
| 71-0700 | Rb anti-CX43 | Thomas MA, et al. | J Cell Sci | 116 | 2213-2222 | 2003 | IP, WB |
| 71-0700 | Rb anti-CX43 | Ye Z-C, et al. | J Neurosci | 23(9) | 3588-3596 | 2003 | ICC (Rt neurons, 1ug/mL) |
| 71-0700 | Rb anti-CX43 | Bao X, et al. | J Biol Chem | 279(19) | 20058-20066 | 2004 | WB |
| 71-0700 | Rb anti-CX43 | Bao X, et al. | Am J Physiol Cell Physiol | 286 | C647-654 | 2004 | WB |
| 71-0700 | Rb anti-CX43 | Forster C, et al. | PNAS | 101(39) | 14234-14239 | 2004 | IF (Ms, paraffin, 1:100) |
| 71-0700 | Rb anti-CX43 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | WB (Ms), IHC (froz, Ms) |
| 71-0700 | Rb anti-CX43 | Poelzing S, et al. | Am J Physiol Heart Circ Phy siol | 286 | H2001-2009 | 2004 | IF (Dog heart, FFPE, citrate, 1:400) |
| 71-0700 | Rb anti-CX43 | Poelzing S, Rosenbaum DS. | Am J Physiol Heart Circ Phy siol | 286 | H1762-1780 | 2004 | IF (Dog heart, FFPE, citrate, 1:400) |
| 71-0700 | Rb anti-Cx43 | Cho WJ, Daniel EE. | Am J Physiol Gastroint Live r Physiol | 288 | G571-585 | 2005 | Confocal IF (Ms muscle, 1:100) |
| 71-0700 | Rb anti-Cx43 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine), WB |
| 71-0700 | Rb anti-Cx43 | Momose-Sato Y, et al. | J Neurophysiol | 94 | 1606-1622 | 2005 | IHC (Rt, froz, 1:100) |
| 71-0700 | Rb anti-Cx43 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-0700 | Rb anti-Cx43 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB, IF |
| 71-0700 | Rb anti-Cx43 | Betsuyaku T, et al. | Am J Physiol Heart Circ Phy siol | 290 | H163-171 | 2006 | WB (Ms, 1:5,000), IHC (Ms heart, FFPE, 1:500) |
| 71-2200 | Rb anti-CX30 | Nagy JI, et al. | Neuroscience | 88 | 447-468 | 1999 | WB, IHC, IF |
| 71-2200 | Rb anti-CX30 | Nagy JI, et al. | J Comp Neurol | 441 | 302-323 | 2001 | IF (1:100) |
| 71-2200 | Rb anti-CX30 | Rash JE, et al. | J Neurosci | 21 | 1983-2000 | 2001 | WB, Immunogold labeling |
| 71-2200 | Rb anti-Cx30 | Di W-L, et al. | Hum Mol Genet | 11 | 2005-2014 | 2002 | IF (froz, 1:100) |
| 71-2200 | Rb anti-CX30 | Richard G, et al. | Am J Hum Genet | 70 | 1341-1348 | 2002 | IF |
| 71-2200 | Rb anti-CX30 | Aasen T, et al. | Oncogene | 22 | 7969-7980 | 2003 | IF (paraffin) |
| 71-2200 | Rb anti-Cx30 | Nagy JI, et al. | Glia | 44 | 205-218 | 2003 | IF (1:100), WB |
| 71-2200 | Rb anti-Cx30 | Nagy JI, et al. | J Comp Neurol | 464 | 356-370 | 2003 | IF, WB |
| 71-2200 | Rb anti-CX30 | Teubner B, et al. | Hum Mol Genet | 12 | 13-21 | 2003 | WB |
| 71-2200 | Rb anti-CX30 | Theis M, et al. | J Neurosci | 23(3) | 766-776 | 2003 | IF (Ms, 1:500), WB (Ms, 1:250) |
| 71-2200 | Rb anti-CX30 | Maass K, et al. | Mol Cell Biol | 15(10) | 4597-4608 | 2004 | IF (Ms, froz) |
| 71-2200 | Rb anti-CX30 | Thomas T, et al. | J Biol Chem | 279(18) | 19157-19168 | 2004 | ICC |
| 71-2200 | Rb anti-Cx30 | McCulloch F, et al. | Am J Physiol Renal Physiol | 289 | F1304-1312 | 2005 | WB (Rt, 1:250), IF (Rt kidney, 1:50) |
| 71-2200 | Rb anti-Cx30 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | WB (1:1,000), IF |
| Tight Junction Antibody Product References | |||||||
| 32-5600 | Ms anti-Claudin-2 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:4000) |
| 32-5600 | Ms anti-Claudin-2 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9400 | Ms anti-Claudin-4 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 32-9400 | Ms anti-Claudin-4 | Colegio OR, et al. | Am J Physiol Cell Physiol | 283 | C142-147 | 2002 | WB (1:4000) |
| 32-9400 | Ms anti-Claudin-4 | Bonne S, et al. | J Cell Biol | 161(2) | 403-416 | 2003 | IF (1:1000) |
| 32-9400 | Ms anti-Claudin-4 | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:4000), IF |
| 32-9400 | Ms anti-Claudin-4 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9400 | Ms anti-Claudin-4 | Mitic LL, et al. | Protein Sci | 12 | 218-227 | 2003 | WB (1:4000) |
| 32-9400 | Ms anti-Claudin-4 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:250) |
| 32-9400 | Ms anti-Claudin-4 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 32-9400 | Ms anti-Claudin-4 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 32-9400 | Ms anti-Claudin-4 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | WB (Hu) |
| 32-9400 | Ms anti-Claudin-4 | Jones C, et al. | Cancer Res | 64(9) | 3037-3045 | 2004 | IHC (paraffin, 1:100) |
| 32-9400 | Ms anti-Claudin-4 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 32-9400 | Ms anti-Claudin-4 | Lo D, et al. | Int Immunol | 16(1) | 91-99 | 2004 | IHC (froz, Hu, Ms) |
| 32-9400 | Ms anti-Claudin-4 | Matsuda M, et al. | J Cell Sci | 117 | 1247-1257 | 2004 | IF (transfected) |
| 32-9400 | Ms anti-Claudin-4 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 32-9400 | Ms anti-Claudin-4 | Yamauchi K, et al. | PNAS | 101 | 4690-4694 | 2004 | WB |
| 32-9400 | Ms anti-Claudin-4 | Agarwal R, et al. | Cancer Res | 65(16) | 7378-7385 | 2005 | WB (verification of gene knockdown) |
| 32-9400 | Ms anti-Claudin-4 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 32-9400 | Ms anti-Claudin-4 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 32-9400 | Ms anti-Claudin-4 | De Craene B, et al. | Cancer Res | 65(14) | 6237-6244 | 2005 | IF/ICC |
| 32-9400 | Ms anti-Claudin-4 | D'Souza T, et al. | J Biol Chem | 280(28) | 26233-26240 | 2005 | WB (1:250), IP |
| 32-9400 | Ms anti-Claudin-4 | Le Moellic C, et al. | Am J Physiol Cell Physiol | 289 | C1513-1521 | 2005 | IF (1:50), IP (1:40), WB (1:1,000) |
| 32-9400 | Ms anti-Claudin-4 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:200), IF (MDCK, 1:500) |
| 32-9400 | Ms anti-Claudin-4 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:400), IF (1:400), WB |
| 32-9400 | Ms anti-Claudin-4 | Santin AD, et al. | Cancer Res | 65(10) | 4334-4342 | 2005 | IHC (FFPE, Hu ovarian tumors, citrate) |
| 32-9400 | Ms anti-Claudin-4 | Shlyonsky V, et al. | J Biol Chem | 280(25) | 24181-24187 | 2005 | ICC |
| 32-9400 | Ms anti-Claudin-4 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:2,000), WB (DIEC) |
| 32-9400 | Ms anti-Claudin-4 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 32-9800 | Ms anti-Claudin-15 | Colegio OR, et al. | Am J Physiol Cell Physiol | 283 | C142-147 | 2002 | WB (1:2000), IF (1:100) |
| 32-9800 | Ms anti-Claudin-15 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 32-9800 | Ms anti-Claudin-15 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 33-1500 | Ms anti-Occludin | Clarke H, et al. | J Cell Sci | 113 | 3187-3196 | 2000 | IF |
| 33-1500 | Ms anti-Occludin | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IF (1:250), WB |
| 33-1500 | Ms anti-Occludin | Mohammad-Panah, et al. | J Biol Chem | 276(11) | 8306-8313 | 2001 | IF |
| 33-1500 | Ms anti-Occludin | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | IHC, WB |
| 33-1500 | Ms anti-Occludin | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | IF |
| 33-1500 | Ms anti-Occludin | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB |
| 33-1500 | Ms anti-Occludin | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 33-1500 | Ms anti-Occludin | Gudjonsson T, et al. | Genes Dev | 16(6) | 693-706 | 2002 | ICC |
| 33-1500 | Ms anti-Occludin | Lemmers C, et al. | J Biol Chem | 277(28) | 25408-25415 | 2002 | ICC |
| 33-1500 | Ms anti-Occludin | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | WB, IF |
| 33-1500 | Ms anti-Occludin | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | IF |
| 33-1500 | Ms anti-Occludin | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:1500) |
| 33-1500 | Ms anti-Occludin | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 33-1500 | Ms anti-Occludin | Taouil K, et al. | J Biol Chem | 278(19) | 17320-17327 | 2003 | IF |
| 33-1500 | Ms anti-Occludin | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 33-1500 | Ms anti-Occludin | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | IP |
| 33-1500 | Ms anti-Occludin | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 33-1500 | Ms anti-Occludin | Badizadegan K, et al. | Am J Physiol Cell Physiol | 287 | C1453-1462 | 2004 | |
| 33-1500 | Ms anti-Occludin | Banan A, et al. | Am J Physiol Cell Physiol | 287 | C218-234 | 2004 | IF |
| 33-1500 | Ms anti-Occludin | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 33-1500 | Ms anti-Occludin | Lemmers C, et al. | Mol Cell Biol | 15(3) | 1324-1333 | 2004 | IF (1:200) |
| 33-1500 | Ms anti-Occludin | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 33-1500 | Ms anti-Occludin | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | WB (Hu, 1:250) |
| 33-1500 | Ms anti-Occludin | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 33-1500 | Ms anti-Occludin | Smith MS, et al. | J Virol | 78 | 4444-4453 | 2004 | WB (Hu) |
| 33-1500 | Ms anti-Occludin | Basuroy S, et al. | Am J Physiol Gastrointest Li ver Physiol | 289 | G367-375 | 2005 | Confocal IF (Hu) |
| 33-1500 | Ms anti-Occludin | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 33-1500 | Ms anti-Occludin | Mottino AD, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G327-336 | 2005 | IF (1:100) |
| 33-1500 | Ms anti-Occludin | Polette M, et al. | Cancer Res | 65(17) | 7691-7698 | 2005 | IF, WB (MCF-7, BT549 cells) |
| 33-1500 | Ms anti-Occludin | Shifflett DE, et al. | Lab Invest | 85 | 1308-1324 | 2005 | IHC (Ms, froz, 0.5ug/mL), WB |
| 33-1500 | Ms anti-Occludin | Wang G, et al. | PNAS | 102(1) | 186-191 | 2005 | ICC, FC |
| 33-1500 | Ms anti-Occludin | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000), WB (DIEC) |
| 33-1500 | Ms anti-Occludin | Chen X, Macara IG. | J Cell Biol | 172 | 671-678 | 2006 | IF |
| 33-1500 | Ms anti-Occludin | Potempa S, et al. | Mol Biol Cell | 9 | 2185-2200 | 1998 | IF |
| 33-1500 | Ms anti-Occludin | Berglund JJ, et al. | Am J Physiol Gastroint Live r Physiol | 281 | G1487-G149 3 | 2001 | IF |
| 33-1511 | FITC-Ms anti-Occludin | Choe MM, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L427-433 | 2003 | IF |
| 33-1511 | FITC-Ms anti-Occludin | Parkinson SJ, et al. | EMBO J | 23 | 77-88 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Boettner B, et al. | PNAS | 97(16) | 9064-9069 | 2000 | IF |
| 33-9100 | Ms anti-ZO-1 | Cohen CJ, et al. | PNAS | 98(26) | 15191-15196 | 2001 | IF |
| 33-9100 | Ms anti-ZO-1 | Naishiro Y, et al. | Cancer Res | 61 | 2751-2758 | 2001 | WB |
| 33-9100 | Ms anti-ZO-1 | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | WB, IHC |
| 33-9100 | Ms anti-ZO-1 | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | IF |
| 33-9100 | Ms anti-ZO-1 | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Cooper CD, Lampe PD. | J Biol Chem | 277(47) | 44962-44968 | 2002 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Patrie KM, et al. | J Biol Chem | 277(33) | 30183-30190 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Ranaldi G, et al. | Am J Physiol Renal Physiol | 283 | F1365-1375 | 2002 | IF |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Cell Biol | 157(1) | 161-172 | 2002 | ICC (1:2000), IHC (froz, rat) |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Biol Chem | 277(30) | 27501-27509 | 2002 | ICC |
| 33-9100 | Ms anti-ZO-1 | Anders M, et al. | Cancer Res | 63 | 2088-2095 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:1500) |
| 33-9100 | Ms anti-ZO-1 | Gentzsch M, et al. | J Biol Chem | 278(8) | 6440-6449 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Gutstein DE, et al. | J Cell Sci | 116 | 875-885 | 2003 | WB, IF (Ms heart, froz) |
| 33-9100 | Ms anti-ZO-1 | Hirabayashi S, et al. | Mol Cell Biol | 23 | 4267-4282 | 2003 | IF (Rt) |
| 33-9100 | Ms anti-ZO-1 | Hurd TW, et al. | Nature Cell Biol | 5 | 137-142 | 2003 | |
| 33-9100 | Ms anti-ZO-1 | Kominsky SL, et al. | Oncogene | 22 | 2021-2033 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Lu Z, et al, | Cancer Cell | 4(6) | 499-515 | 2003 | |
| 33-9100 | Ms anti-ZO-1 | Narayan S, et al. | Invest Ophthalmol Vis Sci | 44 | 4885-4894 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Neunlist M, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1028-1036 | 2003 | IF (Hu, 1:500), WB (1:1,000) |
| 33-9100 | Ms anti-ZO-1 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 33-9100 | Ms anti-ZO-1 | Roh MH, et al. | J Cell Sci | 116 | 2895-2906 | 2003 | ICC |
| 33-9100 | Ms anti-ZO-1 | Silvis MR, et al. | J Biol Chem | 278(13) | 11554-11560 | 2003 | IF |
| 33-9100 | Ms anti-ZO-1 | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 33-9100 | Ms anti-ZO-1 | Young P, et al. | EMBO J | 22 | 5723-5733 | 2003 | IHC (Ms, PFA_fixed, paraffin) |
| 33-9100 | Ms anti-ZO-1 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Badizadegan K, et al. | Am J Physiol Cell Physiol | 287 | C1453-1462 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Clayburgh DR, et al. | J Biol Chem | 279(53) | 55506-55513 | 2004 | IF (Hu, 2.5 ug/mL) |
| 33-9100 | Ms anti-ZO-1 | Coyne CB, et al. | J Biol Chem | 279(46) | 48079-48084 | 2004 | WB, IF |
| 33-9100 | Ms anti-ZO-1 | Estienne V, et al. | Am J Physiol Cell Physiol | 287 | C1763-1768 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 33-9100 | Ms anti-ZO-1 | Kizhatil K, Bennett V. | J Biol Chem | 279(16) | 16706-16714 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | IF (Ms kidney, froz, 1:100) |
| 33-9100 | Ms anti-ZO-1 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | IP (Ms) |
| 33-9100 | Ms anti-ZO-1 | Liu X-F, et al. | Mol Cell Biol | 24(15) | 6665-6675 | 2004 | IF (Dog, 1:500) |
| 33-9100 | Ms anti-ZO-1 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Mohler PJ, et al. | PNAS | 101(50) | 17533-17538 | 2004 | IF (Rt) |
| 33-9100 | Ms anti-ZO-1 | Parker LH, et al. | Nature | 428 | 754-758 | 2004 | IF |
| 33-9100 | Ms anti-ZO-1 | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | |
| 33-9100 | Ms anti-ZO-1 | Smith MS, et al. | J Virol | 78 | 4444-4453 | 2004 | WB (Hu) |
| 33-9100 | Ms anti-ZO-1 | Bagnoli F, et al. | PNAS | 102(45) | 16339-16344 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Bratt A, et al. | J Biol Chem | 280(41) | 34859-34869 | 2005 | IF (Bv, Ms) |
| 33-9100 | Ms anti-ZO-1 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 33-9100 | Ms anti-ZO-1 | Caruso-Neves C, et al. | PNAS | 102(48) | 17513-17518 | 2005 | IF (pig LLC-PK1 cells) |
| 33-9100 | Ms anti-ZO-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 33-9100 | Ms anti-ZO-1 | Furuya M, et al. | Cancer Res | 65(7) | 2617-2625 | 2005 | IF (Hu HTOA cells) |
| 33-9100 | Ms anti-ZO-1 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine) |
| 33-9100 | Ms anti-ZO-1 | Guerra L, et al. | J Biol Chem | 280(49) | 40925-40933 | 2005 | Confocal IF |
| 33-9100 | Ms anti-ZO-1 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:500), IF (MDCK, 1:100) |
| 33-9100 | Ms anti-ZO-1 | Lopez C, et al. | J Biol Chem | 280(9) | 8221-8228 | 2005 | IF (4ug/mL, MDCK) |
| 33-9100 | Ms anti-ZO-1 | Mandell KJ, et al. | J Biol Chem | 280 | 11665-11674 | 2005 | WB |
| 33-9100 | Ms anti-ZO-1 | Masuda M, et al. | J Biol Chem | 280(51) | 42164-42171 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Navarro C, et al. | Oncogene | 24 | 4330-4339 | 2005 | IF, confocal imaging (MDCK) |
| 33-9100 | Ms anti-ZO-1 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IP, IF, WB |
| 33-9100 | Ms anti-ZO-1 | Polette M, et al. | Cancer Res | 65(17) | 7691-7698 | 2005 | IF, confocal (MCF-7, BT549 cells), WB, IHC (FFPE invasive breast ductal carcinoma) |
| 33-9100 | Ms anti-ZO-1 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IF (1:250) |
| 33-9100 | Ms anti-ZO-1 | Shin K, et al. | J Cell Biol | 168(5) | 705-711 | 2005 | IF (MDCKII) |
| 33-9100 | Ms anti-ZO-1 | Wang Y, et al. | Am J Physiol Renal Physiol | 289 | F850-862 | 2005 | IF (pig LLC-PK1 cells) |
| 33-9100 | Ms anti-ZO-1 | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | ICC |
| 33-9100 | Ms anti-ZO-1 | Wittchen ES, et al. | J Biol Chem | 280(12) | 11675-11682 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Yoshii T, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G564-570 | 2005 | IF |
| 33-9100 | Ms anti-ZO-1 | Harita Y, et al. | Am J Physiol Renal Physiol | 290 | F335-344 | 2006 | IF (Rt kidney, froz) |
| 33-9111 | Ms anti-ZO-1-FITC | Cummins CL, et al. | Pharm Res | 18(8) | 1102-1109 | 2001 | IF |
| 33-9111 | Ms anti-ZO-1-FITC | Wong C-H, et al. | J Cell Sci | 117 | 783-798 | 2004 | IF (Rt testes, froz. 1:100) |
| 33-9111 | Ms anti-ZO-1-FITC | Bandyopadhyay BC, et al. | J Biol Chem | 280(13) | 12908-12916 | 2005 | IF (MDCK, 1:100) |
| 34-1600 | Rb anti-Claudin-5 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 34-1600 | Rb anti-Claudin-5 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 34-1600 | Rb anti-Claudin-5 | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | IHC (Ms, froz) |
| 34-1600 | Rb anti-Claudin-5 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 34-1600 | Rb anti-Claudin-5 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 34-1600 | Rb anti-Claudin-5 | Rahner C, et al. | J Cell Sci | 117 | 3307-3318 | 2004 | IF (Ck retina) |
| 34-1600 | Rb anti-Claudin-5 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 34-1600 | Rb anti-Claudin-5 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | If (dog intestine, 1:2,000) |
| 34-1600 | Rb anti-Claudin-5 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 20 ug/mL) |
| 34-1700 | Rb anti-Claudin-3 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 34-1700 | Rb anti-Claudin-3 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 34-1700 | Rb anti-Claudin-3 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Ikenouchi J, et al. | J Cell Sci | 116 | 1959-1967 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:200) |
| 34-1700 | Rb anti-Claudin-3 | Witt KA, et al. | Am J Physiol Heart Circ Phy siol | 285 | H2820-2831 | 2003 | WB (Rt) |
| 34-1700 | Rb anti-Claudin-3 | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 34-1700 | Rb anti-Claudin-3 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 34-1700 | Rb anti-Claudin-3 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 34-1700 | Rb anti-Claudin-3 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 34-1700 | Rb anti-Claudin-3 | Matsuda M, et al. | J Cell Sci | 117 | 1247-1257 | 2004 | IF (transfected) |
| 34-1700 | Rb anti-Claudin-3 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 34-1700 | Rb anti-Claudin-3 | Yamauchi K, et al. | PNAS | 101 | 4690-4694 | 2004 | WB |
| 34-1700 | Rb anti-Claudin-3 | Agarwal R, et al. | Cancer Res | 65(16) | 7378-7385 | 2005 | WB (verification of gene knockdown) |
| 34-1700 | Rb anti-Claudin-3 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 34-1700 | Rb anti-Claudin-3 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 34-1700 | Rb anti-Claudin-3 | D'Souza T, et al. | J Biol Chem | 280(28) | 26233-26240 | 2005 | WB (1:200), IHC (Hu ovary, ovarian cancer), IF (1:100) |
| 34-1700 | Rb anti-Claudin-3 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | WB, IF (MDCK, 1:500) |
| 34-1700 | Rb anti-Claudin-3 | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin), WB |
| 34-1700 | Rb anti-Claudin-3 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:50), IF (1:200), WB |
| 34-1700 | Rb anti-Claudin-3 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000), WB (DIEC) |
| 34-1700 | Rb anti-Claudin-3 | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 34-1700 | Rb anti-Claudin-3 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 5 ug/mL) |
| 34-5400 | Rb anti-Claudin-16 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB |
| 34-9100 | Rb anti-Claudin-7 | Kominsky SL, et al. | Oncogene | 22(13) | 2021-2033 | 2003 | IHC, IF |
| 34-9100 | Rb anti-Claudin-7 | Li WY, et al. | Am J Physiol Renal Physiol | 286 | F1063-1071 | 2004 | WB (1:1,000), IF (Ms kidney, froz, 1:5,000) |
| 34-9100 | Rb anti-Claudin-7 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 34-9100 | Rb anti-Claudin-7 | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | IF (MDCK, 1:500) |
| 34-9100 | Rb anti-Claudin-7 | Yu ASL, et al. | Am J Physiol Cell Physiol | 299 | C1231-1241 | 2005 | WB |
| 35-2500 | Ms anti-Claudin-5 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF |
| 35-2500 | Ms anti-Claudin-5 | Rahner C, et al. | J Cell Sci | 117 | 3307-3318 | 2004 | IF (Ck retina) |
| 35-2500 | Ms anti-Claudin-5 | Weng X-H, et al. | Am J Physiol Gastrointest Li ver Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 35-2500 | Ms anti-Claudin-5 | Musch MW, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G222-231 | 2006 | Confocal IF (Caco-2), WB |
| 36-1700 | Rb anti-JAM-A | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu), WB |
| 36-1700 | Rb anti-JAM-A | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 36-1700 | Rb anti-JAM-A | Mandell KJ, et al. | J Biol Chem | 280 | 11665-11674 | 2005 | WB, IF |
| 36-1700 | Rb anti-JAM-A | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 36-1700 | Rb anti-JAM-A | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 36-4000 | Rb anti-ZO-3 | Li X, et al. | Neuroscience | 126 | 611-630 | 2004 | |
| 36-4500 | Rb anti-Claudin-11/OSP | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 36-4500 | Rb anti-Claudin-11/OSP | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin) |
| 36-4800 | Rb anti-Claudin-4 | Van Itallie C, et al | J Clin Invest | 107(10) | 1319-27 | 2001 | IF (1:100) human |
| 36-4800 | Rb anti-Claudin-4 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt) |
| 37-4900 | Ms anti-Claudin-1 | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 38-8000 | Rb anti-Claudin-18 (Ms) | Gon Y, et al. | PNAS | 102(26) | 9270-9275 | 2005 | IHC (Ms lung, PFA-fixed, froz) |
| 40-2200 | Rb anti-ZO-1 (Mid) | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF |
| 40-2300 | Rb anti-ZO-1 (N-term) | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF |
| 40-2800 | Rb anti-ZONAB | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF, WB |
| 51-6100 | Rb anti-Claudin-2 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 51-6100 | Rb anti-Claudin-2 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 51-6100 | Rb anti-Claudin-2 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 51-6100 | Rb anti-Claudin-2 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF (Ms sciatic nerve) |
| 51-6100 | Rb anti-Claudin-2 | Sakaguchi T, et al. | J Biol Chem | 277(24) | 21361-21370 | 2002 | IF, IHC (Ms, frozen) |
| 51-6100 | Rb anti-Claudin-2 | Turksen K, Troy T-C. | Development | 129 | 1775-1784 | 2002 | IHC (Ms skin, paraffin, 1:100) |
| 51-6100 | Rb anti-Claudin-2 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | |
| 51-6100 | Rb anti-Claudin-2 | Kansagra K, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1162-1170 | 2003 | WB (Pig, 1:500) |
| 51-6100 | Rb anti-Claudin-2 | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 51-6100 | Rb anti-Claudin-2 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | IF, WB |
| 51-6100 | Rb anti-Claudin-2 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 51-6100 | Rb anti-Claudin-2 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 51-6100 | Rb anti-Claudin-2 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | |
| 51-6100 | Rb anti-Claudin-2 | Balkovetz DF, et al. | Am J Physiol Renal Physiol | 286 | F702-710 | 2004 | WB (MDCK II, 1:250) |
| 51-6100 | Rb anti-Claudin-2 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 51-6100 | Rb anti-Claudin-2 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Hu) |
| 51-6100 | Rb anti-Claudin-2 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 51-6100 | Rb anti-Claudin-2 | Luton F, et al. | Mol Cell Biol | 15(3) | 1134-1145 | 2004 | WB |
| 51-6100 | Rb anti-Claudin-2 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 51-6100 | Rb anti-Claudin-2 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 51-6100 | Rb anti-Claudin-2 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 51-6100 | Rb anti-Claudin-2 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (0.5 ug/mL) |
| 51-6100 | Rb anti-Claudin-2 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 51-6100 | Rb anti-Claudin-2 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | IF (MDCK, 1:500), WB (1:250) |
| 51-6100 | Rb anti-Claudin-2 | Prasad S, et al. | Lab Invest | 85 | 1139-1162 | 2005 | IHC (Hu, 1:40), IF (1:150), WB |
| 51-6100 | Rb anti-Claudin-2 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 51-6100 | Rb anti-Claudin-2 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 51-6100 | Rb anti-Claudin-2 | Jacquillet G, et al. | Am J Physiol Renal Physiol | 290 | F127-137 | 2006 | IF (froz Rt kidney, 1ug/mL) |
| 51-9000 | Rb anti-Claudin-1 | McCarthy KM, et al. | J Cell Sci | 113 | 3387-3398 | 2000 | WB IF |
| 51-9000 | Rb anti-Claudin-1 | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 51-9000 | Rb anti-Claudin-1 | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 51-9000 | Rb anti-Claudin-1 | Kawabe H et al. | J Biol Chem | 276(51) | 48350-48355 | 2001 | IF |
| 51-9000 | Rb anti-Claudin-1 | Kucharzik T, et al. | Am J Pathol | 159(6) | 2001-2009 | 2001 | IF, WB, IHC (FFPE) ventana ES |
| 51-9000 | Rb anti-Claudin-1 | Miyamori H, et al. | J Biol Chem | 276(30) | 28204-28211 | 2001 | IP, IF |
| 51-9000 | Rb anti-Claudin-1 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC (Paraform fix), Blot Hybridization |
| 51-9000 | Rb anti-Claudin-1 | Notterpek L, et al. | PNAS | 98(25) | 14404-14409 | 2001 | IHC |
| 51-9000 | Rb anti-Claudin-1 | Amasheh S, et al. | J Cell Sci | 115 | 4969-4976 | 2002 | IF |
| 51-9000 | Rb anti-Claudin-1 | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 51-9000 | Rb anti-Claudin-1 | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | |
| 51-9000 | Rb anti-Claudin-1 | Jin M, et al. | Invest Ophthalmol Vis Sci | 43 | 2782-2790 | 2002 | IF |
| 51-9000 | Rb anti-Claudin-1 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF (Ms sciatic nerve) |
| 51-9000 | Rb anti-Claudin-1 | Traweger A et al. | J Biol Chem | 277(12) | 10201-10208 | 2002 | IF WB |
| 51-9000 | Rb anti-Claudin-1 | Colegio OR, et al. | Am J Physiol Cell Physiol | 284 | C1346-1354 | 2003 | WB (1:3000) |
| 51-9000 | Rb anti-Claudin-1 | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 51-9000 | Rb anti-Claudin-1 | Coyne CB, et al. | Am J Physiol Lung Cell Mol Physiol | 285 | L1166-1178 | 2003 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Kansagra K, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1162-1170 | 2003 | WB (Pig, 1:250) |
| 51-9000 | Rb anti-Claudin-1 | Lee S-W, et al. | Nature Medicine | 9(7) | 900-906 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | IHC (froz, Ms) |
| 51-9000 | Rb anti-Claudin-1 | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 51-9000 | Rb anti-Claudin-1 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 51-9000 | Rb anti-Claudin-1 | Rangel LBA, et al. | Clin Cancer Res | 9 | 2567-2575 | 2003 | WB (1:200) |
| 51-9000 | Rb anti-Claudin-1 | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | IF |
| 51-9000 | Rb anti-Claudin-1 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 51-9000 | Rb anti-Claudin-1 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | WB |
| 51-9000 | Rb anti-Claudin-1 | Yu ASL, et al. | J Biol Chem | 278(19) | 17350-17359 | 2003 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Dog, Hu) |
| 51-9000 | Rb anti-Claudin-1 | Epple HJ, et al. | Infect Immun | 72 | 4848-4858 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:50) |
| 51-9000 | Rb anti-Claudin-1 | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu) |
| 51-9000 | Rb anti-Claudin-1 | Kahle KT, et al. | PNAS | 101(41) | 14877-14882 | 2004 | IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | McLaughlin J, et al. | Am J Physiol Cell Physiol | 287 | C1412-1417 | 2004 | |
| 51-9000 | Rb anti-Claudin-1 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB, IF |
| 51-9000 | Rb anti-Claudin-1 | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 51-9000 | Rb anti-Claudin-1 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 51-9000 | Rb anti-Claudin-1 | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 51-9000 | Rb anti-Claudin-1 | Carrozzino F, et al. | Am J Physiol Cell Physiol | 289 | C1002-1014 | 2005 | WB (1ug/mL) |
| 51-9000 | Rb anti-Claudin-1 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 51-9000 | Rb anti-Claudin-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 51-9000 | Rb anti-Claudin-1 | Graham C, Simmons NL. | Am J Physiol Regul Integr C omp Physiol | 288 | R173-181 | 2005 | IF (bovine), WB |
| 51-9000 | Rb anti-Claudin-1 | Leyvraz C, et al. | J Cell Biol | 170(3) | 487-496 | 2005 | IF (Ms skin) |
| 51-9000 | Rb anti-Claudin-1 | Lipschutz J, et al. | J Biol Chem | 280(5) | 3780-3788 | 2005 | WB (1:250) |
| 51-9000 | Rb anti-Claudin-1 | Meder D, et al. | J Cell Biol | 168(2) | 303-313 | 2005 | IF |
| 51-9000 | Rb anti-Claudin-1 | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 51-9000 | Rb anti-Claudin-1 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 51-9000 | Rb anti-Claudin-1 | Weng X-H, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G705-717 | 2005 | IF (dog intestine, 1:1,000) |
| 51-9000 | Rb anti-Claudin-1 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 51-9000 | Rb anti-Claudin-1 | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 51-9000 | Rb anti-Claudin-1 | Musch MW, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G222-231 | 2006 | Confocal IF (Caco-2), WB |
| 51-9000 | Rb anti-Claudin-1 | Vermeer PD, et al. | J Biol Chem | 281(3) | 1725-1730 | 2006 | IP (1:500), WB (1:500), ICC (1:100) |
| 61-7300 | Rb anti-ZO-1 | Antonetti DA, et al. | J Biol Chem | 274(33) | 23463-23467 | 1999 | IP |
| 61-7300 | Rb anti-ZO-1 | Mann B, et al. | PNAS | 96 | 1603-1608 | 1999 | WB |
| 61-7300 | Rb anti-ZO-1 | Quinlan MP, Hyatt JL. | Cell Growth Differ | 10(12) | 839-854 | 1999 | IF |
| 61-7300 | Rb anti-ZO-1 | Woo PL, et al. | J Biol Chem | 274(46) | 32818-32828 | 1999 | IF, ICC |
| 61-7300 | Rb anti-ZO-1 | Bazzoni G, et al. | J Biol Chem | 275(27) | 20520-20526 | 2000 | WB, IHC |
| 61-7300 | Rb anti-ZO-1 | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB |
| 61-7300 | Rb anti-ZO-1 | Dickman KG, et al. | Am J Physiol Gastrointestin al Liver Physiol | 279 | 757-766 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 61-7300 | Rb anti-ZO-1 | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IF (1:250), WB |
| 61-7300 | Rb anti-ZO-1 | Li D, Mrsny RJ. | J Cell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Liang TW, et al. | Am J Physiol Cell Physiol | 279 | 1733-1743 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 61-7300 | Rb anti-ZO-1 | Ng KH, et al. | J Cell Sci | 113 | 4241-4251 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 61-7300 | Rb anti-ZO-1 | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Singh U, et al. | J Biol Chem | 275(24) | 18407-18417 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 61-7300 | Rb anti-ZO-1 | Yañez-Mo M, et al | J Cell Sci | 114 | 577-587 | 2000 | IF |
| 61-7300 | Rb anti-ZO-1 | Chen MC, et al. | Am J Physiol Gastrointestin al Liver Physiol | 280 | 264-272 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Cohen CJ, et al. | PNAS | 98(26) | 15191-15196 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Davidson G, et al. | J Cell Sci | 114 | 3359-3366 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Hirata, K et al | J Biol Chem | 276(19) | 16223-16231 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 61-7300 | Rb anti-ZO-1 | Janssens B, et al. | J Cell Sci | 114 | 3177-3188 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Laing, J.G. et al | J Biol Chem | 276(25) | 23051-23055 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Lund RD, et al. | PNAS | 98(17) | 9942-9947 | 2001 | ICC |
| 61-7300 | Rb anti-ZO-1 | Martinez-Estradam O, et al. | J Biol Chem | 276(12) | 9291-9296 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Mauro L, et al. | J Biol Chem | 276(43) | 39892-39897 | 2001 | WB, IP |
| 61-7300 | Rb anti-ZO-1 | Naishiro Y, et al. | Cancer Res | 61 | 2751-2758 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 61-7300 | Rb anti-ZO-1 | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Simons M, et al. | Am J Pathol | 159(3) | 1069-1077 | 2001 | WB |
| 61-7300 | Rb anti-ZO-1 | Straight SW, et al. | Mol Biol Cell | 12 | 1329-1340 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | van der Goes A, et al. | FASEB J | 15(10) | 1852-1854 | 2001 | IHC |
| 61-7300 | Rb anti-ZO-1 | Wang W, et al. | Am J Physiol Heart Circ Phy siol | 280 | 434-440 | 2001 | WB IF |
| 61-7300 | Rb anti-ZO-1 | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 61-7300 | Rb anti-ZO-1 | Cooper CD, Lampe PD. | J Biol Chem | 277(47) | 44962-44968 | 2002 | WB |
| 61-7300 | Rb anti-ZO-1 | Gelebart P, et al. | J Biol Chem | 277(29) | 26310-26320 | 2002 | ICC |
| 61-7300 | Rb anti-ZO-1 | Glynne PA, et al. | J Biol Chem | 277(36) | 33132-33138 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Govindarajan R, et al. | J Biol Chem | 277(51) | 50087-50097 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Gritli-Linde A, et al. | Development | 129 | 5323-5337 | 2002 | IHC (Ms, PFA, paraffin) |
| 61-7300 | Rb anti-ZO-1 | Hamazaki Y, et al. | J Biol Chem | 277(1) | 455-461 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Janda E, et al. | J Cell Biol | 156(2) | 299-313 | 2002 | ICC (froz) |
| 61-7300 | Rb anti-ZO-1 | Lavelle J, et al. | Am J Physiol Renal Physiol | 283 | F242-253 | 2002 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Li Q, et al. | J Biol Chem | 277(48) | 46447-46455 | 2002 | IHC, WB |
| 61-7300 | Rb anti-ZO-1 | Nasdala I, et al. | J Biol Chem | 277(18) | 16294-16303 | 2002 | IF, Confocal microscopy, Immunogold labeling |
| 61-7300 | Rb anti-ZO-1 | Nielsen PA, et al. | J Biol Chem | 277(41) | 38272-38283 | 2002 | IF, WB |
| 61-7300 | Rb anti-ZO-1 | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF, ICC |
| 61-7300 | Rb anti-ZO-1 | Oliver JA, et al. | Am J Physiol Renal Physiol | 283 | F799-809 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Oneyama C, et al. | Oncogene | 21 | 2037-2050 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Pedram A, et al. | J Biol Chem | 277(46) | 44385-44398 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Poliak S, et al. | J Cell Biol | 159(2) | 361-371 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Ramalingam TS, et al. | EMBO J | 21 | 590-601 | 2002 | IF |
| 61-7300 | Rb anti-ZO-1 | Roh MH, et al. | J Cell Biol | 157(1) | 161-172 | 2002 | ICC (1:500), IHC (froz rat) |
| 61-7300 | Rb anti-ZO-1 | Sahai E, Marshall CJ. | Nature Cell Biol | 4 | 408-415 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Vecsey-Semjen B, et al. | Oncogene | 21 | 4646-4662 | 2002 | |
| 61-7300 | Rb anti-ZO-1 | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | IP |
| 61-7300 | Rb anti-ZO-1 | You Y, et al. | Am J Physiol Lung Cell Mol Physiol | 283 | L1315-1321 | 2002 | IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Anders M, et al. | Cancer Res | 63 | 2088-2095 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | WB, IF, IP |
| 61-7300 | Rb anti-ZO-1 | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:2000) |
| 61-7300 | Rb anti-ZO-1 | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Chin AC, et al. | PNAS | 100(19) | 11104-11109 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Coyne CB, et al. | J Pharmacol Exp Ther | 305(2) | 440-450 | 2003 | IF (1:1000) |
| 61-7300 | Rb anti-ZO-1 | DeBellefeuille S, et al. | Endocrinology | 144(11) | 5040-5049 | 2003 | ICC (Rt), WB (Rt) |
| 61-7300 | Rb anti-ZO-1 | Ebnet K, et al. | J Cell Sci | 116 | 3879-3891 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Gookin JL, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G967-979 | 2003 | IF (Pig, froz, 1:250) |
| 61-7300 | Rb anti-ZO-1 | Gu X, et al. | Invest Ophthalmol Vis Sci | 44(7) | 3219-3225 | 2003 | ICC (Hu, 1:100) |
| 61-7300 | Rb anti-ZO-1 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt), IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Hirabayashi S, et al. | Mol Cell Biol | 23 | 4267-4282 | 2003 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Hopkins AM, et al. | J Cell Sci | 116 | 725-742 | 2003 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Kinnemann SC. | EMBO J | 22(16) | 4143-4154 | 2003 | IF (Rt) |
| 61-7300 | Rb anti-ZO-1 | Ko J, et al. | J Neurosci | 23(5) | 1667-1677 | 2003 | WB (2ug/mL) |
| 61-7300 | Rb anti-ZO-1 | Liu G, et al. | J Clin Invest | 112(2) | 209-221 | 2003 | WB |
| 61-7300 | Rb anti-ZO-1 | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | IHC (froz, Ms) |
| 61-7300 | Rb anti-ZO-1 | Mehalow AK, et al. | Hum Mol Genet | 12(17) | 2179-2189 | 2003 | IHC (4% PFA, paraffin); 1:200 |
| 61-7300 | Rb anti-ZO-1 | Nielsen PA, et al. | Mol Biol Cell | 14 | 2470-2481 | 2003 | IHC (Ms eye, PFA-fixed) |
| 61-7300 | Rb anti-ZO-1 | Ostedgaard LS, et al. | PNAS | 100(4) | 1937-1942 | 2003 | ICC |
| 61-7300 | Rb anti-ZO-1 | Peng S, et al. | Invest Ophthalmol Vis Sci | 44(2) | 808-817 | 2003 | IF (Ck embryo, 1:200) |
| 61-7300 | Rb anti-ZO-1 | Shingai T, et al. | J Biol Chem | 278(37) | 35421-35427 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Tugizov SM, et al. | Nature Medicine | 9(3) | 307-314 | 2003 | IF |
| 61-7300 | Rb anti-ZO-1 | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 61-7300 | Rb anti-ZO-1 | Wadham C, et al. | Mol Biol Cell | 14(6) | 2520-2529 | 2003 | IF (MDCK) |
| 61-7300 | Rb anti-ZO-1 | Walters RW, et al. | Cell | 110 | 789-799 | 2003 | ICC |
| 61-7300 | Rb anti-ZO-1 | Wang S-X, et al. | J Biol Chem | 278(4) | 2713-2722 | 2003 | ICC, IF |
| 61-7300 | Rb anti-ZO-1 | Yang R, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G621-629 | 2003 | IP |
| 61-7300 | Rb anti-ZO-1 | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Alvarado JA, et al. | Am J Physiol Cell Physiol | 286 | C621-663 | 2004 | IHC (Hu cornea, froz, 1:200) |
| 61-7300 | Rb anti-ZO-1 | Bailey TA, et al. | Invest Ophthalmol Vis Sci | 45 | 675-684 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | IF (Dog), WB (Hu) |
| 61-7300 | Rb anti-ZO-1 | Brown KA, et al. | Breast Cancer Res | 6 | R215-231 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Chavakis T, et al. | J Biol Chem | 279(53) | 55602-55608 | 2004 | IF (Hu, 5ug/mL) |
| 61-7300 | Rb anti-ZO-1 | Economou CG, et al. | J Cell Sci | 117 | 3281-3294 | 2004 | Confocal microscopy (HGEC) |
| 61-7300 | Rb anti-ZO-1 | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:500) |
| 61-7300 | Rb anti-ZO-1 | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IP, IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Han X, et al. | Am J Physiol Lung Cell Mol Physiol | 286 | L259-267 | 2004 | IP, IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Ikari A, et al. | J Biol Chem | 279(52) | 54826-54832 | 2004 | IF (MDCK) |
| 61-7300 | Rb anti-ZO-1 | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu) |
| 61-7300 | Rb anti-ZO-1 | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 61-7300 | Rb anti-ZO-1 | Kausalya PJ, et al. | Mol Cell Biol | 15(12) | 5503-5515 | 2004 | IP, IF (Dog) |
| 61-7300 | Rb anti-ZO-1 | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Li X, et al. | Eur J Neurosci | 19 | 2132-2146 | 2004 | WB (Ms, Hu) |
| 61-7300 | Rb anti-ZO-1 | Maass K, et al. | Mol Cell Biol | 15(10) | 4597-4608 | 2004 | IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 61-7300 | Rb anti-ZO-1 | Oliver JA, et al. | J Clin Invest | 114(6) | 795-804 | 2004 | IF (Rt kidney) |
| 61-7300 | Rb anti-ZO-1 | Otte J-M, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 613-626 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Parkinson SJ, et al. | EMBO J | 23 | 77-88 | 2004 | IF |
| 61-7300 | Rb anti-ZO-1 | Reiser J, et al. | J Clin Invest | 113(10) | 1390-1397 | 2004 | IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Roselli S, et al. | Mol Cell Biol | 24(2) | 550-560 | 2004 | IF (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Sajjan U, et al. | Infect Immun | 72 | 4188-4199 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 61-7300 | Rb anti-ZO-1 | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB |
| 61-7300 | Rb anti-ZO-1 | Somasiri A, et al. | Cancer Res | 64(15) | 5068-5073 | 2004 | ICC (1:200) |
| 61-7300 | Rb anti-ZO-1 | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 61-7300 | Rb anti-ZO-1 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IF (Dog, PFA-fixed, 1:300), IP |
| 61-7300 | Rb anti-ZO-1 | Bagnoli F, et al. | PNAS | 102(45) | 16339-16344 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 61-7300 | Rb anti-ZO-1 | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 61-7300 | Rb anti-ZO-1 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB, IF |
| 61-7300 | Rb anti-ZO-1 | Jacob C, et al. | J Biol Chem | 280(36) | 31936-31948 | 2005 | WB, IF (T84 cells) |
| 61-7300 | Rb anti-ZO-1 | Koike C, et al. | J Neurosci | 25(44) | 10290-10298 | 2005 | IHC (Ms eye, frozen) |
| 61-7300 | Rb anti-ZO-1 | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 61-7300 | Rb anti-ZO-1 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Penes MC, et al. | Eur J Neurosci | 22 | 404-418 | 2005 | IF, WB |
| 61-7300 | Rb anti-ZO-1 | Qi A-D, et al. | J Biol Chem | 280(32) | 29169-29175 | 2005 | Confocal microscopy |
| 61-7300 | Rb anti-ZO-1 | Quitsch A, et al. | J Neurosci | 25(2) | 479-487 | 2005 | ICC (MDCKII, 1:750) |
| 61-7300 | Rb anti-ZO-1 | Shifflett DE, et al. | Lab Invest | 85 | 1308-1324 | 2005 | IHC (Ms, froz, 0.5ug/mL), WB |
| 61-7300 | Rb anti-ZO-1 | Singh D, et al. | J Biol Chem | 280(34) | 30416-30421 | 2005 | IP, WB, IF |
| 61-7300 | Rb anti-ZO-1 | Swiatecka-Urban A, et al. | J Biol Chem | 280(44) | 36762-36772 | 2005 | ICC |
| 61-7300 | Rb anti-ZO-1 | Vieira OV, et al. | J Cell Biol | 170(4) | 521-526 | 2005 | IF |
| 61-7300 | Rb anti-ZO-1 | Wang Y, et al. | Am J Physiol Renal Physiol | 289 | F850-862 | 2005 | IF (pig LLC-PK1 cells) |
| 61-7300 | Rb anti-ZO-1 | Wei C-J, et al. | J Biol Chem | 280(20) | 19925-19936 | 2005 | ICC |
| 61-7300 | Rb anti-ZO-1 | Wolff SC, et al. | Am J Physiol Cell Physiol | 288 | C624-632 | 2005 | Confocal IF |
| 61-7300 | Rb anti-ZO-1 | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
| 61-7300 | Rb anti-ZO-1 | Yoshii T, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G564-570 | 2005 | WB |
| 61-7300 | Rb anti-ZO-1 | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 71-1400 | Rb anti-ZO-2 | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 71-1400 | Rb anti-ZO-2 | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-1400 | Rb anti-ZO-2 | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 71-1400 | Rb anti-ZO-2 | Meyer TN, et al. | J Biol Chem | 276(25) | 22048-22055 | 2001 | WB |
| 71-1400 | Rb anti-ZO-2 | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 71-1400 | Rb anti-ZO-2 | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 71-1400 | Rb anti-ZO-2 | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 71-1400 | Rb anti-ZO-2 | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | |
| 71-1400 | Rb anti-ZO-2 | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | IP |
| 71-1400 | Rb anti-ZO-2 | Guo X, et al. | Am J Physiol Cell Physiol | 285 | C1174-1187 | 2003 | WB (Rt), IF (Rt) |
| 71-1400 | Rb anti-ZO-2 | Rafiee P, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G1277-1292 | 2003 | IF (Hu) |
| 71-1400 | Rb anti-ZO-2 | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | WB, IP, IF |
| 71-1400 | Rb anti-ZO-2 | Yoo J, et al. | Am J Physiol Cell Physiol | 285 | C300-309 | 2003 | |
| 71-1400 | Rb anti-ZO-2 | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | WB (Hu) |
| 71-1400 | Rb anti-ZO-2 | Kausalya PJ, et al. | Mol Cell Biol | 15(12) | 5503-5515 | 2004 | IF (Dog) |
| 71-1400 | Rb anti-ZO-2 | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 71-1400 | Rb anti-ZO-2 | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-1400 | Rb anti-ZO-2 | Singh D, et al. | J Biol Chem | 280(34) | 30416-30421 | 2005 | IP, WB, IF |
| 71-1400 | Rb anti-ZO-2 | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 71-1400 | Rb anti-ZO-2 | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | Feb 2005; 10.1152/ajpgi.00407.2004 | |||
| 71-1500 | Rb anti-Occludin | Antonetti DA, et al. | J Biol Chem | 274(33) | 23463-23467 | 1999 | WB |
| 71-1500 | Rb anti-Occludin | Lawlor P, et al. | J Neurosci | 19(21) | 9445-9458 | 1999 | ICC |
| 71-1500 | Rb anti-Occludin | Strazielle N, Ghersi-Egea J-F. | J Neurosci | 19(15) | 6275-6289 | 1999 | ICC |
| 71-1500 | Rb anti-Occludin | Tsukamoto T, et al. | J Biol Chem | 274(35) | 24579-24584 | 1999 | WB, ICC |
| 71-1500 | Rb anti-Occludin | Wittchen ES, et al. | J Biol Chem | 274(49) | 35179-35185 | 1999 | IF |
| 71-1500 | Rb anti-Occludin | Bazzoni, G et al | J Biol Chem | 275(27) | 20520-20526 | 2000 | WB, IHC |
| 71-1500 | Rb anti-Occludin | Charron AJ, et al. | J Cell Biol | 149(1) | 111-124 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB, IF |
| 71-1500 | Rb anti-Occludin | Clarke H, et al. | J Cell Sci | 113 | 3187-3196 | 2000 | WB |
| 71-1500 | Rb anti-Occludin | Dickman KG, et al. | Am J Physiol Gastrointestin al Liver Physiol | 279 | 757-766 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 71-1500 | Rb anti-Occludin | Kevil CG, et al. | Am J Physiol Cell Physiol | 279 | C21-30 | 2000 | IP (1:1000) |
| 71-1500 | Rb anti-Occludin | Li D, Mrsny RJ. | J Bell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 71-1500 | Rb anti-Occludin | Liang TW, et al. | Am J Physiol Cell Physiol | 279 | 1733-1743 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Mattagajasingh SN, et al. | J Biol Chem | 275(39) | 30573-30585 | 2000 | WB, IP, IF |
| 71-1500 | Rb anti-Occludin | McCarthy KM, et al. | J Cell Sci | 113 | 3387-3398 | 2000 | WB IF |
| 71-1500 | Rb anti-Occludin | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-1500 | Rb anti-Occludin | Ryeom SM, et al. | Mol Biol of Cell | 11 | 1687-1696 | 2000 | IF |
| 71-1500 | Rb anti-Occludin | Troxell ML, et al. | J Cell Sci | 113 | 985-996 | 2000 | WB IF |
| 71-1500 | Rb anti-Occludin | Andreeva AY, et al. | J Biol Chem | 276(42) | 38480-38486 | 2001 | IP, IF |
| 71-1500 | Rb anti-Occludin | Hirase T, et al. | J Biol Chem | 276(13) | 10423-10431 | 2001 | IP |
| 71-1500 | Rb anti-Occludin | Huber JD, et al. | Am J Physiol Heart Circ Phy siol | 280 | 1241-1248 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Kucharzik T, et al. | Am J Pathol | 159(6) | 2001-2009 | 2001 | IF, WB |
| 71-1500 | Rb anti-Occludin | Meyer TN, et al | J Biol Chem | 276(25) | 22048-22055 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Nishiyama R, et al. | J Biol Chem | 276(38) | 35571-35580 | 2001 | IHC, Blot Hybridization |
| 71-1500 | Rb anti-Occludin | Palmer HG, et al. | J Cell Biol | 154(2) | 369-387 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Singh U, et al. | J Biol Chem | 276(36) | 33402-33412 | 2001 | WB |
| 71-1500 | Rb anti-Occludin | Wang W, et al. | Am J Physiol Heart Circ Phy siol | 280 | 434-440 | 2001 | WB IF |
| 71-1500 | Rb anti-Occludin | Wojciak-Stothard B, et al. | J Cell Sci | 114 | 1343-1355 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Yeaman C, et al. | J Cell Biol | 155(4) | 593-604 | 2001 | IF |
| 71-1500 | Rb anti-Occludin | Burgel N, et al. | Gastroenterology | 123 | 433-443 | 2002 | WB |
| 71-1500 | Rb anti-Occludin | Chen ML, et al. | J Biol Chem | 277(6) | 4247-4254 | 2002 | IF, WB |
| 71-1500 | Rb anti-Occludin | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF, WB |
| 71-1500 | Rb anti-Occludin | Feltri ML, et al. | J Cell Biol | 156(1) | 199-209 | 2002 | IHC (Ms, PFA-fixed, froz) |
| 71-1500 | Rb anti-Occludin | Forster C, et al. | PNAS | 99(24) | 15578-15583 | 2002 | IHC (frozen, Ms) |
| 71-1500 | Rb anti-Occludin | Nasdala I, et al. | J Biol Chem | 277(18) | 16294-16303 | 2002 | Confocal microscopy, Immunogold labeling |
| 71-1500 | Rb anti-Occludin | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 71-1500 | Rb anti-Occludin | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | WB, IP, IF |
| 71-1500 | Rb anti-Occludin | Traweger A, et al. | J Biol Chem | 277(12) | 10201-10208 | 2002 | IF WB |
| 71-1500 | Rb anti-Occludin | Wang Y, et al. | Am J Obstet Gynecol | 186 | 214-220 | 2002 | IF |
| 71-1500 | Rb anti-Occludin | Ward PD, et al. | J Biol Chem | 277(38) | 35760-35765 | 2002 | WB |
| 71-1500 | Rb anti-Occludin | Barber AJ, Antonetti DA. | Invest Ophthalmol Vis Sci | 44 | 5410-5416 | 2003 | IHC (Rt retina, PFA-fixed) |
| 71-1500 | Rb anti-Occludin | Basuroy S, et al. | J Biol Chem | 278(14) | 11916-11924 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:2000) |
| 71-1500 | Rb anti-Occludin | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 71-1500 | Rb anti-Occludin | Hopkins AM, et al. | J Cell Sci | 116 | 725-742 | 2003 | WB, IF |
| 71-1500 | Rb anti-Occludin | Leung LW, et al. | Am J Physiol Cell Physiol | 284 | C1021-1030 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | McDermott JR, et al. | PNAS | 100(13) | 7761-7766 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | Meyer TN, et al. | Am J Physiol Cell Physiol | 285 | C1281-1293 | 2003 | IP, WB |
| 71-1500 | Rb anti-Occludin | Mizuno K, et al. | J Biol Chem | 278(33) | 31240-31250 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Nunbhakdi-Craig V, et al. | J Virol | 77(5) | 2807-2818 | 2003 | IF, WB, Confocal |
| 71-1500 | Rb anti-Occludin | Peng B-H, et al. | J Biol Chem | 278(49) | 49644-49651 | 2003 | WB, IP |
| 71-1500 | Rb anti-Occludin | Rajasekaran SA, et al. | Am J Physiol Cell Physiol | 284 | C1497-1507 | 2003 | IP |
| 71-1500 | Rb anti-Occludin | Reuss B, et al. | J Neurosci | 23(16) | 6404-6412 | 2003 | IF (Ms), WB (Ms) |
| 71-1500 | Rb anti-Occludin | Rukstalis JM, et al. | J Cell Sci | 116 | 3315-3325 | 2003 | IHC (Ms, 1:100) |
| 71-1500 | Rb anti-Occludin | Tafazoli F, et al. | Infect Immun | 71(2) | 872-881 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Takekuni K, et al. | J Biol Chem | 278(8) | 5497-5500 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Tian Y-C, et al. | Am J Physiol Renal Physiol | 285 | F130-142 | 2003 | ICC (1:100) |
| 71-1500 | Rb anti-Occludin | Traweger A, et al. | J Biol Chem | 278(4) | 2692-2700 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Tugizov SM, et al. | Nature Medicine | 9(3) | 307-314 | 2003 | IF |
| 71-1500 | Rb anti-Occludin | Van Itallie CM, et al. | Am J Physiol Renal Physiol | 285 | F1078-1084 | 2003 | WB |
| 71-1500 | Rb anti-Occludin | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF (mouse) |
| 71-1500 | Rb anti-Occludin | Yang R, et al. | Am J Physiol Gastrointest Li ver Physiol | 285 | G621-629 | 2003 | IP |
| 71-1500 | Rb anti-Occludin | Acharya P, et al. | Am J Physiol Renal Physiol | 287 | F305-318 | 2004 | IF |
| 71-1500 | Rb anti-Occludin | Bailey TA, et al. | Invest Ophthalmol Vis Sci | 45 | 675-684 | 2004 | IF |
| 71-1500 | Rb anti-Occludin | Barmeyer C, et al. | Am J Physiol Gastrointest Li ver Physiol | 286 | G244-252 | 2004 | WB (Ms) |
| 71-1500 | Rb anti-Occludin | Bojarski C, et al. | J Cell Sci | 117 | 2097-2107 | 2004 | IF (Dog), WB |
| 71-1500 | Rb anti-Occludin | Broughman JR, et al. | Am J Physiol Cell Physiol | 287 | C1312-1323 | 2004 | |
| 71-1500 | Rb anti-Occludin | Epple HJ, et al. | Infect Immun | 72 | 4848-4858 | 2004 | |
| 71-1500 | Rb anti-Occludin | Gao L, Macara IG. | J Biol Chem | 279(40) | 41557-41562 | 2004 | IF (1:500) |
| 71-1500 | Rb anti-Occludin | Han X, et al. | Am J Physiol Gastroint Live r Physiol | 286 | 126-136 | 2004 | IP, IF (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Han X, et al. | Am J Physiol Lung Cell Mol Physiol | 286 | L259-267 | 2004 | IP, IF (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Ivanov AI, et al. | Mol Cell Biol | 15(1) | 176-188 | 2004 | IF (Hu), WB |
| 71-1500 | Rb anti-Occludin | Ivanov AI, et al. | Mol Cell Biol | 15(6) | 2639-2651 | 2004 | IF (Hu) |
| 71-1500 | Rb anti-Occludin | Lee DBN, et al. | Am J Physiol Renal Physiol | 287 | F481-491 | 2004 | |
| 71-1500 | Rb anti-Occludin | Luton F, et al. | Mol Cell Biol | 15(3) | 1134-1145 | 2004 | WB |
| 71-1500 | Rb anti-Occludin | Ogawa T, et al. | J Cell Sci | 117 | 2087-2096 | 2004 | WB (Rt, 1:2,000) |
| 71-1500 | Rb anti-Occludin | Seth A, et al. | Am J Physiol Gastroint Live r Physiol | 287 | G510-517 | 2004 | |
| 71-1500 | Rb anti-Occludin | Singh AB, Harris RC. | J Biol Chem | 279(5) | 3543-3552 | 2004 | WB |
| 71-1500 | Rb anti-Occludin | Wang X, et al. | J Cell Sci | 117 | 53-62 | 2004 | IHC (Ms, froz) |
| 71-1500 | Rb anti-Occludin | Yeaman C, et al. | J Cell Sci | 117 | 559-570 | 2004 | IP, WB |
| 71-1500 | Rb anti-Occludin | Brooks TA, et al. | Am J Physiol Heart Circ Phy siol | 289 | H738-743 | 2005 | |
| 71-1500 | Rb anti-Occludin | Chung E, et al. | J Invest Dermatol | 124 | 1134-1140 | 2005 | WB |
| 71-1500 | Rb anti-Occludin | Cross WR, et al. | Am J Physiol Renal Physiol | 289 | F459-468 | 2005 | Confocal |
| 71-1500 | Rb anti-Occludin | Guo X, et al. | Am J Physiol Gastroint Live r Physiol | 288 | G1159-1169 | 2005 | WB, IF |
| 71-1500 | Rb anti-Occludin | Lipschutz J, et al. | J Biol Chem | 280 | 3780-3788 | 2005 | WB (1:1000), IF (MDCK, 1:250) |
| 71-1500 | Rb anti-Occludin | Meng J, et al. | PNAS | 102(46) | 16696-16700 | 2005 | IF (Ms testis, paraffin) |
| 71-1500 | Rb anti-Occludin | Mertens AEE, et al. | J Cell Biol | 170(7) | 1029-1037 | 2005 | WB, IF (Ms) |
| 71-1500 | Rb anti-Occludin | Peitsch WK, et al. | J Invest Dermatol | 125 | 761-774 | 2005 | IF |
| 71-1500 | Rb anti-Occludin | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
| 71-1500 | Rb anti-Occludin | Yu ASL, et al. | Am J Physiol Cell Physiol | 288 | C1231-1241 | 2005 | WB |
| 71-1500 | Rb anti-Occludin | Dokladny K, et al. | Am J Physiol Gastrointest Li ver Physiol | 290 | G204-212 | 2006 | WB, IF (Caco-2) |
| 71-1500 | Rb anti-Occludin | Eugenin EA, et al. | J Neurosci | 26(4) | 1098-1106 | 2006 | Confocal IF (1:800) |
| 71-1500 | Rb anti-Occludin | Vermeer PD, et al. | J Biol Chem | 281(3) | 1725-1730 | 2006 | WB (1:500), ICC (1:100) |
| 71-1500 | Rb anti-Occludin | Sakakibara A, et al. | J Cell Biol | 137(6) | 1393-1401 | 1997 | IP |
| 71-1500 | Rb anti-Occludin | Van Itallie CM, et al | J Cell Sci | 110 | 1113-1121 | 1997 | WB (1:1000) |
| 71-1500 | Rb anti-Occludin | Fanning AS, et al. | J Biol Chem | 275(45) | 29745-29753 | 1998 | IF |
| 71-1500 | Rb anti-Occludin | Jou TS, et al. | J Cell Biology | 142(1) | 101-115 | 1998 | IF, WB |
| 71-1500 | Rb anti-Occludin | Martin-Padura I, et al. | J Cell Biol | 142(1) | 117-127 | 1998 | IF |
| 71-1500 | Rb anti-Occludin | Wu S, et al. | PNAS | 95 | 14979-14848 | 1998 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Chen Y-H, et al. | Mol Biol Cell | 11 | 849-862 | 2000 | IP, WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Hellstrom M, et al. | J Cell Biol | 153(3) | 543-553 | 2000 | IHC (Ms brain) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Li D, Mrsny RJ. | J Cell Biol | 148(4) | 791-800 | 2000 | WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nursat A, et al. | J Biol Chem | 275(38) | 29816-29822 | 2000 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Van Itallie C, et al. | J Clin Invest | 107 | 1319-1327 | 2001 | WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Edens HA, et al. | J Immunol | 169 | 476-486 | 2002 | IF, WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Folpe AL, et al. | Am J Surg Pathol | 26(12) | 1620-26 | 2002 | IHC (FFPE) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Furuse M, et al. | J Cell Biol | 156(6) | 1099-1111 | 2002 | IF (Ms liver, froz), WB |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Gudjonsson T, et al. | Genes Dev | 16(6) | 693-706 | 2002 | ICC |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Kiuchi-Saishin M, et al. | J Am Soc Nephrol | 13 | 875-886 | 2002 | IF (Ms kidney, froz) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nishimura M, et al. | J Biol Chem | 277(7) | 5583-5587 | 2002 | IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nunbhakdi-Craig V, et al. | J Cell Biol | 158(5) | 967-978 | 2002 | IP, WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Sakaguchi T, et al. | J Biol Chem | 277(24) | 21361-21370 | 2002 | IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Turksen K, Troy T-C. | Development | 129 | 1775-1784 | 2002 | IHC (Ms, paraffin, 1:100) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Brown RC, et al. | J Cell Sci | 116 | 693-700 | 2003 | WB (Bv brain, 1:1000) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Bruewer M, et al. | J Immunol | 171 | 6164-6172 | 2003 | WB, IF |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Fukuhara A, et al. | J Biol Chem | 278(51) | 51885-51893 | 2003 | ICC |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Nunbhakdi-Craig V, et al. | J Virol | 77(5) | 2807-2818 | 2003 | IF, WB, Confocal |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Wolburg H, et al. | Acta Neuropathol | 105 | 586-592 | 2003 | IF, WB (mouse) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Young P, et al. | EMBO J | 22 | 5723-5733 | 2003 | IHC (Ms, PFA_fixed, paraffin) |
| 71-7800 | Rb anti-Claudin-1/-3 (MH25) | Xu H, et al. | Invest Ophthalmol Vis Sci | 46 | 2487-2494 | 2005 | confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000) |
 |
